[
  {
    "id": 153950,
    "drug": {
      "current_status": "MARKETED",
      "id": 244,
      "drug_code": 10666,
      "updated_date": "2025-05-15T02:30:50-04:00",
      "company": {
        "id": 94,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 9307,
        "mfr_code": "AZC08",
        "name": "ASTRAZENECA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1004 MIDDLEGATE ROAD, SUITE 5000",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L4Y 1M4",
        "post_office_box": "",
        "contact_information": "Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: medinfo.canada@astrazeneca.com."
      },
      "drug_ingredients": [
        {
          "id": 8251371,
          "ingredient": {
            "id": 198,
            "ingredient_code": 7581,
            "en_name": "BUDESONIDE",
            "fr_name": "Budésonide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "00851752",
      "brand_name": "PULMICORT TURBUHALER",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "70669",
      "number_of_ais": "1",
      "ai_group_no": "0116807001"
    },
    "created_date": "2022-02-01T02:18:54-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00851752",
    "company_name": "ASTRAZENECA CANADA INC",
    "atc_number": "R03BA",
    "atc_description": "OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",
    "anticipated_start_date": "2022-02-04T00:00:00-05:00",
    "estimated_end_date": "2022-02-16T00:00:00-05:00",
    "actual_start_date": "2022-02-04T00:00:00-05:00",
    "actual_end_date": "2022-02-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-02-15T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PULMICORT TURBUHALER",
    "en_drug_common_name": "budesonide",
    "fr_drug_brand_name": "PULMICORT TURBUHALER",
    "fr_drug_common_name": "budésonide",
    "en_ingredients": "BUDESONIDE",
    "fr_ingredients": "Budésonide",
    "drug_strength": "200MCG",
    "drug_dosage_form": "POWDER (METERED DOSE)",
    "drug_dosage_form_fr": "Poudre (à dose mesurée)",
    "drug_route": "INHALATION\r\nINHALATION",
    "drug_route_fr": "Inhalation\r\nInhalation",
    "drug_package_quantity": "200 inhalations",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 153966,
    "drug": {
      "current_status": "MARKETED",
      "id": 22606,
      "drug_code": 85131,
      "updated_date": "2025-05-15T02:32:56-04:00",
      "company": {
        "id": 226,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 8892,
        "mfr_code": "RAX08",
        "name": "STERIMAX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2770 PORTLAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 6R4",
        "post_office_box": "",
        "contact_information": "1-800-881-3550"
      },
      "drug_ingredients": [
        {
          "id": 8258146,
          "ingredient": {
            "id": 3712,
            "ingredient_code": 11311,
            "en_name": "REMIFENTANIL",
            "fr_name": "Rémifentanil (Chlorhydrate de rémifentanil)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02366460",
      "brand_name": "REMIFENTANIL HYDROCHLORIDE FOR INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133098001"
    },
    "created_date": "2022-02-01T18:36:02-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02366460",
    "company_name": "STERIMAX INC",
    "atc_number": "N01AH",
    "atc_description": "ANESTHETICS, GENERAL",
    "actual_start_date": "2022-02-02T00:00:00-05:00",
    "actual_end_date": "2022-10-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-10-02T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Product is now off allocation as of October 1st, 2022.",
    "fr_comments": "Produit est maintenant hors allocation à partir du 1ier octobre.",
    "en_drug_brand_name": "REMIFENTANIL HYDROCHLORIDE FOR INJECTION",
    "en_drug_common_name": "REMIFENTANIL HYDROCHLORIDE FOR INJECTION",
    "fr_drug_brand_name": "CHLORHYDRATEE DE RÉMIFENTANIL POUR INJECTION",
    "fr_drug_common_name": "CHLORHYDRATE DE RÉMIFENTANIL POUR INJECTION",
    "en_ingredients": "REMIFENTANIL",
    "fr_ingredients": "RÉMIFENTANIL",
    "drug_strength": "1MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10 VIALS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 153969,
    "drug": {
      "current_status": "MARKETED",
      "id": 22608,
      "drug_code": 85132,
      "updated_date": "2025-05-15T02:32:56-04:00",
      "company": {
        "id": 226,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 8892,
        "mfr_code": "RAX08",
        "name": "STERIMAX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2770 PORTLAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 6R4",
        "post_office_box": "",
        "contact_information": "1-800-881-3550"
      },
      "drug_ingredients": [
        {
          "id": 8258147,
          "ingredient": {
            "id": 3712,
            "ingredient_code": 11311,
            "en_name": "REMIFENTANIL",
            "fr_name": "Rémifentanil (Chlorhydrate de rémifentanil)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02366479",
      "brand_name": "REMIFENTANIL HYDROCHLORIDE FOR INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133098002"
    },
    "created_date": "2022-02-01T18:39:47-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02366479",
    "company_name": "STERIMAX INC",
    "atc_number": "N01AH",
    "atc_description": "ANESTHETICS, GENERAL",
    "actual_start_date": "2022-01-21T00:00:00-05:00",
    "actual_end_date": "2022-07-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-09-27T17:43:19-04:00",
    "status": "resolved",
    "en_comments": "Product is on allocation at 100% at McKesson.",
    "fr_comments": "Produit est en allocation à 100% chez McKesson.",
    "en_drug_brand_name": "REMIFENTANIL HYDROCHLORIDE FOR INJECTION",
    "en_drug_common_name": "REMIFENTANIL HYDROCHLORIDE FOR INJECTION",
    "fr_drug_brand_name": "CHLORHYDRATE DE RÉMIFENTANIL POUR INJECTION",
    "fr_drug_common_name": "CHLORHYDRATE DE RÉMIFENTANIL POUR INJECTION",
    "en_ingredients": "REMIFENTANIL",
    "fr_ingredients": "RÉMIFENTANIL",
    "drug_strength": "2MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10 VIALS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 153981,
    "drug": {
      "current_status": "MARKETED",
      "id": 11190,
      "drug_code": 67521,
      "updated_date": "2025-05-15T02:31:14-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8254204,
          "ingredient": {
            "id": 2580,
            "ingredient_code": 11784,
            "en_name": "MONTELUKAST",
            "fr_name": "Montélukast (Montélukast sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02243602",
      "brand_name": "SINGULAIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133823003"
    },
    "created_date": "2022-02-01T22:06:34-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243602",
    "company_name": "ORGANON CANADA INC.",
    "atc_number": "R03DC",
    "atc_description": "OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES",
    "anticipated_start_date": "2022-02-18T00:00:00-05:00",
    "estimated_end_date": "2022-03-30T00:00:00-04:00",
    "actual_start_date": "2022-02-03T00:00:00-05:00",
    "actual_end_date": "2022-03-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-03-28T13:33:59-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SINGULAIR",
    "en_drug_common_name": "montelukast tablets",
    "fr_drug_brand_name": "SINGULAIR",
    "fr_drug_common_name": "comprimés de montélukast",
    "en_ingredients": "MONTELUKAST",
    "fr_ingredients": "montélukast",
    "drug_strength": "4MG",
    "drug_dosage_form": "TABLET (CHEWABLE)",
    "drug_dosage_form_fr": "Comprimé (à mâcher)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154002,
    "drug": {
      "current_status": "MARKETED",
      "id": 29350,
      "drug_code": 91352,
      "updated_date": "2025-05-15T02:34:25-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8260643,
          "ingredient": {
            "id": 2974,
            "ingredient_code": 12108,
            "en_name": "BIMATOPROST",
            "fr_name": "Bimatoprost"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.03",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02429063",
      "brand_name": "VISTITAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0147303001"
    },
    "created_date": "2022-02-02T03:26:51-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02429063",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "S01EE",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "estimated_end_date": "2022-03-25T00:00:00-04:00",
    "actual_start_date": "2022-02-01T00:00:00-05:00",
    "actual_end_date": "2022-03-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-03-25T18:13:29-04:00",
    "status": "resolved",
    "en_drug_brand_name": "VISTITAN",
    "en_drug_common_name": "VISTITAN",
    "fr_drug_brand_name": "VISTITAN",
    "fr_drug_common_name": "VISTITAN",
    "en_ingredients": "BIMATOPROST",
    "fr_ingredients": "Bimatoprost",
    "drug_strength": "0.03%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "5ML LDP",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154004,
    "drug": {
      "current_status": "MARKETED",
      "id": 3004,
      "drug_code": 17416,
      "updated_date": "2025-05-15T02:30:57-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8252206,
          "ingredient": {
            "id": 1328,
            "ingredient_code": 8138,
            "en_name": "SULFASALAZINE",
            "fr_name": "Sulfasalazine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02064480",
      "brand_name": "SALAZOPYRIN TAB 500MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "79569",
      "number_of_ais": "1",
      "ai_group_no": "0106101001"
    },
    "created_date": "2022-02-02T03:27:01-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02064480",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "A07EC",
    "atc_description": "INTESTINALANTIINFLAMMATORY AGENTS",
    "estimated_end_date": "2022-04-29T00:00:00-04:00",
    "actual_start_date": "2022-01-31T00:00:00-05:00",
    "actual_end_date": "2022-04-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-04-22T16:30:34-04:00",
    "status": "resolved",
    "en_comments": "Some inventory will be available until resolution.",
    "fr_comments": "Un peu d'inventaire sera disponible.",
    "en_drug_brand_name": "SALAZOPYRIN TAB 500MG",
    "en_drug_common_name": "SALAZOPYRIN",
    "fr_drug_brand_name": "SALAZOPYRIN TAB 500MG",
    "fr_drug_common_name": "SALAZOPYRIN",
    "en_ingredients": "SULFASALAZINE",
    "fr_ingredients": "Sulfasalazine",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100's",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154008,
    "drug": {
      "current_status": "MARKETED",
      "id": 27542,
      "drug_code": 89784,
      "updated_date": "2025-05-15T02:34:04-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8259954,
          "ingredient": {
            "id": 3280,
            "ingredient_code": 12477,
            "en_name": "TRAVOPROST",
            "fr_name": "Travoprost"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.004",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02413167",
      "brand_name": "SANDOZ TRAVOPROST",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0145801001"
    },
    "created_date": "2022-02-02T03:28:34-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02413167",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "S01EE",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "estimated_end_date": "2022-05-06T00:00:00-04:00",
    "actual_start_date": "2022-02-01T00:00:00-05:00",
    "actual_end_date": "2022-05-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-05-05T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ TRAVOPROST",
    "en_drug_common_name": "TRAVOPROST",
    "fr_drug_brand_name": "SANDOZ TRAVOPROST",
    "fr_drug_common_name": "TRAVOPROST",
    "en_ingredients": "TRAVOPROST",
    "fr_ingredients": "Travoprost",
    "drug_strength": "0.004%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "5ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154012,
    "drug": {
      "current_status": "MARKETED",
      "id": 3004,
      "drug_code": 17416,
      "updated_date": "2025-05-15T02:30:57-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8252206,
          "ingredient": {
            "id": 1328,
            "ingredient_code": 8138,
            "en_name": "SULFASALAZINE",
            "fr_name": "Sulfasalazine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02064480",
      "brand_name": "SALAZOPYRIN TAB 500MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "79569",
      "number_of_ais": "1",
      "ai_group_no": "0106101001"
    },
    "created_date": "2022-02-02T03:29:11-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02064480",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "A07EC",
    "atc_description": "INTESTINALANTIINFLAMMATORY AGENTS",
    "anticipated_start_date": "2022-03-28T00:00:00-04:00",
    "estimated_end_date": "2022-04-25T00:00:00-04:00",
    "actual_start_date": "2022-02-07T00:00:00-05:00",
    "actual_end_date": "2022-04-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-04-22T16:31:13-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SALAZOPYRIN TAB 500MG",
    "en_drug_common_name": "SALAZOPYRIN",
    "fr_drug_brand_name": "SALAZOPYRIN TAB 500MG",
    "fr_drug_common_name": "SALAZOPYRIN",
    "en_ingredients": "SULFASALAZINE",
    "fr_ingredients": "Sulfasalazine",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "300's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154015,
    "drug": {
      "current_status": "MARKETED",
      "id": 19642,
      "drug_code": 81002,
      "updated_date": "2025-05-15T02:32:23-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256860,
          "ingredient": {
            "id": 2792,
            "ingredient_code": 11987,
            "en_name": "RIVASTIGMINE",
            "fr_name": "Rivastigmine (Tartrate hydrogénée de rivastigmine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02324571",
      "brand_name": "SANDOZ RIVASTIGMINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0140521002"
    },
    "created_date": "2022-02-02T03:30:20-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02324571",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N06DA",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "estimated_end_date": "2022-03-11T00:00:00-05:00",
    "actual_start_date": "2022-02-01T00:00:00-05:00",
    "actual_end_date": "2022-03-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-03-11T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ RIVASTIGMINE",
    "en_drug_common_name": "RIVASTIGMINE",
    "fr_drug_brand_name": "SANDOZ RIVASTIGMINE",
    "fr_drug_common_name": "RIVASTIGMINE",
    "en_ingredients": "RIVASTIGMINE",
    "fr_ingredients": "Rivastigmine",
    "drug_strength": "3MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "56HGC",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154018,
    "drug": {
      "current_status": "MARKETED",
      "id": 4356,
      "drug_code": 20353,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8252727,
          "ingredient": {
            "id": 1658,
            "ingredient_code": 7335,
            "en_name": "ALPROSTADIL",
            "fr_name": "Alprostadil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02215756",
      "brand_name": "CAVERJECT STERILE POWDER",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "82663",
      "number_of_ais": "1",
      "ai_group_no": "0115288006"
    },
    "created_date": "2022-02-02T03:31:10-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02215756",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "G04BE",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "anticipated_start_date": "2022-03-25T00:00:00-04:00",
    "actual_start_date": "2022-03-02T00:00:00-05:00",
    "actual_end_date": "2024-05-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-05-15T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CAVERJECT STERILE POWDER",
    "en_drug_common_name": "CAVERJECT",
    "fr_drug_brand_name": "CAVERJECT STERILE POWDER",
    "fr_drug_common_name": "CAVERJECT",
    "en_ingredients": "ALPROSTADIL",
    "fr_ingredients": "Alprostadil",
    "drug_strength": "20MCG",
    "drug_dosage_form": "POWDER FOR SOLUTION\r\nLIQUID\r\nKIT",
    "drug_dosage_form_fr": "Poudre pour solution\r\nLiquide\r\nTrousse",
    "drug_route": "INTRACAVERNOSAL\r\nINTRACAVERNOSAL",
    "drug_route_fr": "Intracaverneuse\r\nIntracaverneuse",
    "drug_package_quantity": "5 X 20MCG",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154021,
    "drug": {
      "current_status": "MARKETED",
      "id": 66526,
      "drug_code": 98405,
      "updated_date": "2025-05-15T02:39:00-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8264582,
          "ingredient": {
            "id": 3044,
            "ingredient_code": 1218,
            "en_name": "BISOPROLOL FUMARATE",
            "fr_name": "Fumarate de bisoprolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02494035",
      "brand_name": "SANDOZ BISOPROLOL TABLETS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122418001"
    },
    "created_date": "2022-02-02T03:32:02-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02494035",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C07AB",
    "atc_description": "BETA BLOCKING AGENTS",
    "estimated_end_date": "2022-03-11T00:00:00-05:00",
    "actual_start_date": "2022-02-01T00:00:00-05:00",
    "actual_end_date": "2022-03-03T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-03-04T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ BISOPROLOL TABLETS",
    "en_drug_common_name": "BISOPROLOL",
    "fr_drug_brand_name": "SANDOZ BISOPROLOL TABLETS",
    "fr_drug_common_name": "BISOPROLOL",
    "en_ingredients": "BISOPROLOL FUMARATE",
    "fr_ingredients": "Fumarate de bisoprolol",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100FCT BO",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154024,
    "drug": {
      "current_status": "DORMANT",
      "id": 17776,
      "drug_code": 78843,
      "updated_date": "2025-05-15T06:55:36-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8368115,
          "ingredient": {
            "id": 170,
            "ingredient_code": 9060,
            "en_name": "HEPARIN SODIUM",
            "fr_name": "Héparine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02303108",
      "brand_name": "HEPARIN SODIUM INJECTION USP    (MULTIDOSE VIAL-WITH PRESERVATIVE)",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104596002"
    },
    "created_date": "2022-02-02T03:33:47-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02303108",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "B01AB",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "estimated_end_date": "2023-01-13T00:00:00-05:00",
    "actual_start_date": "2022-02-01T00:00:00-05:00",
    "actual_end_date": "2023-01-18T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-01-19T16:37:35-05:00",
    "status": "resolved",
    "en_drug_brand_name": "HEPARIN SODIUM INJECTION USP       (MULTIDOSE VIAL-WITH PRESERVATIVE)",
    "en_drug_common_name": "HEPARIN SODIUM",
    "fr_drug_brand_name": "HEPARIN SODIUM INJECTION USP       (MULTIDOSE VIAL-WITH PRESERVATIVE)",
    "fr_drug_common_name": "HEPARIN SODIUM",
    "en_ingredients": "HEPARIN SODIUM",
    "fr_ingredients": "Héparine sodique",
    "drug_strength": "10000UNIT",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nSUBCUTANEOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nSous-cutanée\r\nIntraveineuse",
    "drug_package_quantity": "50ML 1LIVI",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154027,
    "drug": {
      "current_status": "MARKETED",
      "id": 22680,
      "drug_code": 85213,
      "updated_date": "2025-05-15T02:32:56-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8258175,
          "ingredient": {
            "id": 2418,
            "ingredient_code": 11458,
            "en_name": "LATANOPROST",
            "fr_name": "Latanoprost"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02367335",
      "brand_name": "SANDOZ LATANOPROST",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132916002"
    },
    "created_date": "2022-02-02T03:35:19-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02367335",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "S01EE",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "estimated_end_date": "2022-03-25T00:00:00-04:00",
    "actual_start_date": "2022-02-01T00:00:00-05:00",
    "actual_end_date": "2022-03-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-03-26T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ LATANOPROST",
    "en_drug_common_name": "LATANOPROST",
    "fr_drug_brand_name": "SANDOZ LATANOPROST",
    "fr_drug_common_name": "LATANOPROST",
    "en_ingredients": "LATANOPROST",
    "fr_ingredients": "Latanoprost",
    "drug_strength": "50MCG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "2.5ML LDP",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154030,
    "drug": {
      "current_status": "MARKETED",
      "id": 25110,
      "drug_code": 87623,
      "updated_date": "2025-05-15T02:33:39-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8259099,
          "ingredient": {
            "id": 3228,
            "ingredient_code": 15568,
            "en_name": "PREGABALIN",
            "fr_name": "Prégabaline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02390833",
      "brand_name": "SANDOZ PREGABALIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151121003"
    },
    "created_date": "2022-02-02T03:36:36-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02390833",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2022-02-11T00:00:00-05:00",
    "actual_start_date": "2022-02-01T00:00:00-05:00",
    "actual_end_date": "2022-02-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-02-18T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ PREGABALIN",
    "en_drug_common_name": "PREGABALIN",
    "fr_drug_brand_name": "SANDOZ PREGABALIN",
    "fr_drug_common_name": "PREGABALIN",
    "en_ingredients": "PREGABALIN",
    "fr_ingredients": "Prégabaline",
    "drug_strength": "75MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500HGC BO",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154043,
    "drug": {
      "current_status": "MARKETED",
      "id": 9700,
      "drug_code": 63577,
      "updated_date": "2025-05-15T02:31:07-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8253732,
          "ingredient": {
            "id": 1366,
            "ingredient_code": 1960,
            "en_name": "INDAPAMIDE",
            "fr_name": "Indapamide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02240067",
      "brand_name": "MYLAN-INDAPAMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115402002"
    },
    "created_date": "2022-02-02T12:41:44-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02240067",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C03BA",
    "atc_description": "LOW-CEILING DIURETICS, EXCL THIAZIDES",
    "hc_updated_date": "2022-02-25T18:06:43-05:00",
    "anticipated_start_date": "2022-02-09T00:00:00-05:00",
    "estimated_end_date": "2022-02-15T00:00:00-05:00",
    "actual_end_date": "2022-01-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-02-25T18:06:47-05:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "MYLAN-INDAPAMIDE",
    "en_drug_common_name": "INDAPAMIDE",
    "fr_drug_brand_name": "MYLAN-INDAPAMIDE",
    "fr_drug_common_name": "INDAPAMIDE",
    "en_ingredients": "INDAPAMIDE",
    "fr_ingredients": "Indapamide",
    "drug_strength": "1.25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100BT",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154062,
    "drug": {
      "current_status": "MARKETED",
      "id": 23762,
      "drug_code": 86422,
      "updated_date": "2025-05-15T02:33:10-04:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8258561,
          "ingredient": {
            "id": 1012,
            "ingredient_code": 763,
            "en_name": "ENOXAPARIN SODIUM",
            "fr_name": "Énoxaparine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "0.6",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02378426",
      "brand_name": "LOVENOX",
      "brand_name_fr": "",
      "descriptor": "SINGLE DOSE PRE-FILLED SYRINGE 60MG/0.6ML",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131860001"
    },
    "created_date": "2022-02-02T15:11:54-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02378426",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "B01AB",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "anticipated_start_date": "2022-03-15T00:00:00-04:00",
    "estimated_end_date": "2022-03-30T00:00:00-04:00",
    "actual_end_date": "2022-03-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-03-30T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Product on allocation. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.",
    "fr_comments": "Produit en allocation. La date estimée de disponibilité représente des estimées de disponibilités à l’entrepôt de Sanofi. Les dates de disponibilités à l’entrepôt des distributeurs peuvent varier. Les pharmacies sont invitées à communiquer avec leurs distributeurs préférentiels pour obtenir la date de disponibilité des produits.",
    "en_drug_brand_name": "LOVENOX",
    "en_drug_common_name": "Lovenox 60mg",
    "fr_drug_brand_name": "LOVENOX",
    "fr_drug_common_name": "Lovenox 60mg",
    "en_ingredients": "ENOXAPARIN SODIUM",
    "fr_ingredients": "Énoxaparine sodique",
    "drug_strength": "60MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée\r\nSous-cutanée",
    "drug_package_quantity": "10",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154065,
    "drug": {
      "current_status": "MARKETED",
      "id": 12052,
      "drug_code": 69999,
      "updated_date": "2025-05-15T02:31:19-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254469,
          "ingredient": {
            "id": 2978,
            "ingredient_code": 5863,
            "en_name": "METHAZOLAMIDE",
            "fr_name": "Méthazolamide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02245882",
      "brand_name": "METHAZOLAMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107657001"
    },
    "created_date": "2022-02-02T16:32:09-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02245882",
    "company_name": "AA PHARMA INC",
    "atc_number": "S01EC",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "anticipated_start_date": "2022-03-04T00:00:00-05:00",
    "estimated_end_date": "2022-04-01T00:00:00-04:00",
    "actual_end_date": "2022-03-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-01T17:23:55-04:00",
    "status": "resolved",
    "en_drug_brand_name": "METHAZOLAMIDE",
    "en_drug_common_name": "Methazolamide",
    "fr_drug_brand_name": "Methazolamide",
    "fr_drug_common_name": "Methazolamide",
    "en_ingredients": "METHAZOLAMIDE",
    "fr_ingredients": "Méthazolamide",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1000 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154095,
    "drug": {
      "current_status": "MARKETED",
      "id": 23430,
      "drug_code": 86019,
      "updated_date": "2025-05-15T02:33:04-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258458,
          "ingredient": {
            "id": 2168,
            "ingredient_code": 932,
            "en_name": "RAMIPRIL",
            "fr_name": "Ramipril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02374846",
      "brand_name": "RAMIPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122858004"
    },
    "created_date": "2022-02-02T20:09:47-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02374846",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "anticipated_start_date": "2022-03-16T00:00:00-04:00",
    "estimated_end_date": "2022-04-15T00:00:00-04:00",
    "actual_end_date": "2022-04-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-06T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "RAMIPRIL",
    "en_drug_common_name": "RAMIPRIL",
    "fr_drug_brand_name": "RAMIPRIL",
    "fr_drug_common_name": "RAMIPRIL",
    "en_ingredients": "RAMIPRIL",
    "fr_ingredients": "Ramipril",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154100,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 22282,
      "drug_code": 84685,
      "updated_date": "2025-05-15T04:17:52-04:00",
      "company": {
        "id": 94,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 9307,
        "mfr_code": "AZC08",
        "name": "ASTRAZENECA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1004 MIDDLEGATE ROAD, SUITE 5000",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L4Y 1M4",
        "post_office_box": "",
        "contact_information": "Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: medinfo.canada@astrazeneca.com."
      },
      "drug_ingredients": [
        {
          "id": 8349776,
          "ingredient": {
            "id": 3702,
            "ingredient_code": 20660,
            "en_name": "EXENATIDE",
            "fr_name": "Exénatide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02361809",
      "brand_name": "BYETTA",
      "brand_name_fr": "",
      "descriptor": "1.2ML PREFILLED PEN. 60 DOSES OF 5MCG/DOSE.",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152872003"
    },
    "created_date": "2022-02-02T21:23:45-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02361809",
    "company_name": "ASTRAZENECA CANADA INC",
    "atc_number": "A10BJ",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "discontinuation_date": "2022-01-06T00:00:00-05:00",
    "anticipated_discontinuation_date": "2022-07-31T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "Product has been discontinued. No supply available for sale.",
    "fr_supply_disruption_mitigation": "Product has been discontinued. No supply available for sale.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2022-07-27T12:50:39-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "BYETTA",
    "en_drug_common_name": "exenatide injection",
    "fr_drug_brand_name": "BYETTA",
    "fr_drug_common_name": "exénatide injectable",
    "en_ingredients": "EXENATIDE",
    "fr_ingredients": "Exénatide",
    "drug_strength": "5MCG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée\r\nSous-cutanée",
    "drug_package_quantity": "single 1.2 mL prefilled pen (5mcg per dose) per carton",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154103,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 22284,
      "drug_code": 84686,
      "updated_date": "2025-05-15T04:17:52-04:00",
      "company": {
        "id": 94,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 9307,
        "mfr_code": "AZC08",
        "name": "ASTRAZENECA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1004 MIDDLEGATE ROAD, SUITE 5000",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L4Y 1M4",
        "post_office_box": "",
        "contact_information": "Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: medinfo.canada@astrazeneca.com."
      },
      "drug_ingredients": [
        {
          "id": 8349777,
          "ingredient": {
            "id": 3702,
            "ingredient_code": 20660,
            "en_name": "EXENATIDE",
            "fr_name": "Exénatide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02361817",
      "brand_name": "BYETTA",
      "brand_name_fr": "",
      "descriptor": "2.4ML PREFILLED PEN. 60 DOSES OF 10¿CG/DOSE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152872004"
    },
    "created_date": "2022-02-02T21:34:33-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02361817",
    "company_name": "ASTRAZENECA CANADA INC",
    "atc_number": "A10BJ",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "discontinuation_date": "2022-01-31T00:00:00-05:00",
    "anticipated_discontinuation_date": "2022-01-31T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2022-02-02T21:38:29-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "BYETTA",
    "en_drug_common_name": "exenatide injection",
    "fr_drug_brand_name": "BYETTA",
    "fr_drug_common_name": "exénatide injectable",
    "en_ingredients": "EXENATIDE",
    "fr_ingredients": "Exénatide",
    "drug_strength": "10MCG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée\r\nSous-cutanée",
    "drug_package_quantity": "single 2.4 mL prefilled pen (10 mcg per dose) per carton",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154106,
    "drug": {
      "current_status": "MARKETED",
      "id": 7856,
      "drug_code": 51066,
      "updated_date": "2025-05-15T02:31:05-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8253411,
          "ingredient": {
            "id": 1838,
            "ingredient_code": 1896,
            "en_name": "LABETALOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de labétalol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02231689",
      "brand_name": "LABETALOL HYDROCHLORIDE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0116170002"
    },
    "created_date": "2022-02-02T21:36:44-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02231689",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C07AG",
    "atc_description": "BETA BLOCKING AGENTS",
    "anticipated_start_date": "2022-02-28T00:00:00-05:00",
    "estimated_end_date": "2022-04-01T00:00:00-04:00",
    "actual_end_date": "2022-03-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-03-11T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "LABETALOL HYDROCHLORIDE INJECTION USP",
    "en_drug_common_name": "LABETALOL HCL",
    "fr_drug_brand_name": "LABETALOL HYDROCHLORIDE INJECTION USP",
    "fr_drug_common_name": "LABETALOL HCL",
    "en_ingredients": "LABETALOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de labétalol",
    "drug_strength": "5MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "20ML 1LIVI",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154110,
    "drug": {
      "current_status": "MARKETED",
      "id": 11954,
      "drug_code": 69790,
      "updated_date": "2025-05-15T02:31:18-04:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8254435,
          "ingredient": {
            "id": 2970,
            "ingredient_code": 12724,
            "en_name": "INSULIN GLARGINE",
            "fr_name": "Insuline glargine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02245689",
      "brand_name": "LANTUS",
      "brand_name_fr": "",
      "descriptor": "VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0147062001"
    },
    "created_date": "2022-02-02T21:59:47-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02245689",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "A10AE",
    "atc_description": "INSULINS AND ANALOGUES",
    "estimated_end_date": "2022-09-30T00:00:00-04:00",
    "actual_start_date": "2022-01-31T00:00:00-05:00",
    "actual_end_date": "2022-09-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-09-14T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Product on allocation. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.",
    "fr_comments": "Produit en allocation. La date estimée de disponibilité représente des estimées de disponibilités à l’entrepôt de Sanofi. Les dates de disponibilités à l’entrepôt des distributeurs peuvent varier. Les pharmacies sont invitées à communiquer avec leurs distributeurs préférentiels pour obtenir la date de disponibilité des produits.",
    "en_drug_brand_name": "LANTUS",
    "en_drug_common_name": "Lantus Vial",
    "fr_drug_brand_name": "LANTUS",
    "fr_drug_common_name": "Lantus Vial",
    "en_ingredients": "INSULIN GLARGINE",
    "fr_ingredients": "Insuline glargine",
    "drug_strength": "100UNIT",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée\r\nSous-cutanée",
    "drug_package_quantity": "1",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154113,
    "drug": {
      "current_status": "MARKETED",
      "id": 15600,
      "drug_code": 76285,
      "updated_date": "2025-05-15T02:31:43-04:00",
      "company": {
        "id": 16952,
        "created_date": "2020-09-03T01:00:04-04:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 17643,
        "mfr_code": "",
        "name": "ELVIUM LIFE SCIENCES",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255594,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02277204",
      "brand_name": "BIPHENTIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107548012"
    },
    "created_date": "2022-02-02T22:11:39-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02277204",
    "company_name": "ELVIUM LIFE SCIENCES",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "anticipated_start_date": "2022-02-02T00:00:00-05:00",
    "estimated_end_date": "2022-04-08T00:00:00-04:00",
    "actual_start_date": "2022-02-02T00:00:00-05:00",
    "actual_end_date": "2022-04-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-04-07T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "BIPHENTIN",
    "en_drug_common_name": "Methylphenidate hydrochloride Controlled Release Capsules",
    "fr_drug_brand_name": "BIPHENTIN",
    "fr_drug_common_name": "Chlorhydrate de méthylphénidate Capsules à libération contrôlée",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "60MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "50",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154141,
    "drug": {
      "current_status": "MARKETED",
      "id": 22752,
      "drug_code": 85279,
      "updated_date": "2025-12-03T00:31:47-05:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8258199,
          "ingredient": {
            "id": 368,
            "ingredient_code": 7626,
            "en_name": "METHYLPREDNISOLONE",
            "fr_name": "Méthylprednisolone (Succinate sodique de méthylprednisolone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02367963",
      "brand_name": "SOLU-MEDROL",
      "brand_name_fr": "",
      "descriptor": "ACT-O-VIAL. SINGLE-DOSE. WITHOUT PRESERVATIVE. SUPPLIED WITH DILUENT.",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106290005"
    },
    "created_date": "2022-02-03T15:37:43-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02367963",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "H02AB",
    "atc_description": "CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",
    "actual_start_date": "2022-02-02T00:00:00-05:00",
    "actual_end_date": "2022-03-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-03-18T16:03:51-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SOLU-MEDROL",
    "en_drug_common_name": "SOLU-MEDROL",
    "fr_drug_brand_name": "SOLU-MEDROL",
    "fr_drug_common_name": "SOLU-MEDROL",
    "en_ingredients": "METHYLPREDNISOLONE",
    "fr_ingredients": "Méthylprednisolone",
    "drug_strength": "500MG",
    "drug_dosage_form": "POWDER FOR SOLUTION\r\nKIT",
    "drug_dosage_form_fr": "Poudre pour solution\r\nTrousse",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "5 x 4mL vial",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154144,
    "drug": {
      "current_status": "MARKETED",
      "id": 10612,
      "drug_code": 66196,
      "updated_date": "2025-05-15T02:31:10-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8254020,
          "ingredient": {
            "id": 2806,
            "ingredient_code": 12005,
            "en_name": "IBUTILIDE FUMARATE",
            "fr_name": "Fumarate d'ibutilide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02242470",
      "brand_name": "CORVERT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0141264001"
    },
    "created_date": "2022-02-03T15:41:54-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242470",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "C01BD",
    "atc_description": "ANTIARRHYTHMICS, CLASS I AND III",
    "actual_start_date": "2022-02-02T00:00:00-05:00",
    "actual_end_date": "2022-03-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-03-16T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CORVERT",
    "en_drug_common_name": "CORVERT",
    "fr_drug_brand_name": "CORVERT",
    "fr_drug_common_name": "CORVERT",
    "en_ingredients": "IBUTILIDE FUMARATE",
    "fr_ingredients": "Fumarate d'ibutilide",
    "drug_strength": "0.1MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10mL vial",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154147,
    "drug": {
      "current_status": "MARKETED",
      "id": 7088,
      "drug_code": 4802,
      "updated_date": "2025-05-15T02:30:31-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8250681,
          "ingredient": {
            "id": 1658,
            "ingredient_code": 7335,
            "en_name": "ALPROSTADIL",
            "fr_name": "Alprostadil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00559253",
      "brand_name": "PROSTIN VR STERILE SOLUTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "58786",
      "number_of_ais": "1",
      "ai_group_no": "0115288001"
    },
    "created_date": "2022-02-03T15:43:49-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00559253",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "C01EA",
    "atc_description": "OTHER CARDIAC PREPARATIONS",
    "actual_start_date": "2022-02-02T00:00:00-05:00",
    "actual_end_date": "2022-05-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-05-25T17:08:52-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PROSTIN VR STERILE SOLUTION",
    "en_drug_common_name": "PROSTIN VR STERILE SOLUTION",
    "fr_drug_brand_name": "PROSTIN VR STERILE SOLUTION",
    "fr_drug_common_name": "PROSTIN VR STERILE SOLUTION",
    "en_ingredients": "ALPROSTADIL",
    "fr_ingredients": "Alprostadil",
    "drug_strength": "500MCG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRA-ARTERIAL\r\nINTRAVENOUS\r\nINTRA-ARTERIAL",
    "drug_route_fr": "Intraveineuse\r\nIntra-artérielle\r\nIntraveineuse\r\nIntra-artérielle",
    "drug_package_quantity": "5 x1mL amp",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154155,
    "drug": {
      "current_status": "MARKETED",
      "id": 54636,
      "drug_code": 95931,
      "updated_date": "2025-05-15T02:36:11-04:00",
      "company": {
        "id": 16952,
        "created_date": "2020-09-03T01:00:04-04:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 17643,
        "mfr_code": "",
        "name": "ELVIUM LIFE SCIENCES",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262891,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "70",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02470330",
      "brand_name": "FOQUEST",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107548017"
    },
    "created_date": "2022-02-03T18:27:20-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02470330",
    "company_name": "ELVIUM LIFE SCIENCES",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "anticipated_start_date": "2022-02-03T00:00:00-05:00",
    "estimated_end_date": "2022-02-25T00:00:00-05:00",
    "actual_start_date": "2022-02-03T00:00:00-05:00",
    "actual_end_date": "2022-02-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-02-17T16:17:44-05:00",
    "status": "resolved",
    "en_drug_brand_name": "FOQUEST",
    "en_drug_common_name": "methylphenidate hydrochloride Controlled Release Capsules",
    "fr_drug_brand_name": "FOQUEST",
    "fr_drug_common_name": "chlorhydrate de méthylphénidate Capsules à libération contrôlée",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "70MG",
    "drug_dosage_form": "CAPSULE (CONTROLLED RELEASE)",
    "drug_dosage_form_fr": "Capsule à libération contrôlée",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154158,
    "drug": {
      "current_status": "MARKETED",
      "id": 15254,
      "drug_code": 75772,
      "updated_date": "2025-05-15T02:31:42-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8255429,
          "ingredient": {
            "id": 3256,
            "ingredient_code": 16581,
            "en_name": "PEGVISOMANT",
            "fr_name": "Pegvisomant"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02272199",
      "brand_name": "SOMAVERT",
      "brand_name_fr": "",
      "descriptor": "KIT INCLUDES 1 SINGLE DOSE VIAL & STERILE WATER",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151545001"
    },
    "created_date": "2022-02-03T20:34:46-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02272199",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "H01AX",
    "atc_description": "ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES",
    "estimated_end_date": "2022-03-04T00:00:00-05:00",
    "actual_start_date": "2022-02-03T00:00:00-05:00",
    "actual_end_date": "2022-03-03T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-03-04T06:00:03-05:00",
    "status": "resolved",
    "en_comments": "Other presentation available under preventative allocation",
    "fr_comments": "D'autres présentation sont disponible en allocation préventive",
    "en_drug_brand_name": "SOMAVERT",
    "en_drug_common_name": "SOMAVERT",
    "fr_drug_brand_name": "SOMAVERT",
    "fr_drug_common_name": "SOMAVERT",
    "en_ingredients": "PEGVISOMANT",
    "fr_ingredients": "Pegvisomant",
    "drug_strength": "10MG",
    "drug_dosage_form": "POWDER FOR SOLUTION\r\nKIT",
    "drug_dosage_form_fr": "Poudre pour solution\r\nTrousse",
    "drug_route": "SUBCUTANEOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée\r\nSous-cutanée",
    "drug_package_quantity": "30x1ml GVL+SYR",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154168,
    "drug": {
      "current_status": "MARKETED",
      "id": 27340,
      "drug_code": 89591,
      "updated_date": "2025-12-03T00:32:21-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8259887,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259886,
          "ingredient": {
            "id": 782,
            "ingredient_code": 11344,
            "en_name": "AMLODIPINE",
            "fr_name": "Amlodipine (Bésylate d'amlodipine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02411296",
      "brand_name": "APO-AMLODIPINE-ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0251555004"
    },
    "created_date": "2022-02-04T13:37:01-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02411296",
    "company_name": "APOTEX INC",
    "atc_number": "C10BX",
    "atc_description": "LIPID MODIFYING AGENTS, COMBINATIONS",
    "estimated_end_date": "2022-03-18T00:00:00-04:00",
    "actual_start_date": "2022-01-31T00:00:00-05:00",
    "actual_end_date": "2022-03-11T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-01T21:09:55-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-AMLODIPINE-ATORVASTATIN",
    "en_drug_common_name": "AMLODIPINE ATORVASTATIN",
    "fr_drug_brand_name": "APO AMLO-ATORVASTATIN",
    "fr_drug_common_name": "AMLODIPINE ATORVASTATIN",
    "en_ingredients": "ATORVASTATIN\r\nAMLODIPINE",
    "fr_ingredients": "ATORVASTATIN \r\nAMLODIPINE",
    "drug_strength": "80MG\r\n5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154175,
    "drug": {
      "current_status": "MARKETED",
      "id": 22470,
      "drug_code": 84906,
      "updated_date": "2025-05-15T02:32:56-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8258069,
          "ingredient": {
            "id": 74,
            "ingredient_code": 20280,
            "en_name": "HYDROMORPHONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'hydromorphone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02364123",
      "brand_name": "APO-HYDROMORPHONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108698003"
    },
    "created_date": "2022-02-04T13:42:50-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02364123",
    "company_name": "APOTEX INC",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2022-02-22T00:00:00-05:00",
    "actual_start_date": "2022-01-31T00:00:00-05:00",
    "actual_end_date": "2022-02-18T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-02-22T14:48:14-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-HYDROMORPHONE",
    "en_drug_common_name": "HYDROMORPHONE",
    "fr_drug_brand_name": "APO-HYDROMORPHONE",
    "fr_drug_common_name": "HYDROMORPHONE",
    "en_ingredients": "HYDROMORPHONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'hydromorphone",
    "drug_strength": "2MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154178,
    "drug": {
      "current_status": "DORMANT",
      "id": 6332,
      "drug_code": 43222,
      "updated_date": "2025-05-15T06:55:26-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8367206,
          "ingredient": {
            "id": 340,
            "ingredient_code": 1253,
            "en_name": "LISINOPRIL",
            "fr_name": "Lisinopril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02217503",
      "brand_name": "APO-LISINOPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9549",
      "number_of_ais": "1",
      "ai_group_no": "0121550001"
    },
    "created_date": "2022-02-04T13:45:54-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02217503",
    "company_name": "APOTEX INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2022-03-25T00:00:00-04:00",
    "actual_start_date": "2022-01-31T00:00:00-05:00",
    "actual_end_date": "2022-03-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-03-24T13:19:17-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-LISINOPRIL TABLET 10 MG",
    "en_drug_common_name": "LISINOPRIL",
    "fr_drug_brand_name": "APO-LISINOPRIL",
    "fr_drug_common_name": "LISINOPRIL",
    "en_ingredients": "LISINOPRIL",
    "fr_ingredients": "Lisinopril",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154181,
    "drug": {
      "current_status": "MARKETED",
      "id": 16300,
      "drug_code": 77089,
      "updated_date": "2025-05-15T02:31:47-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255814,
          "ingredient": {
            "id": 2666,
            "ingredient_code": 11852,
            "en_name": "MODAFINIL",
            "fr_name": "Modafinil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02285398",
      "brand_name": "APO-MODAFINIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0136083001"
    },
    "created_date": "2022-02-04T13:52:48-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02285398",
    "company_name": "APOTEX INC",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2022-02-22T00:00:00-05:00",
    "actual_start_date": "2022-01-31T00:00:00-05:00",
    "actual_end_date": "2022-02-18T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-02-22T14:50:16-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-MODAFINIL",
    "en_drug_common_name": "MODAFINIL",
    "fr_drug_brand_name": "APO-MODAFINIL",
    "fr_drug_common_name": "MODAFINIL",
    "en_ingredients": "MODAFINIL",
    "fr_ingredients": "Modafinil",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154184,
    "drug": {
      "current_status": "MARKETED",
      "id": 16534,
      "drug_code": 77362,
      "updated_date": "2025-05-15T02:31:51-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255878,
          "ingredient": {
            "id": 2138,
            "ingredient_code": 11104,
            "en_name": "ONDANSETRON",
            "fr_name": "Ondansétron"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02288184",
      "brand_name": "APO-ONDANSETRON",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131120003"
    },
    "created_date": "2022-02-04T14:00:36-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02288184",
    "company_name": "APOTEX INC",
    "atc_number": "A04AA",
    "atc_description": "ANTIEMETICS AND ANTINAUSEANTS",
    "estimated_end_date": "2022-02-28T00:00:00-05:00",
    "actual_start_date": "2022-01-31T00:00:00-05:00",
    "actual_end_date": "2022-02-25T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-02-28T13:28:53-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ONDANSETRON",
    "en_drug_common_name": "ONDANSETRON",
    "fr_drug_brand_name": "APO-ONDANSETRON",
    "fr_drug_common_name": "ONDANSETRON",
    "en_ingredients": "ONDANSETRON",
    "fr_ingredients": "Ondansétron",
    "drug_strength": "4MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154187,
    "drug": {
      "current_status": "MARKETED",
      "id": 16814,
      "drug_code": 77773,
      "updated_date": "2025-05-15T02:31:54-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255941,
          "ingredient": {
            "id": 2540,
            "ingredient_code": 11733,
            "en_name": "PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE",
            "fr_name": "Dichlorhydrate de pramipexole monohydraté"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02292386",
      "brand_name": "APO-PRAMIPEXOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152169002"
    },
    "created_date": "2022-02-04T14:06:17-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02292386",
    "company_name": "APOTEX INC",
    "atc_number": "N04BC",
    "atc_description": "DOPAMINERGIC AGENTS",
    "estimated_end_date": "2022-04-15T00:00:00-04:00",
    "actual_start_date": "2022-01-31T00:00:00-05:00",
    "actual_end_date": "2022-04-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-15T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-PRAMIPEXOLE",
    "en_drug_common_name": "PRAMIPEXOLE",
    "fr_drug_brand_name": "APO-PRAMIPEXOLE",
    "fr_drug_common_name": "PRAMIPEXOLE",
    "en_ingredients": "PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE",
    "fr_ingredients": "Dichlorhydrate de pramipexole monohydraté",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154197,
    "drug": {
      "current_status": "MARKETED",
      "id": 23700,
      "drug_code": 86354,
      "updated_date": "2025-05-15T02:33:10-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8258545,
          "ingredient": {
            "id": 2640,
            "ingredient_code": 11819,
            "en_name": "RISEDRONATE SODIUM",
            "fr_name": "Risédronate sodique (Hémipentahydrate de risédronate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02377721",
      "brand_name": "APO-RISEDRONATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135301005"
    },
    "created_date": "2022-02-04T14:18:45-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02377721",
    "company_name": "APOTEX INC",
    "atc_number": "M05BA",
    "atc_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
    "estimated_end_date": "2022-03-02T00:00:00-05:00",
    "actual_start_date": "2022-01-31T00:00:00-05:00",
    "actual_end_date": "2022-03-04T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-03-07T19:11:06-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-RISEDRONATE",
    "en_drug_common_name": "RISEDRONATE",
    "fr_drug_brand_name": "APO-RISEDRONATE",
    "fr_drug_common_name": "RISEDRONATE",
    "en_ingredients": "RISEDRONATE SODIUM",
    "fr_ingredients": "Risédronate sodique",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154205,
    "drug": {
      "current_status": "MARKETED",
      "id": 3152,
      "drug_code": 18040,
      "updated_date": "2025-05-15T02:30:57-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8252242,
          "ingredient": {
            "id": 946,
            "ingredient_code": 1939,
            "en_name": "TRAZODONE HYDROCHLORIDE",
            "fr_name": "Chlohydrate de trazodone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02147653",
      "brand_name": "APO-TRAZODONE D TABLETS 150MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "80254",
      "number_of_ais": "1",
      "ai_group_no": "0115713003"
    },
    "created_date": "2022-02-04T14:26:13-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02147653",
    "company_name": "APOTEX INC",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2022-05-06T00:00:00-04:00",
    "actual_start_date": "2022-01-31T00:00:00-05:00",
    "actual_end_date": "2022-05-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-05-06T17:49:43-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-TRAZODONE D TABLETS 150MG",
    "en_drug_common_name": "TRAZODONE",
    "fr_drug_brand_name": "APO-TRAZODONE",
    "fr_drug_common_name": "TRAZODONE",
    "en_ingredients": "TRAZODONE HYDROCHLORIDE",
    "fr_ingredients": "Chlohydrate de trazodone",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154208,
    "drug": {
      "current_status": "MARKETED",
      "id": 101665,
      "drug_code": 99687,
      "updated_date": "2021-04-08T05:03:28-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8265766,
          "ingredient": {
            "id": 3590,
            "ingredient_code": 20524,
            "en_name": "SAXAGLIPTIN",
            "fr_name": "Saxagliptine (Chlorhydrate de saxagliptine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02507498",
      "brand_name": "APO-SAXAGLIPTIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152653001"
    },
    "created_date": "2022-02-04T14:27:06-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02507498",
    "company_name": "APOTEX INC",
    "atc_number": "A10BH",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "estimated_end_date": "2022-07-15T00:00:00-04:00",
    "actual_start_date": "2022-02-03T00:00:00-05:00",
    "actual_end_date": "2022-07-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2022-07-11T13:11:16-04:00",
    "status": "resolved",
    "en_comments": "limited inventory has been allocated",
    "fr_comments": "limited inventory has been allocated",
    "en_drug_brand_name": "APO-SAXAGLIPTIN",
    "en_drug_common_name": "SAXAGLIPTIN",
    "fr_drug_brand_name": "APO-SAXAGLIPTIN",
    "fr_drug_common_name": "SAXAGLIPTIN",
    "en_ingredients": "SAXAGLIPTIN",
    "fr_ingredients": "Saxagliptin",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154254,
    "drug": {
      "current_status": "MARKETED",
      "id": 17394,
      "drug_code": 78457,
      "updated_date": "2025-05-15T02:32:00-04:00",
      "company": {
        "id": 16976,
        "created_date": "2020-10-02T23:51:29-04:00",
        "updated_date": "2025-12-03T00:30:15-05:00",
        "company_code": 17602,
        "mfr_code": "",
        "name": "HIKMA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "55 STANDISH COURT, SUITE 1050",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 0G3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256131,
          "ingredient": {
            "id": 482,
            "ingredient_code": 8826,
            "en_name": "WATER",
            "fr_name": "Eau"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02299186",
      "brand_name": "STERILE WATER FOR INJECTION USP",
      "brand_name_fr": "EAU STÉRILE POUR PRÉPARATIONS INJECTABLES USP",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0105143002"
    },
    "created_date": "2022-02-04T17:34:20-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02299186",
    "company_name": "TELIP, LLC, A SUBSIDIARY OF TELIGENT, INC.",
    "atc_number": "V07AB",
    "atc_description": "ALL OTHER NON-THERAPEUTIC PRODUCTS",
    "anticipated_start_date": "2022-02-04T00:00:00-05:00",
    "estimated_end_date": "2022-08-15T00:00:00-04:00",
    "actual_end_date": "2022-08-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-08-16T14:35:17-04:00",
    "status": "resolved",
    "en_drug_brand_name": "STERILE WATER FOR INJECTION USP",
    "en_drug_common_name": "STERILE WATER FOR INJECTION USP",
    "fr_drug_brand_name": "STERILE WATER FOR INJECTION USP",
    "fr_drug_common_name": "STERILE WATER FOR INJECTION USP",
    "en_ingredients": "WATER",
    "fr_ingredients": "Eau",
    "drug_strength": "100%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR\r\nSUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nIntramusculaire\r\nSous-cutanée\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "10ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": true
  },
  {
    "id": 154258,
    "drug": {
      "current_status": "MARKETED",
      "id": 1658,
      "drug_code": 13563,
      "updated_date": "2025-12-03T00:30:31-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8251784,
          "ingredient": {
            "id": 912,
            "ingredient_code": 582,
            "en_name": "COPPER",
            "fr_name": "Cuivre ((FR) COPPER OXIDE)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": true
        }
      ],
      "din": "00786969",
      "brand_name": "MICRO CU",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "74973",
      "number_of_ais": "1",
      "ai_group_no": "0110446008"
    },
    "created_date": "2022-02-04T18:38:27-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00786969",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "A12CX",
    "atc_description": "OTHER MINERAL SUPPLEMENTS",
    "anticipated_start_date": "2022-02-07T00:00:00-05:00",
    "estimated_end_date": "2022-02-25T00:00:00-05:00",
    "actual_end_date": "2022-03-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-03-15T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MICRO CU",
    "en_drug_common_name": "MICRO CU",
    "fr_drug_brand_name": "MICRO CU",
    "fr_drug_common_name": "MICRO CU",
    "en_ingredients": "COPPER",
    "fr_ingredients": "Cuivre",
    "drug_strength": "0.4MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10ML 10LIVI",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154319,
    "drug": {
      "current_status": "MARKETED",
      "id": 61716,
      "drug_code": 81460,
      "updated_date": "2025-05-15T02:32:29-04:00",
      "company": {
        "id": 458,
        "created_date": "2017-03-09T13:22:47-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 12573,
        "mfr_code": "",
        "name": "GE HEALTHCARE CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1919 MINNESOTA COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C9",
        "post_office_box": "",
        "contact_information": "800-387-7146   \r\n\r\ncanadainfo@gehealthcare.com"
      },
      "drug_ingredients": [
        {
          "id": 8257074,
          "ingredient": {
            "id": 1446,
            "ingredient_code": 8910,
            "en_name": "SODIUM THIOSULFATE",
            "fr_name": "Thiosulfate de Sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02328933",
      "brand_name": "TECHNETIUM TC 99M TSC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0109248003"
    },
    "created_date": "2022-02-07T17:15:32-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02328933",
    "company_name": "GE HEALTHCARE CANADA INC",
    "atc_number": "V09XX",
    "estimated_end_date": "2022-02-14T00:00:00-05:00",
    "actual_start_date": "2022-02-07T00:00:00-05:00",
    "actual_end_date": "2022-02-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-02-11T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TECHNETIUM TC 99M TSC",
    "en_drug_common_name": "Kit for the Preparation of Technetium Tc 99m Sulfur Colloid Injection",
    "fr_drug_brand_name": "Technétium Tc99m TSC",
    "fr_drug_common_name": "Trousse de préparation de colloïde sulfuré au technétium Tc99m injectable",
    "en_ingredients": "SODIUM THIOSULFATE",
    "fr_ingredients": "Thiosulfate de Sodium",
    "drug_strength": "2MG",
    "drug_dosage_form": "POWDER FOR SOLUTION\r\nKIT\r\nSOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution\r\nTrousse\r\nSolution",
    "drug_route": "ORAL\r\nINTRAVENOUS\r\nINTRAPERITONEAL\r\nORAL\r\nINTRAVENOUS\r\nINTRAPERITONEAL",
    "drug_route_fr": "Orale\r\nIntraveineuse\r\nIntrapéritonéale\r\nOrale\r\nIntraveineuse\r\nIntrapéritonéale",
    "drug_package_quantity": "5 kit package",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154333,
    "drug": {
      "current_status": "MARKETED",
      "id": 59669,
      "drug_code": 81546,
      "updated_date": "2025-05-15T02:32:29-04:00",
      "company": {
        "id": 10230,
        "created_date": "2018-10-02T03:00:06-04:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 14691,
        "mfr_code": "",
        "name": "JUBILANT DRAXIMAGE INC. DBA JUBILANT RADIOPHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "16751 TRANS CANADA HWY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4J4",
        "post_office_box": "",
        "contact_information": "Hiba Soulaihi \r\nHSoulaihi@jubl.com"
      },
      "drug_ingredients": [
        {
          "id": 8257094,
          "ingredient": {
            "id": 13851,
            "ingredient_code": 8086,
            "en_name": "SODIUM IODIDE 131 I",
            "fr_name": "Iodure 131 I de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "7400",
          "strength_unit": "MBq",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02329743",
      "brand_name": "DRAXIMAGE SODIUM IODIDE I131 CAPSULES, USP THERAPEUTIC",
      "brand_name_fr": "",
      "descriptor": "74 TO 7400 MBQ",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152597028"
    },
    "created_date": "2022-02-07T19:06:05-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02329743",
    "company_name": "JUBILANT DRAXIMAGE INC. DBA JUBILANT RADIOPHARMA",
    "atc_number": "V10XA",
    "estimated_end_date": "2022-03-07T00:00:00-05:00",
    "actual_start_date": "2022-01-10T00:00:00-05:00",
    "actual_end_date": "2022-03-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2022-03-08T06:00:02-05:00",
    "status": "resolved",
    "en_comments": "Jubilant is providing limited supply, therefore, product is not fully in shortage.",
    "fr_comments": "Jubilant fournit un approvisionnement limité, par conséquent, le produit n'est pas totalement en pénurie.",
    "en_drug_brand_name": "DRAXIMAGE SODIUM IODIDE I131 CAPSULES, USP THERAPEUTIC",
    "en_drug_common_name": "SODIUM IODIDE I131 CAPSULES, USP THERAPEUTIC",
    "fr_drug_brand_name": "DRAXIMAGE SODIUM IODIDE I131 CAPSULES, USP THERAPEUTIC",
    "fr_drug_common_name": "SODIUM IODIDE I131 CAPSULES, USP THERAPEUTIC",
    "en_ingredients": "SODIUM IODIDE 131 I",
    "fr_ingredients": "SODIUM IODIDE I131",
    "drug_strength": "7400MBq",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1 Capsule/Vial",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154362,
    "drug": {
      "current_status": "MARKETED",
      "id": 3260,
      "drug_code": 1830,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 216,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17065,
        "mfr_code": "",
        "name": "ASPEN PHARMACARE CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2030 BRISTOL CIRCLE, SUITE 201",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 0H2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250326,
          "ingredient": {
            "id": 664,
            "ingredient_code": 8926,
            "en_name": "EPINEPHRINE",
            "fr_name": "Épinéphrine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8250325,
          "ingredient": {
            "id": 164,
            "ingredient_code": 10225,
            "en_name": "LIDOCAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de lidocaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00284106",
      "brand_name": "XYLOCAINE 2% W EPINEPHRINE 1:200000",
      "brand_name_fr": "",
      "descriptor": "20 ML SINGLE USE VIAL",
      "pediatric_flag": false,
      "accession_number": "44825",
      "number_of_ais": "2",
      "ai_group_no": "0201284006"
    },
    "created_date": "2022-02-07T21:00:53-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00284106",
    "company_name": "ASPEN PHARMACARE CANADA INC.",
    "atc_number": "N01BB",
    "atc_description": "ANESTHETICS, LOCAL",
    "anticipated_start_date": "2022-06-15T00:00:00-04:00",
    "estimated_end_date": "2022-06-30T00:00:00-04:00",
    "actual_end_date": "2022-02-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-02-16T15:27:48-05:00",
    "status": "avoided_shortage",
    "en_comments": "VR44557CA1",
    "en_drug_brand_name": "XYLOCAINE 2% W EPINEPHRINE 1:200000",
    "en_drug_common_name": "lidocaine HCI 2% w/epin. 1:200M 10x20mL SU Vial",
    "fr_drug_brand_name": "XYLOCAINE 2% W EPINEPHRINE 1:200000",
    "fr_drug_common_name": "lidocaine HCI 2% w/epin. 1:200M 10x20mL SU Vial",
    "en_ingredients": "EPINEPHRINE\r\nLIDOCAINE HYDROCHLORIDE",
    "fr_ingredients": "Épinéphrine\r\nChlorhydrate de lidocaïne",
    "drug_strength": "5MCG\r\n20MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "EPIDURAL\r\nEPIDURAL",
    "drug_route_fr": "Épidurale\r\nÉpidurale",
    "drug_package_quantity": "10 vials",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154365,
    "drug": {
      "current_status": "MARKETED",
      "id": 2800,
      "drug_code": 16733,
      "updated_date": "2025-05-15T02:30:56-04:00",
      "company": {
        "id": 216,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17065,
        "mfr_code": "",
        "name": "ASPEN PHARMACARE CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2030 BRISTOL CIRCLE, SUITE 201",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 0H2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252149,
          "ingredient": {
            "id": 444,
            "ingredient_code": 9471,
            "en_name": "LIDOCAINE",
            "fr_name": "Lidocaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8252148,
          "ingredient": {
            "id": 442,
            "ingredient_code": 5776,
            "en_name": "PRILOCAINE",
            "fr_name": "Prilocaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02057794",
      "brand_name": "EMLA PATCH",
      "brand_name_fr": "TIMBRE EMLA",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "78649",
      "number_of_ais": "2",
      "ai_group_no": "0222447001"
    },
    "created_date": "2022-02-07T21:06:03-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02057794",
    "company_name": "ASPEN PHARMACARE CANADA INC.",
    "atc_number": "D04AB",
    "atc_description": "ANTIPRURITICS,INCL ANTIHIST,ANESTHET,ETC.",
    "anticipated_start_date": "2022-06-01T00:00:00-04:00",
    "estimated_end_date": "2022-06-30T00:00:00-04:00",
    "actual_end_date": "2022-02-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-02-16T15:30:02-05:00",
    "status": "avoided_shortage",
    "en_comments": "VR44862CA1",
    "en_drug_brand_name": "EMLA PATCH",
    "en_drug_common_name": "lidocaine 2.5% and prilocaine 2.5% 2x1g Patch",
    "fr_drug_brand_name": "Emla® Patch",
    "fr_drug_common_name": "lidocaine 2.5% and prilocaine 2.5% 2x1g Patch",
    "en_ingredients": "PRILOCAINE\r\nLIDOCAINE",
    "fr_ingredients": "Prilocaïne\r\nLidocaïne",
    "drug_strength": "2.5%\r\n2.5%",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "2 Patch",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154368,
    "drug": {
      "current_status": "MARKETED",
      "id": 17700,
      "drug_code": 78774,
      "updated_date": "2025-05-15T02:32:03-04:00",
      "company": {
        "id": 216,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17065,
        "mfr_code": "",
        "name": "ASPEN PHARMACARE CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2030 BRISTOL CIRCLE, SUITE 201",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 0H2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256219,
          "ingredient": {
            "id": 164,
            "ingredient_code": 10225,
            "en_name": "LIDOCAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de lidocaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02302438",
      "brand_name": "XYLOCAINE 2%",
      "brand_name_fr": "",
      "descriptor": "WITH PRESERVATIVE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101280001"
    },
    "created_date": "2022-02-07T21:23:07-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02302438",
    "company_name": "ASPEN PHARMACARE CANADA INC.",
    "atc_number": "N01BB",
    "atc_description": "ANESTHETICS, LOCAL",
    "anticipated_start_date": "2022-06-15T00:00:00-04:00",
    "estimated_end_date": "2022-06-30T00:00:00-04:00",
    "actual_end_date": "2022-02-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-02-16T15:30:38-05:00",
    "status": "avoided_shortage",
    "en_comments": "VR44565CA1",
    "en_drug_brand_name": "XYLOCAINE 2%",
    "en_drug_common_name": "lidocaine HCI 2% Plain 10x50mL MD Vial",
    "fr_drug_brand_name": "Xylocaine®",
    "fr_drug_common_name": "lidocaine HCI 2% Plain 10x50mL MD Vial",
    "en_ingredients": "LIDOCAINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de lidocaïne",
    "drug_strength": "20MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "BLOCK/INFILTRATION\r\nBLOCK/INFILTRATION",
    "drug_route_fr": "Bloc/Infiltration\r\nBloc/Infiltration",
    "drug_package_quantity": "10 vials",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154373,
    "drug": {
      "current_status": "MARKETED",
      "id": 6626,
      "drug_code": 4389,
      "updated_date": "2025-05-15T02:30:31-04:00",
      "company": {
        "id": 252,
        "created_date": "2017-03-09T13:22:38-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 3893,
        "mfr_code": "CHU08",
        "name": "CHURCH & DWIGHT CANADA CORP",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "635 SECRETARIAT COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5S 0A5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250630,
          "ingredient": {
            "id": 126,
            "ingredient_code": 7531,
            "en_name": "HYDROCORTISONE ACETATE",
            "fr_name": "Acétate d'hydrocortisone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8250629,
          "ingredient": {
            "id": 686,
            "ingredient_code": 8746,
            "en_name": "ZINC SULFATE",
            "fr_name": "Sulfate de zinc"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00505773",
      "brand_name": "ANUSOL-HC OINTMENT",
      "brand_name_fr": "ANUSOL-HC ONGUENT",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "57483",
      "number_of_ais": "2",
      "ai_group_no": "0214222001"
    },
    "created_date": "2022-02-07T22:05:31-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00505773",
    "company_name": "CHURCH & DWIGHT CANADA CORP",
    "atc_number": "C05AA",
    "atc_description": "AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE",
    "estimated_end_date": "2022-03-08T00:00:00-05:00",
    "actual_start_date": "2022-02-01T00:00:00-05:00",
    "actual_end_date": "2022-03-04T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-03-07T18:36:41-05:00",
    "status": "resolved",
    "en_comments": "Delay in the manufacture of the drug product",
    "fr_comments": "Délai de fabrication du produit",
    "en_drug_brand_name": "ANUSOL-HC OINTMENT",
    "en_drug_common_name": "Hydrocortisone Acetate - Zinc Sulfate monohydrate",
    "fr_drug_brand_name": "ANUSOL-HC ONGUENT",
    "fr_drug_common_name": "Acétate d'hydrocortisone / Sulfate de zinc",
    "en_ingredients": "ZINC SULFATE\r\nHYDROCORTISONE ACETATE",
    "fr_ingredients": "Sulfate de zinc\r\nAcétate d'hydrocortisone",
    "drug_strength": "0.5%\r\n0.5%",
    "drug_dosage_form": "OINTMENT",
    "drug_dosage_form_fr": "Pommade",
    "drug_route": "RECTAL\r\nRECTAL",
    "drug_route_fr": "Rectale\r\nRectale",
    "drug_package_quantity": "30g",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154375,
    "drug": {
      "current_status": "MARKETED",
      "id": 59673,
      "drug_code": 81548,
      "updated_date": "2025-05-15T02:32:29-04:00",
      "company": {
        "id": 10230,
        "created_date": "2018-10-02T03:00:06-04:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 14691,
        "mfr_code": "",
        "name": "JUBILANT DRAXIMAGE INC. DBA JUBILANT RADIOPHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "16751 TRANS CANADA HWY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4J4",
        "post_office_box": "",
        "contact_information": "Hiba Soulaihi \r\nHSoulaihi@jubl.com"
      },
      "drug_ingredients": [
        {
          "id": 8257096,
          "ingredient": {
            "id": 13851,
            "ingredient_code": 8086,
            "en_name": "SODIUM IODIDE 131 I",
            "fr_name": "Iodure 131 I de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "7400",
          "strength_unit": "MBq",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02329778",
      "brand_name": "DRAXIMAGE SODIUM IODIDE I131 SOLUTION, USP THERAPEUTIC",
      "brand_name_fr": "",
      "descriptor": "74 TO 7400 MBQ/ VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152597028"
    },
    "created_date": "2022-02-07T22:53:44-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02329778",
    "company_name": "JUBILANT DRAXIMAGE INC. DBA JUBILANT RADIOPHARMA",
    "atc_number": "V10XA",
    "estimated_end_date": "2022-03-07T00:00:00-05:00",
    "actual_start_date": "2022-01-10T00:00:00-05:00",
    "actual_end_date": "2022-03-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2022-03-08T06:00:02-05:00",
    "status": "resolved",
    "en_comments": "Jubilant is providing limited supply, therefore, product is not fully in shortage.",
    "fr_comments": "Jubilant fournit un approvisionnement limité, par conséquent, le produit n'est pas totalement en pénurie.",
    "en_drug_brand_name": "DRAXIMAGE SODIUM IODIDE I131 SOLUTION, USP THERAPEUTIC",
    "en_drug_common_name": "SODIUM IODIDE I131 SOLUTION, USP THERAPEUTIC",
    "fr_drug_brand_name": "DRAXIMAGE SODIUM IODIDE I131 SOLUTION, USP THERAPEUTIC",
    "fr_drug_common_name": "SODIUM IODIDE I131 SOLUTION, USP THERAPEUTIC",
    "en_ingredients": "SODIUM IODIDE 131 I",
    "fr_ingredients": "SODIUM IODIDE I131",
    "drug_strength": "7400MBq",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1/2 oz and 1 oz Vial",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154381,
    "drug": {
      "current_status": "MARKETED",
      "id": 59675,
      "drug_code": 81549,
      "updated_date": "2025-05-15T02:32:29-04:00",
      "company": {
        "id": 10230,
        "created_date": "2018-10-02T03:00:06-04:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 14691,
        "mfr_code": "",
        "name": "JUBILANT DRAXIMAGE INC. DBA JUBILANT RADIOPHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "16751 TRANS CANADA HWY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4J4",
        "post_office_box": "",
        "contact_information": "Hiba Soulaihi \r\nHSoulaihi@jubl.com"
      },
      "drug_ingredients": [
        {
          "id": 8257097,
          "ingredient": {
            "id": 13851,
            "ingredient_code": 8086,
            "en_name": "SODIUM IODIDE 131 I",
            "fr_name": "Iodure 131 I de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "925",
          "strength_unit": "MBq",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02329786",
      "brand_name": "DRAXIMAGE SODIUM IODIDE I131 SOLUTION, USP DIAGNOSTIC",
      "brand_name_fr": "",
      "descriptor": "74 TO 925 MBQ/ VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152597031"
    },
    "created_date": "2022-02-07T23:00:02-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02329786",
    "company_name": "JUBILANT DRAXIMAGE INC. DBA JUBILANT RADIOPHARMA",
    "atc_number": "V09FX",
    "estimated_end_date": "2022-03-07T00:00:00-05:00",
    "actual_start_date": "2022-01-10T00:00:00-05:00",
    "actual_end_date": "2022-03-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2022-03-08T06:00:02-05:00",
    "status": "resolved",
    "en_comments": "Jubilant is providing limited supply, therefore, product is not fully in shortage.",
    "fr_comments": "Jubilant fournit un approvisionnement limité, par conséquent, le produit n'est pas totalement en pénurie.",
    "en_drug_brand_name": "DRAXIMAGE SODIUM IODIDE I131 SOLUTION, USP DIAGNOSTIC",
    "en_drug_common_name": "SODIUM IODIDE I131 SOLUTION, USP DIAGNOSTIC",
    "fr_drug_brand_name": "DRAXIMAGE SODIUM IODIDE I131 SOLUTION, USP DIAGNOSTIC",
    "fr_drug_common_name": "SODIUM IODIDE I131 SOLUTION, USP DIAGNOSTIC",
    "en_ingredients": "SODIUM IODIDE 131 I",
    "fr_ingredients": "SODIUM IODIDE I131",
    "drug_strength": "925MBq",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1 Vial",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154388,
    "drug": {
      "current_status": "MARKETED",
      "id": 6886,
      "drug_code": 4630,
      "updated_date": "2025-05-15T02:30:31-04:00",
      "company": {
        "id": 252,
        "created_date": "2017-03-09T13:22:38-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 3893,
        "mfr_code": "CHU08",
        "name": "CHURCH & DWIGHT CANADA CORP",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "635 SECRETARIAT COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5S 0A5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250655,
          "ingredient": {
            "id": 686,
            "ingredient_code": 8746,
            "en_name": "ZINC SULFATE",
            "fr_name": "Sulfate de zinc"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8250654,
          "ingredient": {
            "id": 126,
            "ingredient_code": 7531,
            "en_name": "HYDROCORTISONE ACETATE",
            "fr_name": "Acétate d'hydrocortisone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00476285",
      "brand_name": "ANUSOL-HC SUPPOSITORIES",
      "brand_name_fr": "ANUSOL-HC SUPPOSITOIRES",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "58291",
      "number_of_ais": "2",
      "ai_group_no": "0214222002"
    },
    "created_date": "2022-02-08T01:19:59-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00476285",
    "company_name": "CHURCH & DWIGHT CANADA CORP",
    "atc_number": "C05AA",
    "atc_description": "AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE",
    "estimated_end_date": "2022-03-05T00:00:00-05:00",
    "actual_start_date": "2022-02-01T00:00:00-05:00",
    "actual_end_date": "2022-03-04T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-03-07T18:35:13-05:00",
    "status": "resolved",
    "en_comments": "Delay in the manufacture of the drug product",
    "fr_comments": "Délai de fabrication du produit",
    "en_drug_brand_name": "ANUSOL-HC SUPPOSITORIES",
    "en_drug_common_name": "Hydrocortisone acetate / Zinc Sulfate",
    "fr_drug_brand_name": "ANUSOL-HC SUPPOSITOIRES",
    "fr_drug_common_name": "Acétate d'hydrocortisone / Sulfate de zinc",
    "en_ingredients": "ZINC SULFATE\r\nHYDROCORTISONE ACETATE",
    "fr_ingredients": "Sulfate de zinc\r\nAcétate d'hydrocortisone",
    "drug_strength": "10MG\r\n10MG",
    "drug_dosage_form": "SUPPOSITORY",
    "drug_dosage_form_fr": "Suppositoire",
    "drug_route": "RECTAL\r\nRECTAL",
    "drug_route_fr": "Rectale\r\nRectale",
    "drug_package_quantity": "24 units box",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154400,
    "drug": {
      "current_status": "MARKETED",
      "id": 10806,
      "drug_code": 66636,
      "updated_date": "2025-05-15T02:31:12-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8254083,
          "ingredient": {
            "id": 2312,
            "ingredient_code": 9011,
            "en_name": "SCOPOLAMINE HYDROBROMIDE",
            "fr_name": "Bromhydrate de scopolamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.6",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02242811",
      "brand_name": "SCOPOLAMINE HYDROBROMIDE INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104674004"
    },
    "created_date": "2022-02-08T14:20:13-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242811",
    "company_name": "OMEGA LABORATORIES LIMITED",
    "atc_number": "N05CM",
    "atc_description": "HYPNOTICS AND SEDATIVES",
    "estimated_end_date": "2022-03-10T00:00:00-05:00",
    "actual_start_date": "2022-02-08T00:00:00-05:00",
    "actual_end_date": "2022-03-11T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-03-14T12:57:55-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SCOPOLAMINE HYDROBROMIDE INJECTION",
    "en_drug_common_name": "Scopolamine Hydrobromide Injection",
    "fr_drug_brand_name": "Injection de bromhydrate de scopolamine",
    "fr_drug_common_name": "Injection de bromhydrate de scopolamine",
    "en_ingredients": "SCOPOLAMINE HYDROBROMIDE",
    "fr_ingredients": "Bromhydrate de scopolamine",
    "drug_strength": "0.6MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR\r\nSUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nIntramusculaire\r\nSous-cutanée\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "10 x 1mL vial /fiole",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154429,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 3970,
      "drug_code": 19627,
      "updated_date": "2025-05-15T03:45:41-04:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8303604,
          "ingredient": {
            "id": 1584,
            "ingredient_code": 1255,
            "en_name": "OCTREOTIDE",
            "fr_name": "Octréotide (Acétate d'octréotide)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": true
        }
      ],
      "din": "02049392",
      "brand_name": "SANDOSTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81924",
      "number_of_ais": "1",
      "ai_group_no": "0121548003"
    },
    "created_date": "2022-02-08T16:41:27-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02049392",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "H01CB",
    "atc_description": "HYPOTHALAMIC HORMONES",
    "discontinuation_date": "2022-02-14T00:00:00-05:00",
    "anticipated_discontinuation_date": "2022-02-28T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2022-03-07T18:33:20-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "SANDOSTATIN",
    "en_drug_common_name": "SANDOSTATIN MDV 200MG 5ML",
    "fr_drug_brand_name": "SANDOSTATIN",
    "fr_drug_common_name": "SANDOSTATIN MDV 200MG X 5ML",
    "en_ingredients": "OCTREOTIDE",
    "fr_ingredients": "OCTREOTIDE",
    "drug_strength": "200MCG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nSUBCUTANEOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nSous-cutanée\r\nIntraveineuse",
    "drug_package_quantity": "5ML",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154439,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 8730,
      "drug_code": 6067,
      "updated_date": "2025-05-15T03:29:24-04:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8279690,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00632775",
      "brand_name": "RITALIN-SR TAB 20MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "62218",
      "number_of_ais": "1",
      "ai_group_no": "0107548002"
    },
    "created_date": "2022-02-08T16:52:36-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00632775",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "discontinuation_date": "2022-04-01T00:00:00-04:00",
    "anticipated_discontinuation_date": "2022-03-31T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2022-04-05T22:22:04-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "RITALIN-SR TAB 20MG",
    "en_drug_common_name": "RITALIN SR 20MG  100'S",
    "fr_drug_brand_name": "RITALIN",
    "fr_drug_common_name": "RITALIN SR 20MG X 100'S",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100'S",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154442,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 3862,
      "drug_code": 19436,
      "updated_date": "2025-05-15T03:45:35-04:00",
      "company": {
        "id": 318,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4174,
        "mfr_code": "FEI08",
        "name": "FERRING INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "500",
        "street_name": "200 YORKLAND BLVD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2J 5C1",
        "post_office_box": "",
        "contact_information": "1-800-263-4057"
      },
      "drug_ingredients": [
        {
          "id": 8303070,
          "ingredient": {
            "id": 970,
            "ingredient_code": 2155,
            "en_name": "DESMOPRESSIN ACETATE",
            "fr_name": "Acétate de desmopressine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00824305",
      "brand_name": "DDAVP TABLETS 0.1MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81733",
      "number_of_ais": "1",
      "ai_group_no": "0112050005"
    },
    "created_date": "2022-02-08T18:24:25-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00824305",
    "company_name": "FERRING INC",
    "atc_number": "H01BA",
    "atc_description": "POSTERIOR PITUITARY LOBE HORMONES",
    "discontinuation_date": "2022-02-28T00:00:00-05:00",
    "anticipated_discontinuation_date": "2022-02-28T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2022-03-07T16:01:04-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "DDAVP TABLETS 0.1MG",
    "en_drug_common_name": "Desmopressin Acetate",
    "fr_drug_brand_name": "COMPRIMÉS DDAVP",
    "fr_drug_common_name": "Acétate de desmopressine",
    "en_ingredients": "DESMOPRESSIN ACETATE",
    "fr_ingredients": "Acétate de desmopressine",
    "drug_strength": "0.1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 tablets bottle",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154449,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 18728,
      "drug_code": 800,
      "updated_date": "2025-05-15T03:23:45-04:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8270865,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00005606",
      "brand_name": "RITALIN 10MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "29957",
      "number_of_ais": "1",
      "ai_group_no": "0107548001"
    },
    "created_date": "2022-02-08T18:46:52-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00005606",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "discontinuation_date": "2022-05-03T00:00:00-04:00",
    "anticipated_discontinuation_date": "2022-04-30T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2022-05-11T13:59:11-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "RITALIN 10MG",
    "en_drug_common_name": "RITALIN 10MG TABS 100'S",
    "fr_drug_brand_name": "RITALIN 10MG",
    "fr_drug_common_name": "RITALIN 10MG TABS 100'S",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100'S",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154453,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 3866,
      "drug_code": 19441,
      "updated_date": "2025-05-15T03:45:35-04:00",
      "company": {
        "id": 318,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4174,
        "mfr_code": "FEI08",
        "name": "FERRING INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "500",
        "street_name": "200 YORKLAND BLVD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2J 5C1",
        "post_office_box": "",
        "contact_information": "1-800-263-4057"
      },
      "drug_ingredients": [
        {
          "id": 8303075,
          "ingredient": {
            "id": 970,
            "ingredient_code": 2155,
            "en_name": "DESMOPRESSIN ACETATE",
            "fr_name": "Acétate de desmopressine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00824143",
      "brand_name": "DDAVP TABLETS 0.2MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81738",
      "number_of_ais": "1",
      "ai_group_no": "0112050003"
    },
    "created_date": "2022-02-08T18:49:50-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00824143",
    "company_name": "FERRING INC",
    "atc_number": "H01BA",
    "atc_description": "POSTERIOR PITUITARY LOBE HORMONES",
    "discontinuation_date": "2022-02-28T00:00:00-05:00",
    "anticipated_discontinuation_date": "2022-02-28T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2022-03-01T06:00:03-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "DDAVP TABLETS 0.2MG",
    "en_drug_common_name": "Desmopressin Acetate",
    "fr_drug_brand_name": "COMPRIMÉS DDAVP",
    "fr_drug_common_name": "Acétate de desmopressine",
    "en_ingredients": "DESMOPRESSIN ACETATE",
    "fr_ingredients": "Acétate de desmopressine",
    "drug_strength": "0.2MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 tablets bottle",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154456,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 3866,
      "drug_code": 19441,
      "updated_date": "2025-05-15T03:45:35-04:00",
      "company": {
        "id": 318,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4174,
        "mfr_code": "FEI08",
        "name": "FERRING INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "500",
        "street_name": "200 YORKLAND BLVD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2J 5C1",
        "post_office_box": "",
        "contact_information": "1-800-263-4057"
      },
      "drug_ingredients": [
        {
          "id": 8303075,
          "ingredient": {
            "id": 970,
            "ingredient_code": 2155,
            "en_name": "DESMOPRESSIN ACETATE",
            "fr_name": "Acétate de desmopressine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00824143",
      "brand_name": "DDAVP TABLETS 0.2MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81738",
      "number_of_ais": "1",
      "ai_group_no": "0112050003"
    },
    "created_date": "2022-02-08T18:51:49-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00824143",
    "company_name": "FERRING INC",
    "atc_number": "H01BA",
    "atc_description": "POSTERIOR PITUITARY LOBE HORMONES",
    "discontinuation_date": "2022-05-31T00:00:00-04:00",
    "anticipated_discontinuation_date": "2022-05-31T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2022-06-01T05:00:04-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "DDAVP TABLETS 0.2MG",
    "en_drug_common_name": "Desmopressin Acetate",
    "fr_drug_brand_name": "COMPRIMÉS DDAVP",
    "fr_drug_common_name": "Acétate de desmopressine",
    "en_ingredients": "DESMOPRESSIN ACETATE",
    "fr_ingredients": "Acétate de desmopressine",
    "drug_strength": "0.2MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 tablets bottle",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154459,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 16264,
      "drug_code": 77054,
      "updated_date": "2025-05-15T04:11:38-04:00",
      "company": {
        "id": 318,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4174,
        "mfr_code": "FEI08",
        "name": "FERRING INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "500",
        "street_name": "200 YORKLAND BLVD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2J 5C1",
        "post_office_box": "",
        "contact_information": "1-800-263-4057"
      },
      "drug_ingredients": [
        {
          "id": 8343139,
          "ingredient": {
            "id": 3340,
            "ingredient_code": 19910,
            "en_name": "DESMOPRESSIN",
            "fr_name": "Desmopressine (Acétate de desmopressine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "240",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02285010",
      "brand_name": "DDAVP MELT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151664003"
    },
    "created_date": "2022-02-08T18:55:57-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02285010",
    "company_name": "FERRING INC",
    "atc_number": "H01BA",
    "atc_description": "POSTERIOR PITUITARY LOBE HORMONES",
    "discontinuation_date": "2022-03-31T00:00:00-04:00",
    "anticipated_discontinuation_date": "2022-03-31T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2022-04-01T05:00:04-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "DDAVP MELT",
    "en_drug_common_name": "Desmopressin Acetate",
    "fr_drug_brand_name": "DDAVP MELT",
    "fr_drug_common_name": "Acétate de desmopressine",
    "en_ingredients": "DESMOPRESSIN",
    "fr_ingredients": "Acétate de desmopressine",
    "drug_strength": "240MCG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "SUBLINGUAL\r\nSUBLINGUAL",
    "drug_route_fr": "Sublinguale\r\nSublinguale",
    "drug_package_quantity": "30 melt tablets per carton",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154470,
    "drug": {
      "current_status": "MARKETED",
      "id": 3870,
      "drug_code": 19443,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252490,
          "ingredient": {
            "id": 1560,
            "ingredient_code": 5881,
            "en_name": "PROTAMINE SULFATE",
            "fr_name": "Sulfate de protamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02139537",
      "brand_name": "PROTAMINE SULFATE INJECTION, USP",
      "brand_name_fr": "SULFATE DE PROTAMINE INJECTABLE, USP",
      "descriptor": "SINGLE-DOSE VIAL",
      "pediatric_flag": false,
      "accession_number": "81740",
      "number_of_ais": "1",
      "ai_group_no": "0107652001"
    },
    "created_date": "2022-02-08T19:40:57-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02139537",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "V03AB",
    "atc_description": "ALL OTHER THERAPEUTIC PRODUCTS",
    "anticipated_start_date": "2022-02-04T00:00:00-05:00",
    "estimated_end_date": "2022-03-01T00:00:00-05:00",
    "actual_start_date": "2022-02-04T00:00:00-05:00",
    "actual_end_date": "2022-03-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-03-04T21:29:38-05:00",
    "status": "resolved",
    "en_comments": "Fresenius Kabi Canada regrets to advise that due to a production delay, we will be encountering a supply interruption on our Protamine Sulfate Injection, USP 10mg/mL Vial 5mL effective February 4, 2022 until March 1, 2022. Our Protamine Sulfate Injection, USP 10mg/mL SD Vial 25mL format is available for substitution.",
    "fr_comments": "Au nom de Fresenius Kabi Canada Ltée, j’ai le regret de vous aviser qu’en raison d’un retard de production, nous allons éprouver une interruption d’approvisionnement qui va toucher notre préparation de Sulfate de protamine injectable à 10 mg/mL en fioles DU de 5 mL, du 4 février 2022 au 1er mars 2022. Notre présentation de Sulfate de protamine injectable, USP à 10 mg/mL en fioles DU de 25 mL est disponible en guise de substitut.",
    "en_drug_brand_name": "PROTAMINE SULFATE INJECTION, USP",
    "en_drug_common_name": "Protamine Sulfate Injection, USP 10mg/mL SD Vial 5mL",
    "fr_drug_brand_name": "SULFATE DE PROTAMINE",
    "fr_drug_common_name": "Sulfate de protamine injectable, USP à 10 mg/mL, fioles de 5 mL",
    "en_ingredients": "PROTAMINE SULFATE",
    "fr_ingredients": "Sulfate de protamine",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "5mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154473,
    "drug": {
      "current_status": "MARKETED",
      "id": 100246,
      "drug_code": 98600,
      "updated_date": "2020-04-03T06:54:32-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8264805,
          "ingredient": {
            "id": 3042,
            "ingredient_code": 13153,
            "en_name": "ERTAPENEM",
            "fr_name": "Ertapénem (Ertapénem sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02496127",
      "brand_name": "ERTAPENEM FOR INJECTION",
      "brand_name_fr": "",
      "descriptor": "SINGLE USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149104002"
    },
    "created_date": "2022-02-08T19:44:42-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02496127",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "J01DH",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "actual_start_date": "2022-05-02T00:00:00-04:00",
    "actual_end_date": "2022-09-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-09-21T16:46:00-04:00",
    "status": "resolved",
    "en_comments": "On 100% allocation.",
    "fr_comments": "Sur 100 % allocation",
    "en_drug_brand_name": "ERTAPENEM FOR INJECTION",
    "en_drug_common_name": "Ertapenem for Injection, 1g SD Vial 20mL",
    "fr_drug_brand_name": "ERTAPENEM POUR INJECTION",
    "fr_drug_common_name": "Ertapénem pour injection, 1 g, fioles DU de 20 mL",
    "en_ingredients": "ERTAPENEM",
    "fr_ingredients": "ERTAPENEM",
    "drug_strength": "1G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "20mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154476,
    "drug": {
      "current_status": "MARKETED",
      "id": 25294,
      "drug_code": 87773,
      "updated_date": "2025-05-15T02:33:40-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259168,
          "ingredient": {
            "id": 170,
            "ingredient_code": 9060,
            "en_name": "HEPARIN SODIUM",
            "fr_name": "Héparine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02392453",
      "brand_name": "HEPARIN SODIUM INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "PRESERVATIVE-FREE. 0.5ML SINGLE-DOSE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104596002"
    },
    "created_date": "2022-02-08T19:48:34-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02392453",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "B01AB",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "estimated_end_date": "2022-04-18T00:00:00-04:00",
    "actual_start_date": "2022-02-01T00:00:00-05:00",
    "actual_end_date": "2022-04-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-13T20:41:16-04:00",
    "status": "resolved",
    "en_comments": "Fresenius Kabi Canada regrets to advise that due to a production delay, our Heparin Sodium Injection, USP 10,000USP units/mL SD Vial 0.5mL allocations will be reduced to 50% effective February 1, 2022 and will be on backorder effective March 1, 2022 until April 18, 2022.",
    "fr_comments": "Fresenius Kabi Canada a le regret de vous informer qu’en raison d’un retard de production, nos allocations sur l’Héparine sodique injectable, USP à 10 000 unités USP/mL en fioles DU de 0,5 mL seront réduites à 50 % à compter du 1er février 2022. De plus, cette présentation sera en rupture de stock du 1er mars 2022 au 18 avril 2022.",
    "en_drug_brand_name": "HEPARIN SODIUM INJECTION, USP",
    "en_drug_common_name": "Heparin Sodium Injection, USP 10,000USP units/mL SD Vial 0.5mL",
    "fr_drug_brand_name": "Héparine sodique injectable",
    "fr_drug_common_name": "Héparine sodique injectable USP, à 10 000 unités USP/mL, en fioles DU de 0,5 mL",
    "en_ingredients": "HEPARIN SODIUM",
    "fr_ingredients": "Héparine sodique",
    "drug_strength": "10000UNIT",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nSUBCUTANEOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nSous-cutanée\r\nIntraveineuse",
    "drug_package_quantity": "0.5mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154479,
    "drug": {
      "current_status": "MARKETED",
      "id": 100125,
      "drug_code": 98382,
      "updated_date": "2021-10-08T04:04:24-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8264567,
          "ingredient": {
            "id": 3158,
            "ingredient_code": 13348,
            "en_name": "VORICONAZOLE",
            "fr_name": "Voriconazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02493829",
      "brand_name": "VORICONAZOLE FOR INJECTION",
      "brand_name_fr": "VORICONAZOLE POUR INJECTION",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150242002"
    },
    "created_date": "2022-02-08T19:51:08-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02493829",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "J02AC",
    "atc_description": "ANTIMYCOTICS FOR SYSTEMIC USE",
    "estimated_end_date": "2022-11-30T00:00:00-05:00",
    "actual_start_date": "2022-02-01T00:00:00-05:00",
    "actual_end_date": "2022-11-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-12-05T03:59:29-05:00",
    "status": "resolved",
    "en_comments": "Effective May 2, 2022 this product will be placed on allocation. Contract customers will be allocated 100% of historical monthly demand.",
    "fr_comments": "À compter du 2 mai 2022, ce produit sera mis en attribution. Les clients sous contrat se verront attribuer 100 % de la demande mensuelle historique.",
    "en_drug_brand_name": "VORICONAZOLE FOR INJECTION",
    "en_drug_common_name": "Voriconazole for Injection, 200mg SD Vial 30mL",
    "fr_drug_brand_name": "Voriconazole pour injection",
    "fr_drug_common_name": "Voriconazole pour injection, 200 mg, fioles DU de 30 mL",
    "en_ingredients": "VORICONAZOLE",
    "fr_ingredients": "Voriconazole",
    "drug_strength": "200MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "30mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154482,
    "drug": {
      "current_status": "MARKETED",
      "id": 14682,
      "drug_code": 74973,
      "updated_date": "2025-05-15T02:31:39-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255279,
          "ingredient": {
            "id": 170,
            "ingredient_code": 9060,
            "en_name": "HEPARIN SODIUM",
            "fr_name": "Héparine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02264307",
      "brand_name": "HEPARIN SODIUM INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "WITH PRESERVATIVE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104596002"
    },
    "created_date": "2022-02-08T20:10:15-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02264307",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "B01AB",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "estimated_end_date": "2023-02-21T00:00:00-05:00",
    "actual_start_date": "2022-02-01T00:00:00-05:00",
    "actual_end_date": "2023-02-15T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2023-02-24T14:23:37-05:00",
    "status": "resolved",
    "en_comments": "On backorder effective September 1, 2022 until February 21, 2023",
    "fr_comments": "En rupture de stock à compter du 1er septembre 2022 jusqu'au 21 février 2023.",
    "en_drug_brand_name": "HEPARIN SODIUM INJECTION, USP",
    "en_drug_common_name": "Heparin Sodium Injection, USP 10 000 USP units/mL MD Vial 1 mL",
    "fr_drug_brand_name": "Héparine sodique injectable",
    "fr_drug_common_name": "Héparine sodique pour injection, USP, 10 000 unités USP/mL, fioles DM, 1 mL",
    "en_ingredients": "HEPARIN SODIUM",
    "fr_ingredients": "Héparine sodique",
    "drug_strength": "10000UNIT",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nSUBCUTANEOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nSous-cutanée\r\nIntraveineuse",
    "drug_package_quantity": "1mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154485,
    "drug": {
      "current_status": "MARKETED",
      "id": 26524,
      "drug_code": 88832,
      "updated_date": "2025-05-15T02:33:53-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259575,
          "ingredient": {
            "id": 10,
            "ingredient_code": 42,
            "en_name": "DEXTROSE",
            "fr_name": "Dextrose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02403536",
      "brand_name": "5% DEXTROSE INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0102181006"
    },
    "created_date": "2022-02-08T20:34:05-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02403536",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "B05BA",
    "atc_description": "I.V. SOLUTIONS",
    "estimated_end_date": "2022-03-22T00:00:00-04:00",
    "actual_start_date": "2022-02-04T00:00:00-05:00",
    "actual_end_date": "2022-03-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-07-07T15:51:36-04:00",
    "status": "resolved",
    "en_comments": "Fresenius Kabi Canada regrets to advise that due to a production delay, we will be encountering a supply interruption on our Dextrose 5% Injection freeflex® Bag 50mL effective today, February 4, 2022 until March 22, 2022.",
    "fr_comments": "Au nom de Fresenius Kabi Canada Ltée, j’ai le regret de vous aviser qu’en raison d’un retard de production, nous allons éprouver une interruption d’approvisionnement qui va toucher notre présentation de Dextrose injectable à 5 % en sacs freeflexMD de 50 mL à partir d'aujourd'hui, le 4 février 2022 jusqu'au 22 mars 2022.",
    "en_drug_brand_name": "DEXTROSE 5% INJECTION",
    "en_drug_common_name": "Dextrose 5% Injection freeflex® Bag 50mL",
    "fr_drug_brand_name": "Dextrose injectable",
    "fr_drug_common_name": "Dextrose injectable à 5 % en sacs freeflexMD de 50 mL",
    "en_ingredients": "DEXTROSE",
    "fr_ingredients": "Dextrose",
    "drug_strength": "50MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "50ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154488,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 53053,
      "drug_code": 95243,
      "updated_date": "2025-05-15T04:25:09-04:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8357309,
          "ingredient": {
            "id": 7984,
            "ingredient_code": 22870,
            "en_name": "LIXISENATIDE",
            "fr_name": "Lixisénatide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02464276",
      "brand_name": "ADLYXINE",
      "brand_name_fr": "",
      "descriptor": "PRE-FILLED PEN",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0159090003"
    },
    "created_date": "2022-02-08T20:56:19-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02464276",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "A10BJ",
    "estimated_end_date": "2022-03-31T00:00:00-04:00",
    "actual_start_date": "2022-02-01T00:00:00-05:00",
    "actual_end_date": "2022-03-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-03-29T18:36:00-04:00",
    "status": "resolved",
    "en_comments": "Supply delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.",
    "fr_comments": "Retard en approvisionnement. La date estimée de disponibilité représente des estimées de disponibilités à l’entrepôt de Sanofi. Les dates de disponibilités à l’entrepôt des distributeurs peuvent varier. Les pharmacies sont invitées à communiquer avec leurs distributeurs préférentiels pour obtenir la date de disponibilité des produits.",
    "en_drug_brand_name": "ADLYXINE",
    "en_drug_common_name": "Adlyxine",
    "fr_drug_brand_name": "ADLYXINE",
    "fr_drug_common_name": "Adlyxine",
    "en_ingredients": "LIXISENATIDE",
    "fr_ingredients": "Lixisenatide injection",
    "drug_strength": "10MCG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée\r\nSous-cutanée",
    "drug_package_quantity": "1",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154511,
    "drug": {
      "current_status": "MARKETED",
      "id": 12998,
      "drug_code": 72248,
      "updated_date": "2025-05-15T02:31:28-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8254748,
          "ingredient": {
            "id": 1902,
            "ingredient_code": 7387,
            "en_name": "VASOPRESSIN",
            "fr_name": "Vasopressine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02247938",
      "brand_name": "VASOPRESSIN INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106469001"
    },
    "created_date": "2022-02-09T03:56:57-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247938",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "H01BA",
    "atc_description": "POSTERIOR PITUITARY LOBE HORMONES",
    "estimated_end_date": "2022-02-18T00:00:00-05:00",
    "actual_start_date": "2022-02-08T00:00:00-05:00",
    "actual_end_date": "2022-02-24T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-02-25T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "VASOPRESSIN INJECTION USP",
    "en_drug_common_name": "VASOPRESSIN",
    "fr_drug_brand_name": "VASOPRESSIN INJECTION USP",
    "fr_drug_common_name": "VASOPRESSIN",
    "en_ingredients": "VASOPRESSIN",
    "fr_ingredients": "Vasopressine",
    "drug_strength": "20UNIT",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAMUSCULAR\r\nSUBCUTANEOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Sous-cutanée\r\nIntramusculaire\r\nSous-cutanée\r\nIntramusculaire",
    "drug_package_quantity": "5ML 1LIVI",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154514,
    "drug": {
      "current_status": "MARKETED",
      "id": 28536,
      "drug_code": 90661,
      "updated_date": "2025-05-15T02:34:15-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8260349,
          "ingredient": {
            "id": 2586,
            "ingredient_code": 11787,
            "en_name": "CAPECITABINE",
            "fr_name": "Capécitabine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02421917",
      "brand_name": "SANDOZ CAPECITABINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0134120001"
    },
    "created_date": "2022-02-09T03:58:22-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02421917",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "L01BC",
    "atc_description": "ANTIMETABOLITES",
    "estimated_end_date": "2022-02-11T00:00:00-05:00",
    "actual_start_date": "2022-02-08T00:00:00-05:00",
    "actual_end_date": "2022-02-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-02-18T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ CAPECITABINE",
    "en_drug_common_name": "CAPECITABINE",
    "fr_drug_brand_name": "SANDOZ CAPECITABINE",
    "fr_drug_common_name": "CAPECITABINE",
    "en_ingredients": "CAPECITABINE",
    "fr_ingredients": "Capécitabine",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60FCT",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154517,
    "drug": {
      "current_status": "MARKETED",
      "id": 51283,
      "drug_code": 94884,
      "updated_date": "2025-05-15T02:35:44-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8262336,
          "ingredient": {
            "id": 274,
            "ingredient_code": 1327,
            "en_name": "GLICLAZIDE",
            "fr_name": "Gliclazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02461331",
      "brand_name": "SANDOZ GLICLAZIDE MR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0119934003"
    },
    "created_date": "2022-02-09T03:59:50-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02461331",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "A10BB",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "estimated_end_date": "2022-02-25T00:00:00-05:00",
    "actual_start_date": "2022-02-08T00:00:00-05:00",
    "actual_end_date": "2022-02-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-02-18T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ GLICLAZIDE MR",
    "en_drug_common_name": "GLICLAZIDE",
    "fr_drug_brand_name": "SANDOZ GLICLAZIDE MR",
    "fr_drug_common_name": "GLICLAZIDE",
    "en_ingredients": "GLICLAZIDE",
    "fr_ingredients": "Gliclazide",
    "drug_strength": "60MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100MRT BO",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154520,
    "drug": {
      "current_status": "MARKETED",
      "id": 13698,
      "drug_code": 73540,
      "updated_date": "2025-05-15T02:31:34-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8254938,
          "ingredient": {
            "id": 2898,
            "ingredient_code": 12209,
            "en_name": "MIRTAZAPINE",
            "fr_name": "Mirtazapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02250594",
      "brand_name": "SANDOZ MIRTAZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0143928001"
    },
    "created_date": "2022-02-09T04:01:14-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02250594",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2022-03-11T00:00:00-05:00",
    "actual_start_date": "2022-02-08T00:00:00-05:00",
    "actual_end_date": "2022-03-03T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2022-03-04T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ MIRTAZAPINE",
    "en_drug_common_name": "MIRTAZAPINE",
    "fr_drug_brand_name": "SANDOZ MIRTAZAPINE",
    "fr_drug_common_name": "MIRTAZAPINE",
    "en_ingredients": "MIRTAZAPINE",
    "fr_ingredients": "Mirtazapine",
    "drug_strength": "15MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "50FCT BO",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154523,
    "drug": {
      "current_status": "MARKETED",
      "id": 2166,
      "drug_code": 14577,
      "updated_date": "2025-12-03T00:30:32-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8251985,
          "ingredient": {
            "id": 1094,
            "ingredient_code": 9967,
            "en_name": "GLYCOPYRROLATE",
            "fr_name": "Glycopyrrolate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02039508",
      "brand_name": "GLYCOPYRROLATE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "76226",
      "number_of_ais": "1",
      "ai_group_no": "0102396002"
    },
    "created_date": "2022-02-09T04:02:38-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02039508",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "A03AB",
    "atc_description": "DRUGS FOR FUNCTIONAL BOWEL DISORDERS",
    "estimated_end_date": "2022-03-18T00:00:00-04:00",
    "actual_start_date": "2022-02-08T00:00:00-05:00",
    "actual_end_date": "2022-03-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2022-03-15T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "GLYCOPYRROLATE INJECTION USP",
    "en_drug_common_name": "GLYCOPYRROLATE",
    "fr_drug_brand_name": "GLYCOPYRROLATE INJECTION USP",
    "fr_drug_common_name": "GLYCOPYRROLATE",
    "en_ingredients": "GLYCOPYRROLATE",
    "fr_ingredients": "Glycopyrrolate",
    "drug_strength": "0.2MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "2ML 10LIVI",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154568,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 29634,
      "drug_code": 9167,
      "updated_date": "2025-05-15T03:34:48-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8284761,
          "ingredient": {
            "id": 284,
            "ingredient_code": 2144,
            "en_name": "PINDOLOL",
            "fr_name": "Pindolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00755877",
      "brand_name": "APO-PINDOL TAB 5MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "68037",
      "number_of_ais": "1",
      "ai_group_no": "0112362001"
    },
    "created_date": "2022-02-09T18:23:33-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00755877",
    "company_name": "APOTEX INC",
    "atc_number": "C07AA",
    "atc_description": "BETA BLOCKING AGENTS",
    "discontinuation_date": "2022-02-09T00:00:00-05:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "there is no inventory remaining of this strength",
    "fr_supply_disruption_mitigation": "there is no inventory remaining of this strength",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2022-02-10T06:00:04-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "APO-PINDOL TAB 5MG",
    "en_drug_common_name": "PINDOLOL",
    "fr_drug_brand_name": "APO-PINDOL",
    "fr_drug_common_name": "PINDOLOL",
    "en_ingredients": "PINDOLOL",
    "fr_ingredients": "Pindolol",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154571,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 29642,
      "drug_code": 9168,
      "updated_date": "2025-05-15T03:34:48-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8284762,
          "ingredient": {
            "id": 284,
            "ingredient_code": 2144,
            "en_name": "PINDOLOL",
            "fr_name": "Pindolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00755885",
      "brand_name": "APO-PINDOL TAB 10MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "68038",
      "number_of_ais": "1",
      "ai_group_no": "0112362003"
    },
    "created_date": "2022-02-09T18:26:06-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00755885",
    "company_name": "APOTEX INC",
    "atc_number": "C07AA",
    "atc_description": "BETA BLOCKING AGENTS",
    "discontinuation_date": "2022-02-09T00:00:00-05:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "there is no inventory remaining of this strength",
    "fr_supply_disruption_mitigation": "there is no inventory remaining of this strength",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2022-02-10T06:00:04-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "APO-PINDOL TAB 10MG",
    "en_drug_common_name": "PINDOLOL",
    "fr_drug_brand_name": "APO-PINDOL",
    "fr_drug_common_name": "PINDOLOL",
    "en_ingredients": "PINDOLOL",
    "fr_ingredients": "Pindolol",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL and 500 BTL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154574,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 29658,
      "drug_code": 9169,
      "updated_date": "2025-05-15T03:34:48-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8284763,
          "ingredient": {
            "id": 284,
            "ingredient_code": 2144,
            "en_name": "PINDOLOL",
            "fr_name": "Pindolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00755893",
      "brand_name": "APO-PINDOL TAB 15MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "68039",
      "number_of_ais": "1",
      "ai_group_no": "0112362002"
    },
    "created_date": "2022-02-09T18:30:00-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00755893",
    "company_name": "APOTEX INC",
    "atc_number": "C07AA",
    "atc_description": "BETA BLOCKING AGENTS",
    "discontinuation_date": "2022-09-28T00:00:00-04:00",
    "anticipated_discontinuation_date": "2022-06-03T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2022-12-09T14:42:37-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "APO-PINDOL TAB 15MG",
    "en_drug_common_name": "PINDOLOL",
    "fr_drug_brand_name": "APO-PINDOL",
    "fr_drug_common_name": "PINDOLOL",
    "en_ingredients": "PINDOLOL",
    "fr_ingredients": "Pindolol",
    "drug_strength": "15MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154624,
    "drug": {
      "current_status": "MARKETED",
      "id": 29954,
      "drug_code": 92020,
      "updated_date": "2025-12-03T00:32:42-05:00",
      "company": {
        "id": 412,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5661,
        "mfr_code": "BSH95",
        "name": "BAUSCH & LOMB INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1400 N GOODMAN STREET",
        "province": "NEW YORK",
        "country": "UNITED STATES",
        "city": "ROCHESTER",
        "postal_code": "14609",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260886,
          "ingredient": {
            "id": 3518,
            "ingredient_code": 20429,
            "en_name": "LOTEPREDNOL ETABONATE",
            "fr_name": "Étabonate de lotéprednol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02435853",
      "brand_name": "LOTEMAX GEL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152508002"
    },
    "created_date": "2022-02-09T21:29:33-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02435853",
    "company_name": "BAUSCH & LOMB INC",
    "atc_number": "S01BA",
    "atc_description": "ANTIINFLAMMATORY AGENTS",
    "estimated_end_date": "2022-03-14T00:00:00-04:00",
    "actual_start_date": "2022-02-08T00:00:00-05:00",
    "actual_end_date": "2022-03-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-03-17T15:29:58-04:00",
    "status": "resolved",
    "en_comments": "waiting with QA",
    "fr_comments": "QA en attente",
    "en_drug_brand_name": "LOTEMAX GEL",
    "en_drug_common_name": "LOTEMAX GEL",
    "fr_drug_brand_name": "LOTEMAX GEL",
    "fr_drug_common_name": "LOTEMAX GEL",
    "en_ingredients": "LOTEPREDNOL ETABONATE",
    "fr_ingredients": "Étabonate de lotéprednol",
    "drug_strength": "0.5%",
    "drug_dosage_form": "GEL",
    "drug_dosage_form_fr": "Gel",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "5 mg",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154629,
    "drug": {
      "current_status": "MARKETED",
      "id": 5110,
      "drug_code": 31096,
      "updated_date": "2025-12-03T00:30:35-05:00",
      "company": {
        "id": 412,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5661,
        "mfr_code": "BSH95",
        "name": "BAUSCH & LOMB INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1400 N GOODMAN STREET",
        "province": "NEW YORK",
        "country": "UNITED STATES",
        "city": "ROCHESTER",
        "postal_code": "14609",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252785,
          "ingredient": {
            "id": 1900,
            "ingredient_code": 4957,
            "en_name": "ACETYLCHOLINE CHLORIDE",
            "fr_name": "Chlorure d'acétylcholine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02133326",
      "brand_name": "MIOCHOL-E",
      "brand_name_fr": "",
      "descriptor": "WITH DILUENT",
      "pediatric_flag": false,
      "accession_number": "F8164",
      "number_of_ais": "1",
      "ai_group_no": "0108463001"
    },
    "created_date": "2022-02-09T21:34:52-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02133326",
    "company_name": "BAUSCH & LOMB INC",
    "atc_number": "S01EB",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "actual_start_date": "2022-02-08T00:00:00-05:00",
    "actual_end_date": "2022-02-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-02-17T19:20:16-05:00",
    "status": "resolved",
    "en_comments": "API issue",
    "fr_comments": "API issue",
    "en_drug_brand_name": "MIOCHOL-E",
    "en_drug_common_name": "MIOCHOL-E",
    "fr_drug_brand_name": "MIOCHOL-E",
    "fr_drug_common_name": "MIOCHOL-E",
    "en_ingredients": "ACETYLCHOLINE CHLORIDE",
    "fr_ingredients": "Chlorure d'acétylcholine",
    "drug_strength": "20MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "2ML- 12/BX",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154632,
    "drug": {
      "current_status": "MARKETED",
      "id": 14792,
      "drug_code": 75157,
      "updated_date": "2025-12-03T00:31:03-05:00",
      "company": {
        "id": 17362,
        "created_date": "2025-03-13T02:30:17-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 19222,
        "mfr_code": "",
        "name": "JAZZ PHARMACEUTICALS OPERATIONS UK LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "BUILDING 730, KENT SCIENCE PARK",
        "province": "KENT",
        "country": "UNITED KINGDOM",
        "city": "SITTINGBOURNE",
        "postal_code": "ME98AG",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255312,
          "ingredient": {
            "id": 3214,
            "ingredient_code": 13359,
            "en_name": "DELTA-9-TETRAHYDROCANNABINOL",
            "fr_name": "Delta-9-tétrahydrocannabinol (Extrait de cannabis sativa)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.7",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        },
        {
          "id": 8255311,
          "ingredient": {
            "id": 3216,
            "ingredient_code": 14448,
            "en_name": "CANNABIDIOL",
            "fr_name": "Cannabidiol (Extrait de cannabis sativa)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02266121",
      "brand_name": "SATIVEX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0250921002"
    },
    "created_date": "2022-02-09T22:00:07-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02266121",
    "company_name": "GW PHARMA LIMITED",
    "atc_number": "N02BG",
    "atc_description": "OTHER ANALGESICS AND ANTIPYRETICS",
    "estimated_end_date": "2022-03-18T00:00:00-04:00",
    "actual_start_date": "2022-03-09T00:00:00-05:00",
    "actual_end_date": "2022-03-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-03-19T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "For all inquiries please contact Bayer Medical  Information on 1-800-265-7382 or email: canada.medinfo@bayer.com",
    "fr_comments": "For all inquiries please contact Bayer Medical  Information on 1-800-265-7382 or email: canada.medinfo@bayer.com",
    "en_drug_brand_name": "SATIVEX",
    "en_drug_common_name": "Sativex",
    "fr_drug_brand_name": "Sativex",
    "fr_drug_common_name": "Sativex",
    "en_ingredients": "CANNABIDIOL\r\nDELTA-9-TETRAHYDROCANNABINOL",
    "fr_ingredients": "CANNABIDIOL\r\nDELTA-9-TETRAHYDROCANNABINOL",
    "drug_strength": "2.5MG\r\n2.7MG",
    "drug_dosage_form": "SPRAY",
    "drug_dosage_form_fr": "Pulvérisation",
    "drug_route": "BUCCAL\r\nBUCCAL",
    "drug_route_fr": "Buccale\r\nBuccale",
    "drug_package_quantity": "3",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154677,
    "drug": {
      "current_status": "MARKETED",
      "id": 31322,
      "drug_code": 93580,
      "updated_date": "2025-05-15T02:35:11-04:00",
      "company": {
        "id": 94,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 9307,
        "mfr_code": "AZC08",
        "name": "ASTRAZENECA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1004 MIDDLEGATE ROAD, SUITE 5000",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L4Y 1M4",
        "post_office_box": "",
        "contact_information": "Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: medinfo.canada@astrazeneca.com."
      },
      "drug_ingredients": [
        {
          "id": 8261654,
          "ingredient": {
            "id": 1118,
            "ingredient_code": 10147,
            "en_name": "METFORMIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de metformine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "850",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8261653,
          "ingredient": {
            "id": 4026,
            "ingredient_code": 22549,
            "en_name": "DAPAGLIFLOZIN",
            "fr_name": "Dapagliflozine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02449935",
      "brand_name": "XIGDUO",
      "brand_name_fr": "XIGDUO",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0257650001"
    },
    "created_date": "2022-02-10T19:29:40-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02449935",
    "company_name": "ASTRAZENECA CANADA INC",
    "atc_number": "A10BD",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "anticipated_start_date": "2022-02-21T00:00:00-05:00",
    "estimated_end_date": "2022-02-22T00:00:00-05:00",
    "actual_end_date": "2022-02-22T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-02-23T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "XIGDUO",
    "en_drug_common_name": "dapagliflozin and metformin hydrochloride tablets",
    "fr_drug_brand_name": "XIGDUO",
    "fr_drug_common_name": "comprimés de dapagliflozine et de chlorhydrate de metformine",
    "en_ingredients": "METFORMIN HYDROCHLORIDE\r\nDAPAGLIFLOZIN",
    "fr_ingredients": "Chlorhydrate de metformine",
    "drug_strength": "850MG\r\n5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "6 blisters (10 tablets per blister) per carton",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154714,
    "drug": {
      "current_status": "MARKETED",
      "id": 10112,
      "drug_code": 6480,
      "updated_date": "2025-05-15T02:30:37-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250906,
          "ingredient": {
            "id": 82,
            "ingredient_code": 150,
            "en_name": "ACETYLSALICYLIC ACID",
            "fr_name": "Acide acétylsalicylique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "330",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8250905,
          "ingredient": {
            "id": 100,
            "ingredient_code": 9358,
            "en_name": "CAFFEINE",
            "fr_name": "Caféine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8250904,
          "ingredient": {
            "id": 582,
            "ingredient_code": 8231,
            "en_name": "BUTALBITAL",
            "fr_name": "Butalbital"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00608238",
      "brand_name": "TEVA-TECNAL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "63206",
      "number_of_ais": "3",
      "ai_group_no": "0301241001"
    },
    "created_date": "2022-02-10T20:47:24-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00608238",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N02BA",
    "atc_description": "OTHER ANALGESICS AND ANTIPYRETICS",
    "estimated_end_date": "2022-06-20T00:00:00-04:00",
    "actual_start_date": "2022-02-08T00:00:00-05:00",
    "actual_end_date": "2022-06-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-07-01T05:00:06-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-TECNAL",
    "en_drug_common_name": "TECNAL CAPS",
    "fr_drug_brand_name": "TEVA-TECNAL CAPS",
    "fr_drug_common_name": "TECNAL CAPS",
    "en_ingredients": "ACETYLSALICYLIC ACID\r\nCAFFEINE\r\nBUTALBITAL",
    "fr_ingredients": "Acide acétylsalicylique\r\nCaféine\r\nButalbital",
    "drug_strength": "330MG\r\n40MG\r\n50MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154717,
    "drug": {
      "current_status": "MARKETED",
      "id": 98274,
      "drug_code": 91194,
      "updated_date": "2020-04-03T06:52:34-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260576,
          "ingredient": {
            "id": 856,
            "ingredient_code": 894,
            "en_name": "CALCIPOTRIOL",
            "fr_name": "Calcipotriol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "G",
          "base": false
        },
        {
          "id": 8260575,
          "ingredient": {
            "id": 84,
            "ingredient_code": 7610,
            "en_name": "BETAMETHASONE",
            "fr_name": "Bétaméthasone (Valérate de bétaméthasone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "G",
          "base": false
        }
      ],
      "din": "02427419",
      "brand_name": "TEVA-BETAMETHASONE/ CALCIPOTRIOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0252270001"
    },
    "created_date": "2022-02-10T20:48:44-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02427419",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "D07XC",
    "atc_description": "CORTICOSTEROIDS, OTHER COMBINATIONS",
    "estimated_end_date": "2022-03-31T00:00:00-04:00",
    "actual_start_date": "2022-02-08T00:00:00-05:00",
    "actual_end_date": "2022-03-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-01T15:03:07-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-BETAMETHASONE/ CALCIPOTRIOL",
    "en_drug_common_name": "BETAMET DIP/CALCIPOT OINT",
    "fr_drug_brand_name": "TEVA-BETAMET DIP/CALCIPOT OINT",
    "fr_drug_common_name": "BETAMET DIP/CALCIPOT OINT",
    "en_ingredients": "CALCIPOTRIOL\r\nBETAMETHASONE",
    "fr_ingredients": "Calcipotriol\r\nBétaméthasone",
    "drug_strength": "50MCG\r\n0.5MG",
    "drug_dosage_form": "OINTMENT",
    "drug_dosage_form_fr": "Pommade",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "60g",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154720,
    "drug": {
      "current_status": "MARKETED",
      "id": 6306,
      "drug_code": 43176,
      "updated_date": "2025-05-15T02:31:02-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253035,
          "ingredient": {
            "id": 1298,
            "ingredient_code": 1945,
            "en_name": "IPRATROPIUM BROMIDE",
            "fr_name": "Bromure d'ipratropium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02216221",
      "brand_name": "TEVA-IPRATROPIUM STERINEBS",
      "brand_name_fr": "",
      "descriptor": "1ML & 2ML SINGLE-USE VIALS",
      "pediatric_flag": false,
      "accession_number": "P9489",
      "number_of_ais": "1",
      "ai_group_no": "0115643001"
    },
    "created_date": "2022-02-10T20:50:44-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02216221",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "R03BB",
    "atc_description": "OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",
    "estimated_end_date": "2022-06-30T00:00:00-04:00",
    "actual_start_date": "2022-02-08T00:00:00-05:00",
    "actual_end_date": "2022-06-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-07-01T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-IPRATROPIUM STERINEBS",
    "en_drug_common_name": "IPRATROPIUM 500MCG/2ML UDV",
    "fr_drug_brand_name": "TEVA-IPRATROPIUM 500MCG/2ML UDV",
    "fr_drug_common_name": "IPRATROPIUM 500MCG/2ML UDV",
    "en_ingredients": "IPRATROPIUM BROMIDE",
    "fr_ingredients": "Bromure d'ipratropium",
    "drug_strength": "250MCG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INHALATION\r\nINHALATION",
    "drug_route_fr": "Inhalation\r\nInhalation",
    "drug_package_quantity": "10x2ml",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154723,
    "drug": {
      "current_status": "MARKETED",
      "id": 14416,
      "drug_code": 74665,
      "updated_date": "2025-12-03T00:31:02-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255197,
          "ingredient": {
            "id": 2776,
            "ingredient_code": 11980,
            "en_name": "LEFLUNOMIDE",
            "fr_name": "Léflunomide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02261251",
      "brand_name": "TEVA-LEFLUNOMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0140182001"
    },
    "created_date": "2022-02-10T20:52:17-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02261251",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "L04AA",
    "atc_description": "IMMUNOSUPPRESSANTS",
    "estimated_end_date": "2022-05-20T00:00:00-04:00",
    "actual_start_date": "2022-02-08T00:00:00-05:00",
    "actual_end_date": "2022-05-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-05-19T17:29:33-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-LEFLUNOMIDE",
    "en_drug_common_name": "TEVA-LEFLUNOMIDE 10MG TAB",
    "fr_drug_brand_name": "TEVA-LEFLUNOMIDE 10MG TAB",
    "fr_drug_common_name": "LEFLUNOMIDE 10MG TAB",
    "en_ingredients": "LEFLUNOMIDE",
    "fr_ingredients": "Léflunomide",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30's and 100's",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154726,
    "drug": {
      "current_status": "MARKETED",
      "id": 14418,
      "drug_code": 74666,
      "updated_date": "2025-12-03T00:31:02-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255198,
          "ingredient": {
            "id": 2776,
            "ingredient_code": 11980,
            "en_name": "LEFLUNOMIDE",
            "fr_name": "Léflunomide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02261278",
      "brand_name": "TEVA-LEFLUNOMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0140182002"
    },
    "created_date": "2022-02-10T20:53:51-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02261278",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "L04AA",
    "atc_description": "IMMUNOSUPPRESSANTS",
    "estimated_end_date": "2022-05-20T00:00:00-04:00",
    "actual_start_date": "2022-02-08T00:00:00-05:00",
    "actual_end_date": "2022-05-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-05-19T17:30:14-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-LEFLUNOMIDE",
    "en_drug_common_name": "LEFLUNOMIDE 20MG TAB",
    "fr_drug_brand_name": "TEVA-LEFLUNOMIDE 20MG TAB",
    "fr_drug_common_name": "LEFLUNOMIDE 20MG TAB",
    "en_ingredients": "LEFLUNOMIDE",
    "fr_ingredients": "Léflunomide",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30's and 100's",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154729,
    "drug": {
      "current_status": "MARKETED",
      "id": 1066,
      "drug_code": 12453,
      "updated_date": "2025-05-15T02:30:52-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251630,
          "ingredient": {
            "id": 236,
            "ingredient_code": 11108,
            "en_name": "PRAZOSIN",
            "fr_name": "Prazosine (Chlorhydrate de prazosine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01934228",
      "brand_name": "TEVA-PRAZOSIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "73558",
      "number_of_ais": "1",
      "ai_group_no": "0111527003"
    },
    "created_date": "2022-02-10T20:55:27-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01934228",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C02CA",
    "atc_description": "ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING",
    "estimated_end_date": "2022-03-20T00:00:00-04:00",
    "actual_start_date": "2022-02-08T00:00:00-05:00",
    "actual_end_date": "2022-03-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-03-24T14:52:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-PRAZOSIN",
    "en_drug_common_name": "PRAZOSIN 5MG TAB",
    "fr_drug_brand_name": "TEVA-PRAZOSIN 5MG TAB",
    "fr_drug_common_name": "PRAZOSIN 5MG TAB",
    "en_ingredients": "PRAZOSIN",
    "fr_ingredients": "PRAZOSIN",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154746,
    "drug": {
      "current_status": "MARKETED",
      "id": 21332,
      "drug_code": 83738,
      "updated_date": "2025-05-15T02:32:42-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257557,
          "ingredient": {
            "id": 286,
            "ingredient_code": 1204,
            "en_name": "FLUCONAZOLE",
            "fr_name": "Fluconazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02352133",
      "brand_name": "FLUCONAZOLE 150",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122529004"
    },
    "created_date": "2022-02-11T13:20:11-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02352133",
    "company_name": "APOTEX INC",
    "atc_number": "J02AC",
    "atc_description": "ANTIMYCOTICS FOR SYSTEMIC USE",
    "estimated_end_date": "2022-04-01T00:00:00-04:00",
    "actual_start_date": "2022-02-07T00:00:00-05:00",
    "actual_end_date": "2022-03-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-01T18:14:50-04:00",
    "status": "resolved",
    "en_drug_brand_name": "FLUCONAZOLE 150",
    "en_drug_common_name": "FLUCONAZOLE",
    "fr_drug_brand_name": "APO-FLUCONAZOLE",
    "fr_drug_common_name": "FLUCONAZOLE",
    "en_ingredients": "FLUCONAZOLE",
    "fr_ingredients": "Fluconazole",
    "drug_strength": "150MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154749,
    "drug": {
      "current_status": "MARKETED",
      "id": 11090,
      "drug_code": 67257,
      "updated_date": "2025-05-15T02:31:14-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254165,
          "ingredient": {
            "id": 498,
            "ingredient_code": 11101,
            "en_name": "AMOXICILLIN",
            "fr_name": "Amoxicilline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8254164,
          "ingredient": {
            "id": 1116,
            "ingredient_code": 11247,
            "en_name": "CLAVULANIC ACID",
            "fr_name": "Acide clavulanique (Clavulinate potassique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "125",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02243350",
      "brand_name": "APO-AMOXI CLAV",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0234720008"
    },
    "created_date": "2022-02-11T13:23:05-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243350",
    "company_name": "APOTEX INC",
    "atc_number": "J01CR",
    "atc_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
    "estimated_end_date": "2022-02-18T00:00:00-05:00",
    "actual_start_date": "2022-02-07T00:00:00-05:00",
    "actual_end_date": "2022-02-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-02-18T18:46:29-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-AMOXI CLAV",
    "en_drug_common_name": "AMOXICILLIN",
    "fr_drug_brand_name": "APO-AMOXI CLAV",
    "fr_drug_common_name": "AMOXICILLIN",
    "en_ingredients": "CLAVULANIC ACID\r\nAMOXICILLIN",
    "fr_ingredients": "Amoxicilline",
    "drug_strength": "125MG\r\n250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154753,
    "drug": {
      "current_status": "MARKETED",
      "id": 29674,
      "drug_code": 9170,
      "updated_date": "2025-05-15T02:30:43-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8251123,
          "ingredient": {
            "id": 496,
            "ingredient_code": 8376,
            "en_name": "CEPHALEXIN",
            "fr_name": "Céphalexine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00768715",
      "brand_name": "APO-CEPHALEX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "68040",
      "number_of_ais": "1",
      "ai_group_no": "0105911003"
    },
    "created_date": "2022-02-11T13:29:12-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00768715",
    "company_name": "APOTEX INC",
    "atc_number": "J01DB",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "estimated_end_date": "2022-02-25T00:00:00-05:00",
    "actual_start_date": "2022-02-07T00:00:00-05:00",
    "actual_end_date": "2022-02-18T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-02-22T14:41:10-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-CEPHALEX",
    "en_drug_common_name": "CEPHALEX",
    "fr_drug_brand_name": "APO-CEPHALEX",
    "fr_drug_common_name": "CEPHALEX",
    "en_ingredients": "CEPHALEXIN",
    "fr_ingredients": "Céphalexine",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154756,
    "drug": {
      "current_status": "MARKETED",
      "id": 7694,
      "drug_code": 50638,
      "updated_date": "2025-05-15T02:31:04-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8253381,
          "ingredient": {
            "id": 490,
            "ingredient_code": 1212,
            "en_name": "FLUVOXAMINE MALEATE",
            "fr_name": "Maléate de fluvoxamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02231330",
      "brand_name": "APO-FLUVOXAMINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122450001"
    },
    "created_date": "2022-02-11T13:33:28-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02231330",
    "company_name": "APOTEX INC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2022-02-22T00:00:00-05:00",
    "actual_start_date": "2022-02-07T00:00:00-05:00",
    "actual_end_date": "2022-02-18T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-02-22T14:46:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-FLUVOXAMINE TABLETS",
    "en_drug_common_name": "FLUVOXAMINE",
    "fr_drug_brand_name": "APO-FLUVOXAMINE",
    "fr_drug_common_name": "FLUVOXAMINE",
    "en_ingredients": "FLUVOXAMINE MALEATE",
    "fr_ingredients": "Maléate de fluvoxamine",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154759,
    "drug": {
      "current_status": "MARKETED",
      "id": 7692,
      "drug_code": 50637,
      "updated_date": "2025-05-15T02:31:04-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8253380,
          "ingredient": {
            "id": 490,
            "ingredient_code": 1212,
            "en_name": "FLUVOXAMINE MALEATE",
            "fr_name": "Maléate de fluvoxamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02231329",
      "brand_name": "APO-FLUVOXAMINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122450002"
    },
    "created_date": "2022-02-11T13:40:44-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02231329",
    "company_name": "APOTEX INC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2022-03-01T00:00:00-05:00",
    "actual_start_date": "2022-02-07T00:00:00-05:00",
    "actual_end_date": "2022-02-18T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-02-22T14:44:26-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-FLUVOXAMINE TABLETS",
    "en_drug_common_name": "FLUVOXAMINE",
    "fr_drug_brand_name": "APO-FLUVOXAMINE",
    "fr_drug_common_name": "FLUVOXAMINE",
    "en_ingredients": "FLUVOXAMINE MALEATE",
    "fr_ingredients": "Maléate de fluvoxamine",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154762,
    "drug": {
      "current_status": "MARKETED",
      "id": 106,
      "drug_code": 10294,
      "updated_date": "2025-05-15T02:30:49-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8251313,
          "ingredient": {
            "id": 102,
            "ingredient_code": 2609,
            "en_name": "IBUPROFEN",
            "fr_name": "Ibuprofène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00441643",
      "brand_name": "APO-IBUPROFEN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "70049",
      "number_of_ais": "1",
      "ai_group_no": "0108883004"
    },
    "created_date": "2022-02-11T13:42:58-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00441643",
    "company_name": "APOTEX INC",
    "atc_number": "M01AE",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2022-05-13T00:00:00-04:00",
    "actual_start_date": "2022-02-07T00:00:00-05:00",
    "actual_end_date": "2022-05-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-05-14T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-IBUPROFEN",
    "en_drug_common_name": "IBUPROFEN",
    "fr_drug_brand_name": "APO-IBUPROFEN",
    "fr_drug_common_name": "IBUPROFEN",
    "en_ingredients": "IBUPROFEN",
    "fr_ingredients": "Ibuprofène",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 UD",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154765,
    "drug": {
      "current_status": "MARKETED",
      "id": 11072,
      "drug_code": 67227,
      "updated_date": "2025-05-15T02:31:14-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254159,
          "ingredient": {
            "id": 2870,
            "ingredient_code": 1893,
            "en_name": "PROPAFENONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de propafénone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02243324",
      "brand_name": "APO-PROPAFENONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0116258001"
    },
    "created_date": "2022-02-11T13:49:54-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243324",
    "company_name": "APOTEX INC",
    "atc_number": "C01BC",
    "atc_description": "ANTIARRHYTHMICS, CLASS I AND III",
    "estimated_end_date": "2022-03-25T00:00:00-04:00",
    "actual_start_date": "2022-02-07T00:00:00-05:00",
    "actual_end_date": "2022-03-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-03-25T12:29:27-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-PROPAFENONE",
    "en_drug_common_name": "PROPAFENONE",
    "fr_drug_brand_name": "APO-PROPAFENONE",
    "fr_drug_common_name": "PROPAFENONE",
    "en_ingredients": "PROPAFENONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de propafénone",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154770,
    "drug": {
      "current_status": "MARKETED",
      "id": 12532,
      "drug_code": 71246,
      "updated_date": "2025-05-15T02:31:24-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254604,
          "ingredient": {
            "id": 282,
            "ingredient_code": 1221,
            "en_name": "SIMVASTATIN",
            "fr_name": "Simvastatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247012",
      "brand_name": "APO-SIMVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122415004"
    },
    "created_date": "2022-02-11T13:54:57-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247012",
    "company_name": "APOTEX INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2022-03-25T00:00:00-04:00",
    "actual_start_date": "2022-02-07T00:00:00-05:00",
    "actual_end_date": "2022-03-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-03-25T12:36:58-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-SIMVASTATIN",
    "en_drug_common_name": "SIMVASTATIN",
    "fr_drug_brand_name": "APO-SIMVASTATIN",
    "fr_drug_common_name": "SIMVASTATIN",
    "en_ingredients": "SIMVASTATIN",
    "fr_ingredients": "Simvastatine",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154776,
    "drug": {
      "current_status": "MARKETED",
      "id": 3914,
      "drug_code": 1954,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 500,
        "created_date": "2017-03-09T13:22:49-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 11482,
        "mfr_code": "",
        "name": "AMPHASTAR PHARMACEUTICALS, INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11570 SIXTH STREET",
        "province": "CALIFORNIA",
        "country": "UNITED STATES",
        "city": "RANCHO CUCAMONGA",
        "postal_code": "91730",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250340,
          "ingredient": {
            "id": 1572,
            "ingredient_code": 7516,
            "en_name": "TETRACOSACTIDE",
            "fr_name": "Tétracosactide (Complexe tétracosactide-hydroxyde de zinc)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "00022381",
      "brand_name": "CORTROSYN INJ 0.25MG",
      "brand_name_fr": "CORTROSYN INJ 0.25MG",
      "descriptor": "ALSO KNOWN AS COSYNTROPIN",
      "pediatric_flag": false,
      "accession_number": "45903",
      "number_of_ais": "1",
      "ai_group_no": "0106365002"
    },
    "created_date": "2022-02-11T14:35:47-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00022381",
    "company_name": "AMPHASTAR PHARMACEUTICALS, INC.",
    "atc_number": "H01AA",
    "atc_description": "ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES",
    "anticipated_start_date": "2021-10-25T00:00:00-04:00",
    "estimated_end_date": "2022-04-29T00:00:00-04:00",
    "actual_start_date": "2021-10-25T00:00:00-04:00",
    "actual_end_date": "2022-04-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-04-30T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "manufacturing delay",
    "fr_comments": "retard de fabrication",
    "en_drug_brand_name": "CORTROSYN INJ 0.25MG",
    "en_drug_common_name": "cosyntropin",
    "fr_drug_brand_name": "Cortrosyn",
    "fr_drug_common_name": "Cosyntropin",
    "en_ingredients": "TETRACOSACTIDE",
    "fr_ingredients": "Tétracosactide",
    "drug_strength": "0.25MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "0.25 mg/vial",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154785,
    "drug": {
      "current_status": "MARKETED",
      "id": 11006,
      "drug_code": 67033,
      "updated_date": "2025-05-15T02:31:13-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8254138,
          "ingredient": {
            "id": 500,
            "ingredient_code": 6850,
            "en_name": "BENZOYL PEROXIDE",
            "fr_name": "Peroxyde de benzoyle"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        },
        {
          "id": 8254137,
          "ingredient": {
            "id": 138,
            "ingredient_code": 8551,
            "en_name": "CLINDAMYCIN",
            "fr_name": "Clindamycine (Chlorhydrate de clindamycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02243158",
      "brand_name": "CLINDOXYL GEL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0242561001"
    },
    "created_date": "2022-02-11T15:36:52-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243158",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "D10AF",
    "atc_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
    "estimated_end_date": "2022-04-15T00:00:00-04:00",
    "actual_start_date": "2022-02-07T00:00:00-05:00",
    "actual_end_date": "2022-04-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-04-13T16:36:35-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CLINDOXYL GEL",
    "en_drug_common_name": "clindamycin and benzoyl peroxide gel",
    "fr_drug_brand_name": "CLINDOXYL GEL",
    "fr_drug_common_name": "gel de clindamycine et de peroxyde de benzoyle",
    "en_ingredients": "CLINDAMYCIN\r\nBENZOYL PEROXIDE",
    "fr_ingredients": "Peroxyde de benzoyle; Clindamycine (Phosphate de clindamycine)",
    "drug_strength": "1%\r\n5%",
    "drug_dosage_form": "GEL",
    "drug_dosage_form_fr": "Gel",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "45G",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154792,
    "drug": {
      "current_status": "MARKETED",
      "id": 4272,
      "drug_code": 20171,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 32,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 7054,
        "mfr_code": "PFR08",
        "name": "PURDUE PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252680,
          "ingredient": {
            "id": 74,
            "ingredient_code": 20280,
            "en_name": "HYDROMORPHONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'hydromorphone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02125366",
      "brand_name": "HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 12MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "82474",
      "number_of_ais": "1",
      "ai_group_no": "0108698011"
    },
    "created_date": "2022-02-11T16:22:22-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02125366",
    "company_name": "PURDUE PHARMA",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2022-02-11T00:00:00-05:00",
    "estimated_end_date": "2022-03-04T00:00:00-05:00",
    "actual_start_date": "2022-02-11T00:00:00-05:00",
    "actual_end_date": "2022-03-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-03-02T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 12MG",
    "en_drug_common_name": "Hydrochloride Controlled Release Capsules Capsules",
    "fr_drug_brand_name": "HYDROMORPH CONTIN",
    "fr_drug_common_name": "Capsules de chlorhydrate d’HYDROmorphone* à libération contrôlée",
    "en_ingredients": "HYDROMORPHONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'hydromorphone",
    "drug_strength": "12MG",
    "drug_dosage_form": "CAPSULE (SUSTAINED-RELEASE)",
    "drug_dosage_form_fr": "Capsule (à action soutenue)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154801,
    "drug": {
      "current_status": "MARKETED",
      "id": 6036,
      "drug_code": 4230,
      "updated_date": "2025-05-15T02:30:30-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8250611,
          "ingredient": {
            "id": 14,
            "ingredient_code": 51,
            "en_name": "CALCIUM CHLORIDE",
            "fr_name": "Chlorure de calcium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00294748",
      "brand_name": "CALCIUM CHLORIDE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "57029",
      "number_of_ais": "1",
      "ai_group_no": "0108565001"
    },
    "created_date": "2022-02-11T16:50:14-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00294748",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "actual_start_date": "2022-02-11T00:00:00-05:00",
    "actual_end_date": "2022-05-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-05-19T13:22:39-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CALCIUM CHLORIDE INJECTION USP",
    "en_drug_common_name": "CALCIUM CHLORIDE INJECTION USP",
    "fr_drug_brand_name": "Chlorure de calcium injection USP",
    "fr_drug_common_name": "Chlorure de calcium injection USP",
    "en_ingredients": "CALCIUM CHLORIDE",
    "fr_ingredients": "Chlorure de calcium",
    "drug_strength": "100MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10 x 10mL LIFESHIELD syringe",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154805,
    "drug": {
      "current_status": "MARKETED",
      "id": 6036,
      "drug_code": 4230,
      "updated_date": "2025-05-15T02:30:30-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8250611,
          "ingredient": {
            "id": 14,
            "ingredient_code": 51,
            "en_name": "CALCIUM CHLORIDE",
            "fr_name": "Chlorure de calcium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00294748",
      "brand_name": "CALCIUM CHLORIDE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "57029",
      "number_of_ais": "1",
      "ai_group_no": "0108565001"
    },
    "created_date": "2022-02-11T16:52:48-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00294748",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "actual_start_date": "2022-02-11T00:00:00-05:00",
    "actual_end_date": "2024-10-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-11-20T16:37:27-05:00",
    "status": "resolved",
    "en_drug_brand_name": "CALCIUM CHLORIDE INJECTION USP",
    "en_drug_common_name": "CALCIUM CHLORIDE INJECTION USP",
    "fr_drug_brand_name": "Chlorure de calcium injection USP",
    "fr_drug_common_name": "Chlorure de calcium injection USP",
    "en_ingredients": "CALCIUM CHLORIDE",
    "fr_ingredients": "Chlorure de calcium",
    "drug_strength": "100MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10 x 10mL ANSYR syringe",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154812,
    "drug": {
      "current_status": "MARKETED",
      "id": 694,
      "drug_code": 115,
      "updated_date": "2025-05-15T02:30:26-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8250114,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "9",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00037818",
      "brand_name": "BACTERIOSTATIC SODIUM CHLORIDE INJECTION USP",
      "brand_name_fr": "CHLORURE DE SODIUM AVEC BACTÉRIOSTATIQUE INJECTABLE USP",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "03696",
      "number_of_ais": "1",
      "ai_group_no": "0100053002"
    },
    "created_date": "2022-02-11T17:10:01-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00037818",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "B05CB",
    "atc_description": "IRRIGATING SOLUTIONS",
    "estimated_end_date": "2022-08-31T00:00:00-04:00",
    "actual_start_date": "2022-02-11T00:00:00-05:00",
    "actual_end_date": "2022-08-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-08-02T12:58:59-04:00",
    "status": "resolved",
    "en_comments": "Inventory is on preventative allocation.",
    "fr_comments": "L'inventaire est sous allocation préventive.",
    "en_drug_brand_name": "BACTERIOSTATIC SODIUM CHLORIDE INJECTION USP",
    "en_drug_common_name": "BACTERIOSTATIC SODIUM CHLORIDE INJECTION USP",
    "fr_drug_brand_name": "Chlorure de sodium bacteriostatique injection USP",
    "fr_drug_common_name": "Chlorure de sodium bacteriostatique injection USP",
    "en_ingredients": "SODIUM CHLORIDE",
    "fr_ingredients": "Chlorure de sodium",
    "drug_strength": "9MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR\r\nSUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nIntramusculaire\r\nSous-cutanée\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "25 x 10mL vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154815,
    "drug": {
      "current_status": "MARKETED",
      "id": 694,
      "drug_code": 115,
      "updated_date": "2025-05-15T02:30:26-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8250114,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "9",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00037818",
      "brand_name": "BACTERIOSTATIC SODIUM CHLORIDE INJECTION USP",
      "brand_name_fr": "CHLORURE DE SODIUM AVEC BACTÉRIOSTATIQUE INJECTABLE USP",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "03696",
      "number_of_ais": "1",
      "ai_group_no": "0100053002"
    },
    "created_date": "2022-02-11T17:14:05-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00037818",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "B05CB",
    "atc_description": "IRRIGATING SOLUTIONS",
    "actual_start_date": "2022-02-11T00:00:00-05:00",
    "actual_end_date": "2022-06-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-06-24T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "BACTERIOSTATIC SODIUM CHLORIDE INJECTION USP",
    "en_drug_common_name": "BACTERIOSTATIC SODIUM CHLORIDE INJECTION USP",
    "fr_drug_brand_name": "Chlorure de sodium bacteriostatique injection USP",
    "fr_drug_common_name": "Chlorure de sodium bacteriostatique injection USP",
    "en_ingredients": "SODIUM CHLORIDE",
    "fr_ingredients": "Chlorure de sodium",
    "drug_strength": "9MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR\r\nSUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nIntramusculaire\r\nSous-cutanée\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "25 x 20mL vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154820,
    "drug": {
      "current_status": "MARKETED",
      "id": 5808,
      "drug_code": 3891,
      "updated_date": "2025-05-15T02:30:30-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8250580,
          "ingredient": {
            "id": 570,
            "ingredient_code": 648,
            "en_name": "PROTEASE",
            "fr_name": "Protéase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "45000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8250579,
          "ingredient": {
            "id": 568,
            "ingredient_code": 253,
            "en_name": "AMYLASE",
            "fr_name": "Amylase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "42000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8250578,
          "ingredient": {
            "id": 572,
            "ingredient_code": 649,
            "en_name": "LIPASE",
            "fr_name": "Lipase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10800",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00502790",
      "brand_name": "COTAZYM ECS 8",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "55867",
      "number_of_ais": "3",
      "ai_group_no": "0302964031"
    },
    "created_date": "2022-02-11T18:53:58-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00502790",
    "company_name": "ORGANON CANADA INC.",
    "atc_number": "A09AA",
    "atc_description": "DIGESTIVES, INCL ENZYMES",
    "anticipated_start_date": "2022-03-01T00:00:00-05:00",
    "estimated_end_date": "2022-03-21T00:00:00-04:00",
    "actual_start_date": "2022-02-25T00:00:00-05:00",
    "actual_end_date": "2022-03-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-03-22T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "COTAZYM ECS 8",
    "en_drug_common_name": "PANCRELIPASE DELAYED-RELEASE CAPSULES",
    "fr_drug_brand_name": "COTAZYM E.C.S.",
    "fr_drug_common_name": "CAPSULES DE PANCRÉLIPASE À LIBÉRATION RETARDÉE",
    "en_ingredients": "PROTEASE\r\nAMYLASE\r\nLIPASE",
    "fr_ingredients": "Protéase\r\nAmylase\r\nLipase",
    "drug_strength": "45000UNIT\r\n42000UNIT\r\n10800UNIT",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154842,
    "drug": {
      "current_status": "MARKETED",
      "id": 24782,
      "drug_code": 87337,
      "updated_date": "2025-05-15T02:33:31-04:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8258948,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02387794",
      "brand_name": "ACH-QUETIAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858001"
    },
    "created_date": "2022-02-11T19:57:42-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02387794",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "actual_start_date": "2022-02-11T00:00:00-05:00",
    "actual_end_date": "2022-02-25T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-02-26T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "QUETIAPINE TABLETS",
    "en_drug_common_name": "QUETIAPINE FUMARATE",
    "fr_drug_brand_name": "ACH Quetiapine",
    "fr_drug_common_name": "QUETIAPINE FUMARATE",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "QUETIAPINE FUMARATE",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET (IMMEDIATE RELEASE)\r\nTABLET",
    "drug_dosage_form_fr": "Comprimé (à libération immédiate)\r\nComprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154845,
    "drug": {
      "current_status": "MARKETED",
      "id": 65365,
      "drug_code": 94478,
      "updated_date": "2025-05-15T02:35:36-04:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8262132,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02457741",
      "brand_name": "ACH-ATORVASTATIN CALCIUM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133055001"
    },
    "created_date": "2022-02-11T19:59:02-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02457741",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "actual_start_date": "2022-02-11T00:00:00-05:00",
    "actual_end_date": "2022-02-28T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-03-01T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ACH-ATORVASTATIN CALCIUM",
    "en_drug_common_name": "ATORVASTATIN",
    "fr_drug_brand_name": "ACH ATORVASTATIN",
    "fr_drug_common_name": "ATORVASTATIN",
    "en_ingredients": "ATORVASTATIN",
    "fr_ingredients": "ATORVASTATIN",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "90",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154881,
    "drug": {
      "current_status": "MARKETED",
      "id": 5376,
      "drug_code": 35083,
      "updated_date": "2025-05-15T02:31:00-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8252833,
          "ingredient": {
            "id": 678,
            "ingredient_code": 10292,
            "en_name": "SODIUM ACETATE",
            "fr_name": "Acétate de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "328",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02181746",
      "brand_name": "SODIUM ACETATE INJECTION USP",
      "brand_name_fr": "INJECTION D'ACÉTATE DE SODIUM USP",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "H2201",
      "number_of_ais": "1",
      "ai_group_no": "0113986001"
    },
    "created_date": "2022-02-14T14:22:02-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02181746",
    "company_name": "OMEGA LABORATORIES LIMITED",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "estimated_end_date": "2022-08-08T00:00:00-04:00",
    "actual_start_date": "2022-02-14T00:00:00-05:00",
    "actual_end_date": "2022-08-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-08-08T12:25:36-04:00",
    "status": "resolved",
    "en_comments": "Product available but sales being monitored",
    "fr_comments": "Produit disponible mais ventes sous surveillance",
    "en_drug_brand_name": "SODIUM ACETATE-OMEGA",
    "en_drug_common_name": "Sodium Acetate Injection USP",
    "fr_drug_brand_name": "Sodium Acetate OMEGA",
    "fr_drug_common_name": "Injection d'acétate de sodium USP",
    "en_ingredients": "SODIUM ACETATE",
    "fr_ingredients": "Acétate de sodium",
    "drug_strength": "328MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10 x 50mL vial / fiole",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154916,
    "drug": {
      "current_status": "DORMANT",
      "id": 26462,
      "drug_code": 88786,
      "updated_date": "2025-05-15T06:55:49-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8368931,
          "ingredient": {
            "id": 3016,
            "ingredient_code": 13107,
            "en_name": "LEVETIRACETAM",
            "fr_name": "Lévétiracétam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "750",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02403048",
      "brand_name": "JAMP-LEVETIRACETAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148843003"
    },
    "created_date": "2022-02-14T15:40:13-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02403048",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2022-04-01T00:00:00-04:00",
    "actual_start_date": "2022-02-09T00:00:00-05:00",
    "actual_end_date": "2022-03-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-06T20:37:32-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP-LEVETIRACETAM",
    "en_drug_common_name": "Levetiracetam Tablets USP",
    "fr_drug_brand_name": "JAMP-Levetiracetam",
    "fr_drug_common_name": "Comprimés de lévétiracétam USP",
    "en_ingredients": "LEVETIRACETAM",
    "fr_ingredients": "Lévétiracétam",
    "drug_strength": "750MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "120",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154919,
    "drug": {
      "current_status": "MARKETED",
      "id": 99957,
      "drug_code": 98069,
      "updated_date": "2020-04-03T06:54:14-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8264280,
          "ingredient": {
            "id": 25315,
            "ingredient_code": 9107,
            "en_name": "METHIMAZOLE",
            "fr_name": "Méthimazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02490625",
      "brand_name": "JAMP METHIMAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104552001"
    },
    "created_date": "2022-02-14T15:43:41-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02490625",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "H03BB",
    "atc_description": "ANTITHYROID PREPARATIONS",
    "anticipated_start_date": "2022-02-09T00:00:00-05:00",
    "estimated_end_date": "2023-02-10T00:00:00-05:00",
    "actual_start_date": "2022-04-30T00:00:00-04:00",
    "actual_end_date": "2023-01-27T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-01-31T15:01:46-05:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP METHIMAZOLE",
    "en_drug_common_name": "Methimazole Tablets, USP",
    "fr_drug_brand_name": "JAMP Methimazole",
    "fr_drug_common_name": "Comprimés de méthimazole, USP",
    "en_ingredients": "METHIMAZOLE",
    "fr_ingredients": "methimazole",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154922,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 64608,
      "drug_code": 92673,
      "updated_date": "2025-05-15T04:23:59-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8355958,
          "ingredient": {
            "id": 2580,
            "ingredient_code": 11784,
            "en_name": "MONTELUKAST",
            "fr_name": "Montélukast (Montélukast sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02442361",
      "brand_name": "JAMP-MONTELUKAST",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133823001"
    },
    "created_date": "2022-02-14T15:47:57-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02442361",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "R03DC",
    "atc_description": "OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES",
    "anticipated_start_date": "2022-02-09T00:00:00-05:00",
    "estimated_end_date": "2022-07-29T00:00:00-04:00",
    "actual_end_date": "2022-07-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-07-20T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "This report was created in double",
    "fr_comments": "Ce rapport a été créé en double",
    "en_drug_brand_name": "JAMP-MONTELUKAST",
    "en_drug_common_name": "Montelukast chewable tablets",
    "fr_drug_brand_name": "JAMP-MONTELUKAST",
    "fr_drug_common_name": "Comprimés à croquer de montélukast",
    "en_ingredients": "MONTELUKAST",
    "fr_ingredients": "Montélukast (Montélukast sodique)",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET (CHEWABLE)",
    "drug_dosage_form_fr": "Comprimé (à mâcher)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 (blister pack)",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154925,
    "drug": {
      "current_status": "MARKETED",
      "id": 67184,
      "drug_code": 97562,
      "updated_date": "2020-04-03T06:02:55-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8263880,
          "ingredient": {
            "id": 2792,
            "ingredient_code": 11987,
            "en_name": "RIVASTIGMINE",
            "fr_name": "Rivastigmine (Tartrate hydrogénée de rivastigmine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02485370",
      "brand_name": "JAMP RIVASTIGMINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0140521002"
    },
    "created_date": "2022-02-14T15:52:40-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02485370",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "N06DA",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "estimated_end_date": "2022-05-20T00:00:00-04:00",
    "actual_start_date": "2022-02-09T00:00:00-05:00",
    "actual_end_date": "2022-05-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-06-10T20:12:30-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP RIVASTIGMINE",
    "en_drug_common_name": "Rivastigmine Hydrogen Tartrate Capsules",
    "fr_drug_brand_name": "JAMP Rivastigmine",
    "fr_drug_common_name": "Capsules de tartrate hydrogéné de rivastigmine",
    "en_ingredients": "RIVASTIGMINE",
    "fr_ingredients": "Rivastigmine",
    "drug_strength": "3MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "56 (blister pack)",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154928,
    "drug": {
      "current_status": "MARKETED",
      "id": 67184,
      "drug_code": 97562,
      "updated_date": "2020-04-03T06:02:55-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8263880,
          "ingredient": {
            "id": 2792,
            "ingredient_code": 11987,
            "en_name": "RIVASTIGMINE",
            "fr_name": "Rivastigmine (Tartrate hydrogénée de rivastigmine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02485370",
      "brand_name": "JAMP RIVASTIGMINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0140521002"
    },
    "created_date": "2022-02-14T15:54:58-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02485370",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "N06DA",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "estimated_end_date": "2022-05-20T00:00:00-04:00",
    "actual_start_date": "2022-02-09T00:00:00-05:00",
    "actual_end_date": "2022-05-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-06-13T20:45:35-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP RIVASTIGMINE",
    "en_drug_common_name": "Rivastigmine Hydrogen Tartrate Capsules",
    "fr_drug_brand_name": "JAMP Rivastigmine",
    "fr_drug_common_name": "Capsules de tartrate hydrogéné de rivastigmine",
    "en_ingredients": "RIVASTIGMINE",
    "fr_ingredients": "Rivastigmine",
    "drug_strength": "3MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154931,
    "drug": {
      "current_status": "MARKETED",
      "id": 31278,
      "drug_code": 93491,
      "updated_date": "2025-05-15T02:35:09-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261596,
          "ingredient": {
            "id": 590,
            "ingredient_code": 4922,
            "en_name": "VITAMIN D3",
            "fr_name": "Vitamine D3"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02449099",
      "brand_name": "JAMP-VITAMIN D",
      "brand_name_fr": "JAMP-VITAMINE D",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108524005"
    },
    "created_date": "2022-02-14T15:57:18-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02449099",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "A11CC",
    "atc_description": "VIT A AND D, INCL COMBINATIONS OF THE TWO",
    "anticipated_start_date": "2022-02-09T00:00:00-05:00",
    "estimated_end_date": "2022-04-15T00:00:00-04:00",
    "actual_end_date": "2022-04-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-05-17T21:26:58-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP-VITAMIN D",
    "en_drug_common_name": "Cholecalciferol Capsules",
    "fr_drug_brand_name": "JAMP-VITAMINE D",
    "fr_drug_common_name": "Capsules de cholécalciférol",
    "en_ingredients": "VITAMIN D3",
    "fr_ingredients": "Vitamine D3",
    "drug_strength": "10000UNIT",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154934,
    "drug": {
      "current_status": "MARKETED",
      "id": 99956,
      "drug_code": 98068,
      "updated_date": "2020-04-03T06:54:14-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8264279,
          "ingredient": {
            "id": 2138,
            "ingredient_code": 11104,
            "en_name": "ONDANSETRON",
            "fr_name": "Ondansétron"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02490617",
      "brand_name": "JAMP ONDANSETRON",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131120002"
    },
    "created_date": "2022-02-14T16:01:30-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02490617",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "A04AA",
    "atc_description": "ANTIEMETICS AND ANTINAUSEANTS",
    "anticipated_start_date": "2022-02-09T00:00:00-05:00",
    "estimated_end_date": "2022-04-01T00:00:00-04:00",
    "actual_end_date": "2022-03-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-06T20:35:33-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP ONDANSETRON",
    "en_drug_common_name": "Ondansetron Oral Solution",
    "fr_drug_brand_name": "JAMP Ondansetron",
    "fr_drug_common_name": "Solution buvable d'ondansétron",
    "en_ingredients": "ONDANSETRON",
    "fr_ingredients": "Ondansétron",
    "drug_strength": "4MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "50 mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154937,
    "drug": {
      "current_status": "MARKETED",
      "id": 25182,
      "drug_code": 87677,
      "updated_date": "2025-05-15T02:33:39-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259117,
          "ingredient": {
            "id": 2580,
            "ingredient_code": 11784,
            "en_name": "MONTELUKAST",
            "fr_name": "Montélukast (Montélukast sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02391422",
      "brand_name": "JAMP-MONTELUKAST",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133823002"
    },
    "created_date": "2022-02-14T16:03:52-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02391422",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "R03DC",
    "atc_description": "OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES",
    "anticipated_start_date": "2022-02-09T00:00:00-05:00",
    "estimated_end_date": "2022-06-17T00:00:00-04:00",
    "actual_start_date": "2022-04-30T00:00:00-04:00",
    "actual_end_date": "2022-06-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-07-19T20:13:39-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP-MONTELUKAST",
    "en_drug_common_name": "Montelukast Tablets",
    "fr_drug_brand_name": "JAMP-Montelukast",
    "fr_drug_common_name": "Comprimés de montélukast",
    "en_ingredients": "MONTELUKAST",
    "fr_ingredients": "Montélukast (Montélukast sodique)",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 (blister pack)",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154940,
    "drug": {
      "current_status": "MARKETED",
      "id": 67185,
      "drug_code": 97563,
      "updated_date": "2020-04-03T06:02:55-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8263881,
          "ingredient": {
            "id": 2792,
            "ingredient_code": 11987,
            "en_name": "RIVASTIGMINE",
            "fr_name": "Rivastigmine (Tartrate hydrogénée de rivastigmine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02485389",
      "brand_name": "JAMP RIVASTIGMINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0140521003"
    },
    "created_date": "2022-02-14T16:07:08-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02485389",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "N06DA",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "anticipated_start_date": "2022-02-09T00:00:00-05:00",
    "estimated_end_date": "2022-05-20T00:00:00-04:00",
    "actual_end_date": "2022-05-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-06-13T20:46:59-04:00",
    "status": "resolved",
    "en_comments": "FORMAT 100 AVAILABLE",
    "fr_comments": "Format 100 disponible",
    "en_drug_brand_name": "JAMP RIVASTIGMINE",
    "en_drug_common_name": "Rivastigmine Hydrogen Tartrate Capsules",
    "fr_drug_brand_name": "JAMP Rivastigmine",
    "fr_drug_common_name": "Capsules de tartrate hydrogéné de rivastigmine",
    "en_ingredients": "RIVASTIGMINE",
    "fr_ingredients": "Rivastigmine",
    "drug_strength": "4.5MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "56 (blister pack)",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154943,
    "drug": {
      "current_status": "DORMANT",
      "id": 29924,
      "drug_code": 91989,
      "updated_date": "2025-05-15T06:55:54-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369254,
          "ingredient": {
            "id": 660,
            "ingredient_code": 10187,
            "en_name": "AMITRIPTYLINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'amitriptyline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02435543",
      "brand_name": "JAMP-AMITRIPTYLINE TABLETS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101524003"
    },
    "created_date": "2022-02-14T16:21:45-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02435543",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "N06AA",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2023-12-31T00:00:00-05:00",
    "actual_start_date": "2022-02-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-04-12T17:02:09-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "JAMP-AMITRIPTYLINE TABLETS",
    "en_drug_common_name": "Amitriptyline Hydrochloride Tablets",
    "fr_drug_brand_name": "JAMP-AMITRIPTYLINE TABLETS",
    "fr_drug_common_name": "Comprimés de chlorhydrate d'amitriptyline",
    "en_ingredients": "AMITRIPTYLINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'amitriptyline",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": true,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154946,
    "drug": {
      "current_status": "DORMANT",
      "id": 29924,
      "drug_code": 91989,
      "updated_date": "2025-05-15T06:55:54-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369254,
          "ingredient": {
            "id": 660,
            "ingredient_code": 10187,
            "en_name": "AMITRIPTYLINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'amitriptyline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02435543",
      "brand_name": "JAMP-AMITRIPTYLINE TABLETS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101524003"
    },
    "created_date": "2022-02-14T16:23:25-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02435543",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "N06AA",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2023-12-31T00:00:00-05:00",
    "actual_start_date": "2022-02-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-04-12T17:03:26-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "JAMP-AMITRIPTYLINE TABLETS",
    "en_drug_common_name": "Amitriptyline Hydrochloride Tablets",
    "fr_drug_brand_name": "JAMP-AMITRIPTYLINE TABLETS",
    "fr_drug_common_name": "Comprimés de chlorhydrate d'amitriptyline",
    "en_ingredients": "AMITRIPTYLINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'amitriptyline",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1000",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": true,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154949,
    "drug": {
      "current_status": "DORMANT",
      "id": 29922,
      "drug_code": 91988,
      "updated_date": "2025-05-15T06:55:54-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369253,
          "ingredient": {
            "id": 660,
            "ingredient_code": 10187,
            "en_name": "AMITRIPTYLINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'amitriptyline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02435535",
      "brand_name": "JAMP-AMITRIPTYLINE TABLETS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101524002"
    },
    "created_date": "2022-02-14T16:24:55-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02435535",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "N06AA",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2023-12-31T00:00:00-05:00",
    "actual_start_date": "2022-02-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-04-12T17:04:22-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "JAMP-AMITRIPTYLINE TABLETS",
    "en_drug_common_name": "Amitriptyline Hydrochloride Tablets",
    "fr_drug_brand_name": "JAMP-AMITRIPTYLINE TABLETS",
    "fr_drug_common_name": "Comprimés de chlorhydrate d'amitriptyline",
    "en_ingredients": "AMITRIPTYLINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'amitriptyline",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1000",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": true,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154952,
    "drug": {
      "current_status": "MARKETED",
      "id": 21870,
      "drug_code": 84235,
      "updated_date": "2025-05-15T02:32:49-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257822,
          "ingredient": {
            "id": 862,
            "ingredient_code": 768,
            "en_name": "FINASTERIDE",
            "fr_name": "Finastéride"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02357224",
      "brand_name": "JAMP-FINASTERIDE",
      "brand_name_fr": "",
      "descriptor": "FILM-COATED TABLET",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124110001"
    },
    "created_date": "2022-02-14T16:27:05-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02357224",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "G04CB",
    "atc_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
    "estimated_end_date": "2022-07-29T00:00:00-04:00",
    "actual_start_date": "2022-02-09T00:00:00-05:00",
    "actual_end_date": "2022-07-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-07-27T17:51:16-04:00",
    "status": "resolved",
    "en_comments": "FORMAT 100 AVAILABLE",
    "fr_comments": "Format 100 disponible",
    "en_drug_brand_name": "JAMP-FINASTERIDE",
    "en_drug_common_name": "Finasteride Tablets",
    "fr_drug_brand_name": "JAMP-Finasteride",
    "fr_drug_common_name": "Comprimés de finastéride",
    "en_ingredients": "FINASTERIDE",
    "fr_ingredients": "Finastéride",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 (blister pack)",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154955,
    "drug": {
      "current_status": "MARKETED",
      "id": 23518,
      "drug_code": 86101,
      "updated_date": "2025-05-15T02:33:05-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258484,
          "ingredient": {
            "id": 282,
            "ingredient_code": 1221,
            "en_name": "SIMVASTATIN",
            "fr_name": "Simvastatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02375591",
      "brand_name": "JAMP-SIMVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122415001"
    },
    "created_date": "2022-02-14T16:29:14-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02375591",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2022-08-05T00:00:00-04:00",
    "actual_start_date": "2022-02-09T00:00:00-05:00",
    "actual_end_date": "2022-07-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-08-01T18:41:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP-SIMVASTATIN",
    "en_drug_common_name": "Simvastatin Tablets",
    "fr_drug_brand_name": "JAMP-Simvastatin",
    "fr_drug_common_name": "Comprimés de simvastatine",
    "en_ingredients": "SIMVASTATIN",
    "fr_ingredients": "Simvastatine",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET\r\nTABLET",
    "drug_dosage_form_fr": "Comprimé\r\nComprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154960,
    "drug": {
      "current_status": "MARKETED",
      "id": 23520,
      "drug_code": 86102,
      "updated_date": "2025-05-15T02:33:05-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258485,
          "ingredient": {
            "id": 282,
            "ingredient_code": 1221,
            "en_name": "SIMVASTATIN",
            "fr_name": "Simvastatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02375605",
      "brand_name": "JAMP-SIMVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122415004"
    },
    "created_date": "2022-02-14T16:32:41-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02375605",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2022-05-31T00:00:00-04:00",
    "actual_start_date": "2022-02-09T00:00:00-05:00",
    "actual_end_date": "2022-06-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-06-13T21:02:41-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP-SIMVASTATIN",
    "en_drug_common_name": "Simvastatin tablets",
    "fr_drug_brand_name": "JAMP-Simvastatin",
    "fr_drug_common_name": "Comprimés de simvastatine",
    "en_ingredients": "SIMVASTATIN",
    "fr_ingredients": "Simvastatine",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET\r\nTABLET",
    "drug_dosage_form_fr": "Comprimé\r\nComprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154963,
    "drug": {
      "current_status": "MARKETED",
      "id": 23522,
      "drug_code": 86103,
      "updated_date": "2025-05-15T02:33:05-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258486,
          "ingredient": {
            "id": 282,
            "ingredient_code": 1221,
            "en_name": "SIMVASTATIN",
            "fr_name": "Simvastatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02375613",
      "brand_name": "JAMP-SIMVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122415003"
    },
    "created_date": "2022-02-14T16:35:22-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02375613",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2022-05-24T00:00:00-04:00",
    "actual_start_date": "2022-02-09T00:00:00-05:00",
    "actual_end_date": "2022-06-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-06-13T20:50:33-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP-SIMVASTATIN",
    "en_drug_common_name": "Simvastatin Tablets",
    "fr_drug_brand_name": "JAMP-Simvastatin",
    "fr_drug_common_name": "Comprimés de simvastatine",
    "en_ingredients": "SIMVASTATIN",
    "fr_ingredients": "Simvastatine",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET\r\nTABLET",
    "drug_dosage_form_fr": "Comprimé\r\nComprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154967,
    "drug": {
      "current_status": "MARKETED",
      "id": 23524,
      "drug_code": 86104,
      "updated_date": "2025-05-15T02:33:05-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258487,
          "ingredient": {
            "id": 282,
            "ingredient_code": 1221,
            "en_name": "SIMVASTATIN",
            "fr_name": "Simvastatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02375621",
      "brand_name": "JAMP-SIMVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122415002"
    },
    "created_date": "2022-02-14T16:38:18-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02375621",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2022-05-24T00:00:00-04:00",
    "actual_start_date": "2022-02-09T00:00:00-05:00",
    "actual_end_date": "2022-06-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-06-13T20:51:18-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP-SIMVASTATIN",
    "en_drug_common_name": "Simvastatin Tablets",
    "fr_drug_brand_name": "JAMP-Simvastatin",
    "fr_drug_common_name": "Comprimés de simvastatine",
    "en_ingredients": "SIMVASTATIN",
    "fr_ingredients": "Simvastatine",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET\r\nTABLET",
    "drug_dosage_form_fr": "Comprimé\r\nComprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154970,
    "drug": {
      "current_status": "MARKETED",
      "id": 23526,
      "drug_code": 86105,
      "updated_date": "2025-05-15T02:33:05-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258488,
          "ingredient": {
            "id": 282,
            "ingredient_code": 1221,
            "en_name": "SIMVASTATIN",
            "fr_name": "Simvastatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02375648",
      "brand_name": "JAMP-SIMVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122415005"
    },
    "created_date": "2022-02-14T16:39:51-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02375648",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2022-05-31T00:00:00-04:00",
    "actual_start_date": "2022-02-09T00:00:00-05:00",
    "actual_end_date": "2022-06-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-06-13T21:03:24-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP-SIMVASTATIN",
    "en_drug_common_name": "Simvastatin Tablets",
    "fr_drug_brand_name": "JAMP-Simvastatin",
    "fr_drug_common_name": "Comprimés de simvastatine",
    "en_ingredients": "SIMVASTATIN",
    "fr_ingredients": "Simvastatine",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET\r\nTABLET",
    "drug_dosage_form_fr": "Comprimé\r\nComprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154973,
    "drug": {
      "current_status": "MARKETED",
      "id": 23520,
      "drug_code": 86102,
      "updated_date": "2025-05-15T02:33:05-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258485,
          "ingredient": {
            "id": 282,
            "ingredient_code": 1221,
            "en_name": "SIMVASTATIN",
            "fr_name": "Simvastatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02375605",
      "brand_name": "JAMP-SIMVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122415004"
    },
    "created_date": "2022-02-14T16:41:30-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02375605",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2022-05-31T00:00:00-04:00",
    "actual_start_date": "2022-02-09T00:00:00-05:00",
    "actual_end_date": "2022-06-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-06-13T21:04:08-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP-SIMVASTATIN",
    "en_drug_common_name": "Simvastatin Tablets",
    "fr_drug_brand_name": "JAMP-Simvastatin",
    "fr_drug_common_name": "Comprimés de simvastatine",
    "en_ingredients": "SIMVASTATIN",
    "fr_ingredients": "Simvastatine",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET\r\nTABLET",
    "drug_dosage_form_fr": "Comprimé\r\nComprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 (blister pack)",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154976,
    "drug": {
      "current_status": "MARKETED",
      "id": 23522,
      "drug_code": 86103,
      "updated_date": "2025-05-15T02:33:05-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258486,
          "ingredient": {
            "id": 282,
            "ingredient_code": 1221,
            "en_name": "SIMVASTATIN",
            "fr_name": "Simvastatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02375613",
      "brand_name": "JAMP-SIMVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122415003"
    },
    "created_date": "2022-02-14T16:43:27-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02375613",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2022-05-24T00:00:00-04:00",
    "actual_start_date": "2022-02-09T00:00:00-05:00",
    "actual_end_date": "2022-06-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-06-13T20:52:57-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP-SIMVASTATIN",
    "en_drug_common_name": "Simvastatin Tablets",
    "fr_drug_brand_name": "JAMP-Simvastatin",
    "fr_drug_common_name": "Comprimés de simvastatine",
    "en_ingredients": "SIMVASTATIN",
    "fr_ingredients": "Simvastatine",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET\r\nTABLET",
    "drug_dosage_form_fr": "Comprimé\r\nComprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 (blister pack)",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154979,
    "drug": {
      "current_status": "MARKETED",
      "id": 23524,
      "drug_code": 86104,
      "updated_date": "2025-05-15T02:33:05-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258487,
          "ingredient": {
            "id": 282,
            "ingredient_code": 1221,
            "en_name": "SIMVASTATIN",
            "fr_name": "Simvastatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02375621",
      "brand_name": "JAMP-SIMVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122415002"
    },
    "created_date": "2022-02-14T16:44:34-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02375621",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2022-05-24T00:00:00-04:00",
    "actual_start_date": "2022-02-09T00:00:00-05:00",
    "actual_end_date": "2022-06-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-06-13T20:53:35-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP-SIMVASTATIN",
    "en_drug_common_name": "Simvastatin Tablets",
    "fr_drug_brand_name": "JAMP-Simvastatin",
    "fr_drug_common_name": "Comprimés de simvastatine",
    "en_ingredients": "SIMVASTATIN",
    "fr_ingredients": "Simvastatine",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET\r\nTABLET",
    "drug_dosage_form_fr": "Comprimé\r\nComprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 (blister pack)",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154982,
    "drug": {
      "current_status": "DORMANT",
      "id": 22828,
      "drug_code": 85360,
      "updated_date": "2025-05-15T06:55:43-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8368645,
          "ingredient": {
            "id": 1478,
            "ingredient_code": 2048,
            "en_name": "SOTALOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de sotalol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "160",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02368625",
      "brand_name": "JAMP-SOTALOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0113778001"
    },
    "created_date": "2022-02-14T16:50:12-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02368625",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "C07AA",
    "atc_description": "BETA BLOCKING AGENTS",
    "estimated_end_date": "2023-12-31T00:00:00-05:00",
    "actual_start_date": "2022-02-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-04-12T17:32:26-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "JAMP-SOTALOL",
    "en_drug_common_name": "Sotalol Hydrochloride Tablets",
    "fr_drug_brand_name": "JAMP-SOTALOL",
    "fr_drug_common_name": "Comprimés de chlorhydrate de sotalol",
    "en_ingredients": "SOTALOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de sotalol",
    "drug_strength": "160MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": true,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154985,
    "drug": {
      "current_status": "MARKETED",
      "id": 63402,
      "drug_code": 96702,
      "updated_date": "2025-05-15T02:36:29-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8263273,
          "ingredient": {
            "id": 3124,
            "ingredient_code": 13311,
            "en_name": "VARDENAFIL",
            "fr_name": "Vardénafil (Chlorhydrate de vardénafil)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02476088",
      "brand_name": "JAMP-VARDENAFIL ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150003002"
    },
    "created_date": "2022-02-14T16:53:11-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02476088",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "G04BE",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "estimated_end_date": "2022-04-29T00:00:00-04:00",
    "actual_start_date": "2022-02-09T00:00:00-05:00",
    "actual_end_date": "2022-05-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-05-17T21:58:30-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP-VARDENAFIL ODT",
    "en_drug_common_name": "Vardenafil Hydrochloride Orally Distintegrating Tablets",
    "fr_drug_brand_name": "JAMP-VARDENAFIL ODT",
    "fr_drug_common_name": "Comprimés de chlorhydrate de vardenafil à dissolution orale",
    "en_ingredients": "VARDENAFIL",
    "fr_ingredients": "Vardénafil (trihydrate de chlorhydrate de vardénafil)",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "4 (blister pack)",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 154988,
    "drug": {
      "current_status": "DORMANT",
      "id": 67165,
      "drug_code": 96780,
      "updated_date": "2020-04-03T06:02:47-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369560,
          "ingredient": {
            "id": 2614,
            "ingredient_code": 11793,
            "en_name": "ZOLMITRIPTAN",
            "fr_name": "Zolmitriptan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02477106",
      "brand_name": "JAMP ZOLMITRIPTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0134381001"
    },
    "created_date": "2022-02-14T16:57:14-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02477106",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "estimated_end_date": "2023-12-31T00:00:00-05:00",
    "actual_start_date": "2022-02-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-06-22T19:04:22-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "JAMP ZOLMITRIPTAN",
    "en_drug_common_name": "Zolmitriptan Tablets",
    "fr_drug_brand_name": "JAMP Zolmitriptan",
    "fr_drug_common_name": "Comprimés de zolmitriptan",
    "en_ingredients": "ZOLMITRIPTAN",
    "fr_ingredients": "Zolmitriptan",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "6 (blister pack)",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": true,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155030,
    "drug": {
      "current_status": "MARKETED",
      "id": 23782,
      "drug_code": 86437,
      "updated_date": "2025-12-03T00:31:54-05:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8258570,
          "ingredient": {
            "id": 3772,
            "ingredient_code": 21141,
            "en_name": "VANDETANIB",
            "fr_name": "Vandétanib"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02378582",
      "brand_name": "CAPRELSA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0153066001"
    },
    "created_date": "2022-02-15T14:06:03-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02378582",
    "company_name": "SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC",
    "atc_number": "L01XE",
    "atc_description": "OTHER ANTINEOPLASTIC AGENTS",
    "anticipated_start_date": "2022-12-01T00:00:00-05:00",
    "estimated_end_date": "2023-04-28T00:00:00-04:00",
    "actual_end_date": "2022-06-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-06-30T19:25:57-04:00",
    "status": "avoided_shortage",
    "en_comments": "Manufacturing change. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.",
    "fr_comments": "Changement à la fabrication. La date estimée de disponibilité représente des estimées de disponibilités à l’entrepôt de Sanofi. Les dates de disponibilités à l’entrepôt des distributeurs peuvent varier. Les pharmacies sont invitées à communiquer avec leurs distributeurs préférentiels pour obtenir la date de disponibilité des produits.",
    "en_drug_brand_name": "CAPRELSA",
    "en_drug_common_name": "Caprelsa",
    "fr_drug_brand_name": "CAPRELSA",
    "fr_drug_common_name": "Caprelsa",
    "en_ingredients": "VANDETANIB",
    "fr_ingredients": "Vandétanib",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155037,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 26586,
      "drug_code": 88897,
      "updated_date": "2025-05-15T04:21:05-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8352941,
          "ingredient": {
            "id": 2634,
            "ingredient_code": 20821,
            "en_name": "TOLTERODINE TARTRATE",
            "fr_name": "Toltérodine Tartrate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02404184",
      "brand_name": "MYLAN-TOLTERODINE ER",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135202002"
    },
    "created_date": "2022-02-15T14:24:36-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02404184",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "G04BD",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "discontinuation_date": "2022-02-14T00:00:00-05:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Discontinued in shortage ID 17787. Last lot 3079138 Expiry August-31-2018.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2022-02-15T14:25:33-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-TOLTERODINE ER",
    "en_drug_common_name": "TOLTERODINE TARTRATE CAPSULE",
    "fr_drug_brand_name": "MYLAN-TOLTERODINE ER",
    "fr_drug_common_name": "Toltérodine Tartrate",
    "en_ingredients": "TOLTERODINE TARTRATE",
    "fr_ingredients": "Toltérodine Tartrate",
    "drug_strength": "2MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30BT, 100BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155040,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 26588,
      "drug_code": 88898,
      "updated_date": "2025-05-15T04:21:05-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8352942,
          "ingredient": {
            "id": 2634,
            "ingredient_code": 20821,
            "en_name": "TOLTERODINE TARTRATE",
            "fr_name": "Toltérodine Tartrate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02404192",
      "brand_name": "MYLAN-TOLTERODINE ER",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135202003"
    },
    "created_date": "2022-02-15T14:26:56-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02404192",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "G04BD",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "discontinuation_date": "2022-02-14T00:00:00-05:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "Discontinued in shortage ID 25895. Last lot 3082332 Expiry November-30-2018",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2022-02-15T14:27:28-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-TOLTERODINE ER",
    "en_drug_common_name": "TOLTERODINE TARTRATE",
    "fr_drug_brand_name": "MYLAN-TOLTERODINE ER",
    "fr_drug_common_name": "Toltérodine Tartrate",
    "en_ingredients": "TOLTERODINE TARTRATE",
    "fr_ingredients": "Toltérodine Tartrate",
    "drug_strength": "4MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30BT, 100BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155058,
    "drug": {
      "current_status": "MARKETED",
      "id": 23784,
      "drug_code": 86438,
      "updated_date": "2025-12-03T00:31:54-05:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8258571,
          "ingredient": {
            "id": 3772,
            "ingredient_code": 21141,
            "en_name": "VANDETANIB",
            "fr_name": "Vandétanib"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02378590",
      "brand_name": "CAPRELSA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0153066002"
    },
    "created_date": "2022-02-15T20:37:23-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02378590",
    "company_name": "SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC",
    "atc_number": "L01EX",
    "anticipated_start_date": "2022-09-15T00:00:00-04:00",
    "actual_end_date": "2022-04-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-04-08T12:50:50-04:00",
    "status": "avoided_shortage",
    "en_comments": "Manufacturing change. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.",
    "fr_comments": "Changement à la fabrication. La date estimée de disponibilité représente des estimées de disponibilités à l’entrepôt de Sanofi. Les dates de disponibilités à l’entrepôt des distributeurs peuvent varier. Les pharmacies sont invitées à communiquer avec leurs distributeurs préférentiels pour obtenir la date de disponibilité des produits.",
    "en_drug_brand_name": "CAPRELSA",
    "en_drug_common_name": "Caprelsa",
    "fr_drug_brand_name": "CAPRELSA",
    "fr_drug_common_name": "Caprelsa",
    "en_ingredients": "VANDETANIB",
    "fr_ingredients": "Vandétanib",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155094,
    "drug": {
      "current_status": "MARKETED",
      "id": 2944,
      "drug_code": 17227,
      "updated_date": "2025-05-15T02:30:57-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8252194,
          "ingredient": {
            "id": 170,
            "ingredient_code": 9060,
            "en_name": "HEPARIN SODIUM",
            "fr_name": "Héparine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "01990748",
      "brand_name": "HEPARIN SODIUM IN 0.9% SODIUM CHLORIDE INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "79380",
      "number_of_ais": "1",
      "ai_group_no": "0104596011"
    },
    "created_date": "2022-02-16T21:38:53-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01990748",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "B01AB",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "actual_start_date": "2022-02-16T00:00:00-05:00",
    "actual_end_date": "2022-05-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-05-31T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "HEPARIN SODIUM IN 0.9% SODIUM CHLORIDE INJECTION",
    "en_drug_common_name": "HEPARIN SODIUM IN 0.9% SODIUM CHLORIDE INJECTION",
    "fr_drug_brand_name": "HEPARIN SODIUM IN 0.9% SODIUM CHLORIDE INJECTION",
    "fr_drug_common_name": "HEPARIN SODIUM IN 0.9% SODIUM CHLORIDE INJECTION",
    "en_ingredients": "HEPARIN SODIUM",
    "fr_ingredients": "Héparine sodique",
    "drug_strength": "2UNIT",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "12 x 1L bag",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155134,
    "drug": {
      "current_status": "MARKETED",
      "id": 30316,
      "drug_code": 92366,
      "updated_date": "2025-12-03T00:32:46-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261075,
          "ingredient": {
            "id": 20953,
            "ingredient_code": 23170,
            "en_name": "MIXED SALTS AMPHETAMINE",
            "fr_name": "Sels mixtes d'amphétamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02439271",
      "brand_name": "TEVA-AMPHETAMINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0161310005"
    },
    "created_date": "2022-02-17T15:57:54-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02439271",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2022-04-20T00:00:00-04:00",
    "actual_start_date": "2022-02-16T00:00:00-05:00",
    "actual_end_date": "2022-04-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-21T12:52:26-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-AMPHETAMINE XR",
    "en_drug_common_name": "AMPHETAMINE XR 25MG CAPS",
    "fr_drug_brand_name": "ACT-AMPHETAMINE XR 25MG CAPS",
    "fr_drug_common_name": "AMPHETAMINE XR 25MG CAPS",
    "en_ingredients": "MIXED SALTS AMPHETAMINE",
    "fr_ingredients": "AMPHETAMINE",
    "drug_strength": "25MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155137,
    "drug": {
      "current_status": "MARKETED",
      "id": 30356,
      "drug_code": 92406,
      "updated_date": "2025-12-03T00:32:47-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261094,
          "ingredient": {
            "id": 2566,
            "ingredient_code": 11772,
            "en_name": "BUPROPION HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de bupropion"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02439662",
      "brand_name": "TEVA-BUPROPION XL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131140004"
    },
    "created_date": "2022-02-17T15:59:17-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02439662",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2022-03-31T00:00:00-04:00",
    "actual_start_date": "2022-02-15T00:00:00-05:00",
    "actual_end_date": "2022-03-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-03-24T14:52:32-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-BUPROPION XL",
    "en_drug_common_name": "BUPROPION XL 300MG SR TAB",
    "fr_drug_brand_name": "TEVA-BUPROPION XL 300MG SR TAB",
    "fr_drug_common_name": "BUPROPION XL 300MG SR TAB",
    "en_ingredients": "BUPROPION HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de bupropion",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155140,
    "drug": {
      "current_status": "MARKETED",
      "id": 64614,
      "drug_code": 94374,
      "updated_date": "2025-05-15T02:35:29-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262060,
          "ingredient": {
            "id": 3432,
            "ingredient_code": 20171,
            "en_name": "DULOXETINE",
            "fr_name": "Duloxétine (Chlorhydrate de duloxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02456753",
      "brand_name": "TEVA-DULOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152350001"
    },
    "created_date": "2022-02-17T16:00:48-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02456753",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2023-02-10T00:00:00-05:00",
    "actual_start_date": "2022-02-16T00:00:00-05:00",
    "actual_end_date": "2023-02-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2023-02-09T15:50:26-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-DULOXETINE",
    "en_drug_common_name": "DULOXETINE HCL 30MG CAPS",
    "fr_drug_brand_name": "TEVA-DULOXETINE HCL 30MG CAPS",
    "fr_drug_common_name": "DULOXETINE HCL 30MG CAPS",
    "en_ingredients": "DULOXETINE",
    "fr_ingredients": "DULOXETINE HCL",
    "drug_strength": "30MG",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 blist",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155146,
    "drug": {
      "current_status": "MARKETED",
      "id": 21154,
      "drug_code": 83534,
      "updated_date": "2025-05-15T02:32:40-04:00",
      "company": {
        "id": 316,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4328,
        "mfr_code": "HLR07",
        "name": "HOFFMANN-LA ROCHE LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7070 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 5M8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257514,
          "ingredient": {
            "id": 3652,
            "ingredient_code": 20590,
            "en_name": "TOCILIZUMAB",
            "fr_name": "Tocilizumab"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "10",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02350106",
      "brand_name": "ACTEMRA",
      "brand_name_fr": "",
      "descriptor": "4 SINGLE USE VIALS. PRESERVATIVE-FREE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152713001"
    },
    "created_date": "2022-02-17T16:07:13-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02350106",
    "company_name": "HOFFMANN-LA ROCHE LIMITED",
    "atc_number": "L04AC",
    "atc_description": "IMMUNOSUPPRESSANTS",
    "anticipated_start_date": "2022-07-15T00:00:00-04:00",
    "estimated_end_date": "2022-07-30T00:00:00-04:00",
    "actual_end_date": "2022-06-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-07-20T19:22:56-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "ACTEMRA",
    "en_drug_common_name": "ACTEMRA",
    "fr_drug_brand_name": "ACTEMRA",
    "fr_drug_common_name": "ACTEMRA",
    "en_ingredients": "TOCILIZUMAB",
    "fr_ingredients": "Tocilizumab",
    "drug_strength": "200MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "200MG/10ML 1VIAL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155149,
    "drug": {
      "current_status": "MARKETED",
      "id": 13092,
      "drug_code": 72459,
      "updated_date": "2025-05-15T02:31:28-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254769,
          "ingredient": {
            "id": 348,
            "ingredient_code": 7504,
            "en_name": "MOMETASONE FUROATE",
            "fr_name": "Furoate de mométasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02248130",
      "brand_name": "TEVA-MOMETASONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121732001"
    },
    "created_date": "2022-02-17T16:14:19-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02248130",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "D07AC",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2022-04-20T00:00:00-04:00",
    "actual_start_date": "2022-02-15T00:00:00-05:00",
    "actual_end_date": "2022-04-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-21T12:52:49-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-MOMETASONE",
    "en_drug_common_name": "MOMETASONE 0.1% OINT",
    "fr_drug_brand_name": "TEVA-MOMETASONE 0.1% OINT",
    "fr_drug_common_name": "MOMETASONE 0.1% OINT",
    "en_ingredients": "MOMETASONE FUROATE",
    "fr_ingredients": "Furoate de mométasone",
    "drug_strength": "0.1%",
    "drug_dosage_form": "OINTMENT",
    "drug_dosage_form_fr": "Pommade",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "15",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155152,
    "drug": {
      "current_status": "MARKETED",
      "id": 7762,
      "drug_code": 50822,
      "updated_date": "2025-05-15T02:31:05-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253398,
          "ingredient": {
            "id": 1618,
            "ingredient_code": 1890,
            "en_name": "BUSPIRONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de buspirone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02231492",
      "brand_name": "TEVA-BUSPIRONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0116263001"
    },
    "created_date": "2022-02-17T16:15:16-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02231492",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N05BE",
    "atc_description": "ANXIOLYTICS",
    "estimated_end_date": "2022-04-30T00:00:00-04:00",
    "actual_start_date": "2022-02-15T00:00:00-05:00",
    "actual_end_date": "2022-03-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-03-24T14:53:25-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-BUSPIRONE",
    "en_drug_common_name": "BUSPIRONE 10MG TAB",
    "fr_drug_brand_name": "TEVA-BUSPIRONE 10MG TAB",
    "fr_drug_common_name": "BUSPIRONE 10MG TAB",
    "en_ingredients": "BUSPIRONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de buspirone",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155155,
    "drug": {
      "current_status": "MARKETED",
      "id": 27158,
      "drug_code": 89399,
      "updated_date": "2025-05-15T02:33:59-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259789,
          "ingredient": {
            "id": 1458,
            "ingredient_code": 2298,
            "en_name": "DOXORUBICIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de doxorubicine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02409275",
      "brand_name": "DOXORUBICIN HYDROCHLORIDE INJECTION",
      "brand_name_fr": "",
      "descriptor": "10MG/5ML, 50MG/25ML, & 200MG/100ML VIALS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0110825002"
    },
    "created_date": "2022-02-17T16:16:28-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02409275",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "L01DB",
    "atc_description": "CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES",
    "estimated_end_date": "2022-05-10T00:00:00-04:00",
    "actual_start_date": "2022-02-15T00:00:00-05:00",
    "actual_end_date": "2022-03-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-03-24T14:53:59-04:00",
    "status": "resolved",
    "en_drug_brand_name": "DOXORUBICIN HYDROCHLORIDE INJECTION",
    "en_drug_common_name": "DOXORUBICIN INJ 200MG/100ML",
    "fr_drug_brand_name": "DOXORUBICIN INJ 200MG/100ML",
    "fr_drug_common_name": "DOXORUBICIN INJ 200MG/100ML",
    "en_ingredients": "DOXORUBICIN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de doxorubicine",
    "drug_strength": "2MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVESICAL\r\nINTRAVENOUS\r\nINTRAVESICAL\r\nINTRAVENOUS",
    "drug_route_fr": "Intravésicale\r\nIntraveineuse\r\nIntravésicale\r\nIntraveineuse",
    "drug_package_quantity": "100ml",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155162,
    "drug": {
      "current_status": "MARKETED",
      "id": 4098,
      "drug_code": 19916,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252577,
          "ingredient": {
            "id": 934,
            "ingredient_code": 11130,
            "en_name": "FLUOXETINE",
            "fr_name": "Fluoxétine (Chlorhydrate de fluoxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02216582",
      "brand_name": "TEVA-FLUOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "82215",
      "number_of_ais": "1",
      "ai_group_no": "0116847003"
    },
    "created_date": "2022-02-17T16:17:50-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02216582",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2022-03-31T00:00:00-04:00",
    "actual_start_date": "2022-02-15T00:00:00-05:00",
    "actual_end_date": "2022-02-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-02-17T16:22:05-05:00",
    "status": "resolved",
    "en_comments": "Duplicate Record - created in error do not use.",
    "en_drug_brand_name": "TEVA-FLUOXETINE",
    "en_drug_common_name": "TEVA-FLUOXETINE 10MG CAPS",
    "fr_drug_brand_name": "TEVA-FLUOXETINE 10MG CAPS",
    "fr_drug_common_name": "FLUOXETINE 10MG CAPS",
    "en_ingredients": "FLUOXETINE",
    "fr_ingredients": "FLUOXETINE",
    "drug_strength": "10MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155171,
    "drug": {
      "current_status": "MARKETED",
      "id": 4080,
      "drug_code": 19895,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252576,
          "ingredient": {
            "id": 934,
            "ingredient_code": 11130,
            "en_name": "FLUOXETINE",
            "fr_name": "Fluoxétine (Chlorhydrate de fluoxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02216590",
      "brand_name": "TEVA-FLUOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "82193",
      "number_of_ais": "1",
      "ai_group_no": "0116847001"
    },
    "created_date": "2022-02-17T16:25:30-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02216590",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "actual_start_date": "2022-02-16T00:00:00-05:00",
    "actual_end_date": "2024-05-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-05-09T18:08:44-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-FLUOXETINE",
    "en_drug_common_name": "FLUOXETINE 20MG CAPS",
    "fr_drug_brand_name": "TEVA-FLUOXETINE 20MG CAPS",
    "fr_drug_common_name": "FLUOXETINE 20MG CAPS",
    "en_ingredients": "FLUOXETINE",
    "fr_ingredients": "FLUOXETINE",
    "drug_strength": "20MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155174,
    "drug": {
      "current_status": "MARKETED",
      "id": 11568,
      "drug_code": 68491,
      "updated_date": "2025-05-15T02:31:16-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254313,
          "ingredient": {
            "id": 1190,
            "ingredient_code": 470,
            "en_name": "GABAPENTIN",
            "fr_name": "Gabapentine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02244514",
      "brand_name": "TEVA-GABAPENTIN",
      "brand_name_fr": "",
      "descriptor": "300MG",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0125929003"
    },
    "created_date": "2022-02-17T16:27:09-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02244514",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2022-04-20T00:00:00-04:00",
    "actual_start_date": "2022-02-16T00:00:00-05:00",
    "actual_end_date": "2022-04-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-21T12:53:11-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-GABAPENTIN",
    "en_drug_common_name": "GABAPENTIN 300MG CAPS",
    "fr_drug_brand_name": "TEVA-GABAPENTIN 300MG CAPS",
    "fr_drug_common_name": "GABAPENTIN 300MG CAPS",
    "en_ingredients": "GABAPENTIN",
    "fr_ingredients": "Gabapentine",
    "drug_strength": "300MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155177,
    "drug": {
      "current_status": "MARKETED",
      "id": 7592,
      "drug_code": 50343,
      "updated_date": "2025-05-15T02:31:04-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253353,
          "ingredient": {
            "id": 2246,
            "ingredient_code": 1855,
            "en_name": "KETOCONAZOLE",
            "fr_name": "Kétoconazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02231061",
      "brand_name": "TEVA-KETOCONAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0116793001"
    },
    "created_date": "2022-02-17T16:34:07-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02231061",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J02AB",
    "atc_description": "ANTIMYCOTICS FOR SYSTEMIC USE",
    "estimated_end_date": "2022-05-31T00:00:00-04:00",
    "actual_start_date": "2022-02-16T00:00:00-05:00",
    "actual_end_date": "2022-05-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-05-26T17:41:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-KETOCONAZOLE",
    "en_drug_common_name": "KETOCONAZOLE 200MG TAB",
    "fr_drug_brand_name": "TEVA-KETOCONAZOLE 200MG TAB",
    "fr_drug_common_name": "KETOCONAZOLE 200MG TAB",
    "en_ingredients": "KETOCONAZOLE",
    "fr_ingredients": "Kétoconazole",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155180,
    "drug": {
      "current_status": "MARKETED",
      "id": 24424,
      "drug_code": 87056,
      "updated_date": "2025-05-15T02:33:27-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258825,
          "ingredient": {
            "id": 2350,
            "ingredient_code": 2071,
            "en_name": "NABILONE",
            "fr_name": "Nabilone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02384884",
      "brand_name": "TEVA-NABILONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115009002"
    },
    "created_date": "2022-02-17T16:35:22-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02384884",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "A04AD",
    "atc_description": "ANTIEMETICS AND ANTINAUSEANTS",
    "estimated_end_date": "2022-04-20T00:00:00-04:00",
    "actual_start_date": "2022-02-16T00:00:00-05:00",
    "actual_end_date": "2022-04-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-21T12:53:31-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-NABILONE",
    "en_drug_common_name": "NABILONE 0.5MG CAPS",
    "fr_drug_brand_name": "TEVA-NABILONE 0.5MG CAPS",
    "fr_drug_common_name": "NABILONE 0.5MG CAPS",
    "en_ingredients": "NABILONE",
    "fr_ingredients": "Nabilone",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "50",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155183,
    "drug": {
      "current_status": "MARKETED",
      "id": 21592,
      "drug_code": 83980,
      "updated_date": "2025-05-15T02:32:47-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257721,
          "ingredient": {
            "id": 3022,
            "ingredient_code": 13123,
            "en_name": "ROSUVASTATIN",
            "fr_name": "Rosuvastatine (Rosuvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02354632",
      "brand_name": "TEVA-ROSUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148963003"
    },
    "created_date": "2022-02-17T16:37:41-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02354632",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2022-03-31T00:00:00-04:00",
    "actual_start_date": "2022-02-16T00:00:00-05:00",
    "actual_end_date": "2022-03-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-03-24T14:54:38-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-ROSUVASTATIN",
    "en_drug_common_name": "ROSUVASTATIN 40MG TAB",
    "fr_drug_brand_name": "TEVA-ROSUVASTATIN 40MG TAB",
    "fr_drug_common_name": "ROSUVASTATIN 40MG TAB",
    "en_ingredients": "ROSUVASTATIN",
    "fr_ingredients": "ROSUVASTATIN",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155186,
    "drug": {
      "current_status": "MARKETED",
      "id": 51689,
      "drug_code": 88865,
      "updated_date": "2025-05-15T02:33:53-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259589,
          "ingredient": {
            "id": 3020,
            "ingredient_code": 12251,
            "en_name": "TENOFOVIR DISOPROXIL FUMARATE",
            "fr_name": "Fumarate de ténofovir disoproxil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02403889",
      "brand_name": "TEVA-TENOFOVIR",
      "brand_name_fr": "",
      "descriptor": "EQUIVALENT TO 245 MG TENOFOVIR DISOPROXIL.",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152569001"
    },
    "created_date": "2022-02-17T16:38:56-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02403889",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J05AF",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "estimated_end_date": "2022-12-30T00:00:00-05:00",
    "actual_start_date": "2022-02-16T00:00:00-05:00",
    "actual_end_date": "2022-12-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-12-15T16:08:23-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-TENOFOVIR",
    "en_drug_common_name": "TENOFOVIR DISO FUM 300MG TABS",
    "fr_drug_brand_name": "TEVA-TENOFOVIR DISO FUM 300MG TABS",
    "fr_drug_common_name": "TENOFOVIR DISO FUM 300MG TABS",
    "en_ingredients": "TENOFOVIR DISOPROXIL FUMARATE",
    "fr_ingredients": "Fumarate de ténofovir disoproxil",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155189,
    "drug": {
      "current_status": "MARKETED",
      "id": 23196,
      "drug_code": 85767,
      "updated_date": "2025-05-15T02:33:02-04:00",
      "company": {
        "id": 32,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 7054,
        "mfr_code": "PFR08",
        "name": "PURDUE PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258371,
          "ingredient": {
            "id": 134,
            "ingredient_code": 6165,
            "en_name": "OXYCODONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'oxycodone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02372568",
      "brand_name": "OXYNEO",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107552005"
    },
    "created_date": "2022-02-17T16:42:58-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02372568",
    "company_name": "PURDUE PHARMA",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2022-02-15T00:00:00-05:00",
    "estimated_end_date": "2022-05-06T00:00:00-04:00",
    "actual_start_date": "2022-02-15T00:00:00-05:00",
    "actual_end_date": "2022-04-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-04-12T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "OXYNEO",
    "en_drug_common_name": "Oxycodone Hydrochloride Controlled Release Tablets",
    "fr_drug_brand_name": "OxyNeo",
    "fr_drug_common_name": "Comprimés de chlorhydrate d’oxycodone à libération contrôlée",
    "en_ingredients": "OXYCODONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'oxycodone",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155193,
    "drug": {
      "current_status": "MARKETED",
      "id": 8476,
      "drug_code": 5939,
      "updated_date": "2025-05-15T02:30:36-04:00",
      "company": {
        "id": 32,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 7054,
        "mfr_code": "PFR08",
        "name": "PURDUE PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250854,
          "ingredient": {
            "id": 74,
            "ingredient_code": 20280,
            "en_name": "HYDROMORPHONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'hydromorphone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00125083",
      "brand_name": "DILAUDID",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "61854",
      "number_of_ais": "1",
      "ai_group_no": "0108698003"
    },
    "created_date": "2022-02-17T16:49:30-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00125083",
    "company_name": "PURDUE PHARMA",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2022-02-17T00:00:00-05:00",
    "estimated_end_date": "2022-03-04T00:00:00-05:00",
    "actual_start_date": "2022-02-17T00:00:00-05:00",
    "actual_end_date": "2022-03-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-03-02T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "DILAUDID",
    "en_drug_common_name": "Hydromorphone hydrochloride",
    "fr_drug_brand_name": "DILAUDID",
    "fr_drug_common_name": "chlorhydrate d’Hydromorphone",
    "en_ingredients": "HYDROMORPHONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'hydromorphone",
    "drug_strength": "2MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155206,
    "drug": {
      "current_status": "MARKETED",
      "id": 5326,
      "drug_code": 34574,
      "updated_date": "2025-05-15T02:31:00-04:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252817,
          "ingredient": {
            "id": 1946,
            "ingredient_code": 2184,
            "en_name": "RIBAVIRIN",
            "fr_name": "Ribavirine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "6",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02170140",
      "brand_name": "VIRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "H1532",
      "number_of_ais": "1",
      "ai_group_no": "0111643001"
    },
    "created_date": "2022-02-17T19:09:53-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02170140",
    "company_name": "BAUSCH HEALTH, CANADA INC.",
    "atc_number": "J05AP",
    "actual_start_date": "2022-02-07T00:00:00-05:00",
    "actual_end_date": "2022-08-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-09-27T20:17:24-04:00",
    "status": "resolved",
    "en_drug_brand_name": "VIRAZOLE",
    "en_drug_common_name": "VIRAZOLE",
    "fr_drug_brand_name": "VIRAZOLE",
    "fr_drug_common_name": "VIRAZOLE",
    "en_ingredients": "RIBAVIRIN",
    "fr_ingredients": "Ribavirine",
    "drug_strength": "6G",
    "drug_dosage_form": "POWDER FOR SOLUTION\r\nAEROSOL",
    "drug_dosage_form_fr": "Poudre pour solution\r\nAérosol",
    "drug_route": "INHALATION\r\nINHALATION",
    "drug_route_fr": "Inhalation\r\nInhalation",
    "drug_package_quantity": "6G VIAL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155221,
    "drug": {
      "current_status": "MARKETED",
      "id": 50694,
      "drug_code": 94803,
      "updated_date": "2025-12-03T00:33:17-05:00",
      "company": {
        "id": 226,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 8892,
        "mfr_code": "RAX08",
        "name": "STERIMAX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2770 PORTLAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 6R4",
        "post_office_box": "",
        "contact_information": "1-800-881-3550"
      },
      "drug_ingredients": [
        {
          "id": 8262281,
          "ingredient": {
            "id": 74,
            "ingredient_code": 20280,
            "en_name": "HYDROMORPHONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'hydromorphone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02460602",
      "brand_name": "HYDROMORPHONE HYDROCHLORIDE INJECTION",
      "brand_name_fr": "CHLORHYDRATE D'HYDROMORPHONE INJECTABLE",
      "descriptor": "SINGLE USE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108698003"
    },
    "created_date": "2022-02-17T21:36:12-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02460602",
    "company_name": "STERIMAX INC",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2022-02-25T00:00:00-05:00",
    "estimated_end_date": "2022-03-15T00:00:00-04:00",
    "actual_end_date": "2022-03-03T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-03-04T06:00:02-05:00",
    "status": "resolved",
    "en_comments": "Limited inventory remaining at the Distributors.",
    "fr_comments": "Quantité limitée chez les grossistes.",
    "en_drug_brand_name": "HYDROMORPHONE HYDROCHLORIDE INJECTION",
    "en_drug_common_name": "HYDROMORPHONE HYDROCHLORIDE INJECTION",
    "fr_drug_brand_name": "CHLORHYDRATE D'HYDROMORPHONE INJECTABLE",
    "fr_drug_common_name": "CHLORHYDRATE D'HYDROMORPHONE INJECTABLE",
    "en_ingredients": "HYDROMORPHONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'hydromorphone",
    "drug_strength": "2MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR\r\nSUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nIntramusculaire\r\nSous-cutanée\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "10 AMPOULES",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155238,
    "drug": {
      "current_status": "MARKETED",
      "id": 3396,
      "drug_code": 18627,
      "updated_date": "2025-05-15T02:30:58-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8252343,
          "ingredient": {
            "id": 1418,
            "ingredient_code": 2118,
            "en_name": "COLESTIPOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de colestipol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02132680",
      "brand_name": "COLESTID TABLETS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "80895",
      "number_of_ais": "1",
      "ai_group_no": "0113064002"
    },
    "created_date": "2022-02-17T22:00:44-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02132680",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "C10AC",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2022-03-09T00:00:00-05:00",
    "estimated_end_date": "2022-07-31T00:00:00-04:00",
    "actual_start_date": "2022-03-09T00:00:00-05:00",
    "actual_end_date": "2022-07-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-07-29T17:22:10-04:00",
    "status": "resolved",
    "en_drug_brand_name": "COLESTID TABLETS",
    "en_drug_common_name": "COLESTID 1G",
    "fr_drug_brand_name": "COLESTID",
    "fr_drug_common_name": "COLESTID 1G",
    "en_ingredients": "COLESTIPOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de colestipol",
    "drug_strength": "1G",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "120'S",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155241,
    "drug": {
      "current_status": "MARKETED",
      "id": 20680,
      "drug_code": 82440,
      "updated_date": "2025-12-03T00:31:31-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257317,
          "ingredient": {
            "id": 3022,
            "ingredient_code": 13123,
            "en_name": "ROSUVASTATIN",
            "fr_name": "Rosuvastatine (Rosuvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02338750",
      "brand_name": "SANDOZ ROSUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148963003"
    },
    "created_date": "2022-02-17T22:02:18-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02338750",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2022-02-25T00:00:00-05:00",
    "actual_start_date": "2022-02-17T00:00:00-05:00",
    "actual_end_date": "2022-02-24T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-02-25T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ ROSUVASTATIN",
    "en_drug_common_name": "ROSUVASTATIN",
    "fr_drug_brand_name": "SANDOZ ROSUVASTATIN",
    "fr_drug_common_name": "ROSUVASTATIN",
    "en_ingredients": "ROSUVASTATIN",
    "fr_ingredients": "ROSUVASTATIN",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100FCT BO",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155244,
    "drug": {
      "current_status": "MARKETED",
      "id": 19480,
      "drug_code": 80778,
      "updated_date": "2025-05-15T02:32:20-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256806,
          "ingredient": {
            "id": 2564,
            "ingredient_code": 11770,
            "en_name": "NARATRIPTAN",
            "fr_name": "Naratriptan (Chlorhydrate de naratriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02322323",
      "brand_name": "SANDOZ NARATRIPTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131121002"
    },
    "created_date": "2022-02-17T22:04:03-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02322323",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "estimated_end_date": "2022-03-11T00:00:00-05:00",
    "actual_start_date": "2022-02-17T00:00:00-05:00",
    "actual_end_date": "2022-03-03T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-03-04T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ NARATRIPTAN",
    "en_drug_common_name": "NARATRIPTAN",
    "fr_drug_brand_name": "SANDOZ NARATRIPTAN",
    "fr_drug_common_name": "NARATRIPTAN",
    "en_ingredients": "NARATRIPTAN",
    "fr_ingredients": "NARATRIPTAN",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET\r\nTABLET",
    "drug_dosage_form_fr": "Comprimé\r\nComprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "9FCT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155247,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 3044,
      "drug_code": 17780,
      "updated_date": "2025-05-15T03:43:58-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8299411,
          "ingredient": {
            "id": 1222,
            "ingredient_code": 10127,
            "en_name": "PROPRANOLOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de propranolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02042231",
      "brand_name": "INDERAL-LA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "79986",
      "number_of_ais": "1",
      "ai_group_no": "0101831008"
    },
    "created_date": "2022-02-17T22:04:31-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02042231",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "C07AA",
    "atc_description": "BETA BLOCKING AGENTS",
    "anticipated_start_date": "2022-02-21T00:00:00-05:00",
    "actual_start_date": "2022-02-21T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-02-24T23:42:47-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "INDERAL-LA",
    "en_drug_common_name": "INDERAL LA",
    "fr_drug_brand_name": "INDERAL-LA",
    "fr_drug_common_name": "INDERAL LA",
    "en_ingredients": "PROPRANOLOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de propanolol",
    "drug_strength": "60MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)\r\nCAPSULE (SUSTAINED-RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)\r\nCapsule (à action soutenue)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100's",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155250,
    "drug": {
      "current_status": "MARKETED",
      "id": 3286,
      "drug_code": 18323,
      "updated_date": "2025-05-15T02:30:57-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8252299,
          "ingredient": {
            "id": 74,
            "ingredient_code": 20280,
            "en_name": "HYDROMORPHONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'hydromorphone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02145928",
      "brand_name": "HYDROMORPHONE HP 10",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "80551",
      "number_of_ais": "1",
      "ai_group_no": "0108698001"
    },
    "created_date": "2022-02-17T22:06:14-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02145928",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2022-03-11T00:00:00-05:00",
    "actual_start_date": "2022-02-17T00:00:00-05:00",
    "actual_end_date": "2022-03-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2022-03-15T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "HYDROMORPHONE HP 10",
    "en_drug_common_name": "HYDROMORPHONE HP 10",
    "fr_drug_brand_name": "HYDROMORPHONE HP 10",
    "fr_drug_common_name": "HYDROMORPHONE HP 10",
    "en_ingredients": "HYDROMORPHONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'hydromorphone",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR\r\nSUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nIntramusculaire\r\nSous-cutanée\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "5ML 10LIVI",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155253,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 2548,
      "drug_code": 16123,
      "updated_date": "2025-05-15T03:42:23-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8296508,
          "ingredient": {
            "id": 1222,
            "ingredient_code": 10127,
            "en_name": "PROPRANOLOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de propranolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02042258",
      "brand_name": "INDERAL-LA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "77909",
      "number_of_ais": "1",
      "ai_group_no": "0101831002"
    },
    "created_date": "2022-02-17T22:06:37-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02042258",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "C07AA",
    "atc_description": "BETA BLOCKING AGENTS",
    "anticipated_start_date": "2022-02-21T00:00:00-05:00",
    "actual_start_date": "2022-02-21T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-02-24T23:43:30-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "INDERAL-LA",
    "en_drug_common_name": "INDERAL LA",
    "fr_drug_brand_name": "INDERAL-LA",
    "fr_drug_common_name": "INDERAL LA",
    "en_ingredients": "PROPRANOLOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de propanolol",
    "drug_strength": "80MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)\r\nCAPSULE (SUSTAINED-RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)\r\nCapsule (à action soutenue)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100's",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155256,
    "drug": {
      "current_status": "MARKETED",
      "id": 99917,
      "drug_code": 97997,
      "updated_date": "2020-04-03T06:54:12-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8264216,
          "ingredient": {
            "id": 3356,
            "ingredient_code": 20022,
            "en_name": "DEFERASIROX",
            "fr_name": "Déférasirox"
          },
          "ingredient_supplied_ind": "I",
          "strength": "180",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02489902",
      "brand_name": "SANDOZ DEFERASIROX (TYPE J)",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151733005"
    },
    "created_date": "2022-02-17T22:09:59-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02489902",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "V03AC",
    "atc_description": "ALL OTHER THERAPEUTIC PRODUCTS",
    "estimated_end_date": "2022-02-25T00:00:00-05:00",
    "actual_start_date": "2022-02-17T00:00:00-05:00",
    "actual_end_date": "2022-02-24T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2022-02-25T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ DEFERASIROX (TYPE J)",
    "en_drug_common_name": "DEFERASIROX (TYPE J)",
    "fr_drug_brand_name": "SANDOZ DEFERASIROX (TYPE J)",
    "fr_drug_common_name": "DEFERASIROX (TYPE J)",
    "en_ingredients": "DEFERASIROX",
    "fr_ingredients": "Déférasirox",
    "drug_strength": "180MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30FCT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155259,
    "drug": {
      "current_status": "MARKETED",
      "id": 101134,
      "drug_code": 99623,
      "updated_date": "2020-11-09T00:55:07-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8265718,
          "ingredient": {
            "id": 786,
            "ingredient_code": 93,
            "en_name": "CIPROFLOXACIN",
            "fr_name": "Ciprofloxacine (Chlorhydrate de ciprofloxacine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.3",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        },
        {
          "id": 8265717,
          "ingredient": {
            "id": 290,
            "ingredient_code": 7600,
            "en_name": "DEXAMETHASONE",
            "fr_name": "Dexaméthasone (Phosphate de dexaméthasone sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02506882",
      "brand_name": "SANDOZ CIPROFLOXACIN / DEXAMETHASONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0250083001"
    },
    "created_date": "2022-02-17T22:11:02-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02506882",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "S02CA",
    "atc_description": "CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION",
    "estimated_end_date": "2022-04-15T00:00:00-04:00",
    "actual_start_date": "2022-02-17T00:00:00-05:00",
    "actual_end_date": "2022-04-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2022-04-21T01:09:17-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ CIPROFLOXACIN / DEXAMETHASONE",
    "en_drug_common_name": "CIPROFLOXACIN / DEXAMETHASONE",
    "fr_drug_brand_name": "SANDOZ CIPROFLOXACIN / DEXAMETHASONE",
    "fr_drug_common_name": "CIPROFLOXACIN / DEXAMETHASONE",
    "en_ingredients": "DEXAMETHASONE\r\nCIPROFLOXACIN",
    "fr_ingredients": "Dexaméthasone\r\nCiprofloxacine",
    "drug_strength": "0.1%\r\n0.3%",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "OTIC",
    "drug_route_fr": "Otique",
    "drug_package_quantity": "7.5ML LDP",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155275,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 20020,
      "drug_code": 81376,
      "updated_date": "2025-05-15T04:14:49-04:00",
      "company": {
        "id": 7830,
        "created_date": "2018-06-05T01:45:16-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17447,
        "mfr_code": "",
        "name": "ARALEZ PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6733 MISSISSAUGA RD, SUITE 800",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 6J5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8347181,
          "ingredient": {
            "id": 1926,
            "ingredient_code": 698,
            "en_name": "POLYETHYLENE GLYCOL 3350",
            "fr_name": "POLYETHYLENE GLYCOL 3350"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02328232",
      "brand_name": "PEGALAX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152488002"
    },
    "created_date": "2022-02-18T14:15:54-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02328232",
    "company_name": "ARALEZ PHARMACEUTICALS CANADA INC",
    "atc_number": "A06AD",
    "atc_description": "DRUGS FOR CONSTIPATION",
    "anticipated_start_date": "2022-02-18T00:00:00-05:00",
    "estimated_end_date": "2022-03-09T00:00:00-05:00",
    "actual_start_date": "2022-02-18T00:00:00-05:00",
    "actual_end_date": "2022-03-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-03-10T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PEGALAX",
    "en_drug_common_name": "Polyethylene Glycol 3350 Powder for oral solution",
    "fr_drug_brand_name": "Pegalaz",
    "fr_drug_common_name": "Polyethylene Glycol 3350 Powder for oral solution",
    "en_ingredients": "POLYETHYLENE GLYCOL 3350",
    "fr_ingredients": "Polyethylene Glycol 3350",
    "drug_strength": "100%",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "carton of 14 sachets",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155278,
    "drug": {
      "current_status": "MARKETED",
      "id": 11504,
      "drug_code": 68259,
      "updated_date": "2025-05-15T02:31:16-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8254280,
          "ingredient": {
            "id": 2140,
            "ingredient_code": 637,
            "en_name": "FLUTICASONE PROPIONATE",
            "fr_name": "Propionate de fluticasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "125",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02244292",
      "brand_name": "FLOVENT HFA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124685004"
    },
    "created_date": "2022-02-18T15:09:34-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02244292",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "R03BA",
    "atc_description": "OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",
    "estimated_end_date": "2022-04-20T00:00:00-04:00",
    "actual_start_date": "2022-02-16T00:00:00-05:00",
    "actual_end_date": "2022-04-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-04-13T16:37:54-04:00",
    "status": "resolved",
    "en_comments": "Limited supply currently available.",
    "fr_comments": "Une quantité limitée est disponible en ce moment.",
    "en_drug_brand_name": "FLOVENT HFA",
    "en_drug_common_name": "fluticasone propionate inhalation aerosol",
    "fr_drug_brand_name": "FLOVENT HFA",
    "fr_drug_common_name": "propionate de fluticasone en aérosol pour inhalation",
    "en_ingredients": "FLUTICASONE PROPIONATE",
    "fr_ingredients": "Propionate de fluticasone",
    "drug_strength": "125MCG",
    "drug_dosage_form": "METERED-DOSE AEROSOL",
    "drug_dosage_form_fr": "Aérosol à dose mesurée",
    "drug_route": "ORAL\r\nINHALATION\r\nORAL\r\nINHALATION",
    "drug_route_fr": "Orale\r\nInhalation\r\nOrale\r\nInhalation",
    "drug_package_quantity": "1x120",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155283,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 3990,
      "drug_code": 19655,
      "updated_date": "2025-05-15T03:45:44-04:00",
      "company": {
        "id": 204,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 10774,
        "mfr_code": "",
        "name": "BAYER INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2920 MATHESON BLVD EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L4W 5R6",
        "post_office_box": "",
        "contact_information": "1-800-265-7382"
      },
      "drug_ingredients": [
        {
          "id": 8303648,
          "ingredient": {
            "id": 1588,
            "ingredient_code": 917,
            "en_name": "ACARBOSE",
            "fr_name": "Acarbose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02190893",
      "brand_name": "GLUCOBAY",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81952",
      "number_of_ais": "1",
      "ai_group_no": "0123099001"
    },
    "created_date": "2022-02-18T17:00:14-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02190893",
    "company_name": "BAYER INC",
    "atc_number": "A10BF",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "anticipated_start_date": "2022-04-15T00:00:00-04:00",
    "actual_start_date": "2022-03-16T00:00:00-04:00",
    "actual_end_date": "2023-07-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2023-07-11T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "DIN discontinued",
    "fr_comments": "Contraintes d’approvisionnement",
    "en_drug_brand_name": "GLUCOBAY",
    "en_drug_common_name": "ACARBOSE",
    "fr_drug_brand_name": "GLUCOBAY",
    "fr_drug_common_name": "ACARBOSE",
    "en_ingredients": "ACARBOSE",
    "fr_ingredients": "Acarbose",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "120's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155308,
    "drug": {
      "current_status": "MARKETED",
      "id": 27344,
      "drug_code": 89593,
      "updated_date": "2025-12-03T00:32:21-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8259891,
          "ingredient": {
            "id": 782,
            "ingredient_code": 11344,
            "en_name": "AMLODIPINE",
            "fr_name": "Amlodipine (Bésylate d'amlodipine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259890,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02411326",
      "brand_name": "APO-AMLODIPINE-ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0251555006"
    },
    "created_date": "2022-02-18T19:32:37-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02411326",
    "company_name": "APOTEX INC",
    "atc_number": "C10BX",
    "atc_description": "LIPID MODIFYING AGENTS, COMBINATIONS",
    "estimated_end_date": "2022-04-01T00:00:00-04:00",
    "actual_start_date": "2022-02-15T00:00:00-05:00",
    "actual_end_date": "2022-03-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-01T21:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-AMLODIPINE-ATORVASTATIN",
    "en_drug_common_name": "AMLODIPINE-ATORVASTATIN",
    "fr_drug_brand_name": "APO-AMLODIPINE-ATORVASTATIN",
    "fr_drug_common_name": "AMLODIPINE-ATORVASTATIN",
    "en_ingredients": "ATORVASTATIN\r\nAMLODIPINE",
    "fr_ingredients": "AMLODIPINE-ATORVASTATIN",
    "drug_strength": "20MG\r\n10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155311,
    "drug": {
      "current_status": "MARKETED",
      "id": 31650,
      "drug_code": 93991,
      "updated_date": "2025-12-03T00:33:04-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8261861,
          "ingredient": {
            "id": 2176,
            "ingredient_code": 7942,
            "en_name": "CETIRIZINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de cétirizine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02453363",
      "brand_name": "APO-CETIRIZINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122686003"
    },
    "created_date": "2022-02-18T19:34:48-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02453363",
    "company_name": "APOTEX INC",
    "atc_number": "R06AE",
    "atc_description": "ANTIHISTAMINES FOR SYSTEMIC USE",
    "estimated_end_date": "2022-04-01T00:00:00-04:00",
    "actual_start_date": "2022-02-15T00:00:00-05:00",
    "actual_end_date": "2022-03-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-01T21:02:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-CETIRIZINE",
    "en_drug_common_name": "CETIRIZINE",
    "fr_drug_brand_name": "APO-CETIRIZINE",
    "fr_drug_common_name": "CETIRIZINE",
    "en_ingredients": "CETIRIZINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de cétirizine",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155314,
    "drug": {
      "current_status": "MARKETED",
      "id": 21678,
      "drug_code": 84059,
      "updated_date": "2025-05-15T02:32:47-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257744,
          "ingredient": {
            "id": 3134,
            "ingredient_code": 12429,
            "en_name": "IMATINIB",
            "fr_name": "Imatinib (Mésylate d'imatinib)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02355345",
      "brand_name": "APO-IMATINIB",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0145503003"
    },
    "created_date": "2022-02-18T19:56:24-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02355345",
    "company_name": "APOTEX INC",
    "atc_number": "L01EA",
    "estimated_end_date": "2022-03-25T00:00:00-04:00",
    "actual_start_date": "2022-02-14T00:00:00-05:00",
    "actual_end_date": "2022-03-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-03-21T12:54:33-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-IMATINIB",
    "en_drug_common_name": "IMATINIB",
    "fr_drug_brand_name": "APO-IMATINIB",
    "fr_drug_common_name": "IMATINIB",
    "en_ingredients": "IMATINIB",
    "fr_ingredients": "IMATINIB",
    "drug_strength": "400MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155317,
    "drug": {
      "current_status": "MARKETED",
      "id": 16920,
      "drug_code": 77920,
      "updated_date": "2025-05-15T02:31:55-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255977,
          "ingredient": {
            "id": 1412,
            "ingredient_code": 180,
            "en_name": "LANSOPRAZOLE",
            "fr_name": "Lansoprazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02293838",
      "brand_name": "APO-LANSOPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127666001"
    },
    "created_date": "2022-02-18T19:57:55-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02293838",
    "company_name": "APOTEX INC",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2022-05-06T00:00:00-04:00",
    "actual_start_date": "2022-02-15T00:00:00-05:00",
    "actual_end_date": "2022-05-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-05-06T18:03:33-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-LANSOPRAZOLE",
    "en_drug_common_name": "LANSOPRAZOLE",
    "fr_drug_brand_name": "APO-LANSOPRAZOLE",
    "fr_drug_common_name": "LANSOPRAZOLE",
    "en_ingredients": "LANSOPRAZOLE",
    "fr_ingredients": "Lansoprazole",
    "drug_strength": "30MG",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155321,
    "drug": {
      "current_status": "MARKETED",
      "id": 28540,
      "drug_code": 90663,
      "updated_date": "2025-05-15T02:34:15-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8260351,
          "ingredient": {
            "id": 3072,
            "ingredient_code": 12346,
            "en_name": "TADALAFIL",
            "fr_name": "Tadalafil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02421933",
      "brand_name": "APO-TADALAFIL PAH",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149485002"
    },
    "created_date": "2022-02-18T19:59:30-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02421933",
    "company_name": "APOTEX INC",
    "atc_number": "G04BE",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "estimated_end_date": "2022-04-29T00:00:00-04:00",
    "actual_start_date": "2022-02-15T00:00:00-05:00",
    "actual_end_date": "2022-04-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-18T12:30:06-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-TADALAFIL PAH",
    "en_drug_common_name": "TADALAFIL PAH",
    "fr_drug_brand_name": "APO-TADALAFIL PAH",
    "fr_drug_common_name": "TADALAFIL PAH",
    "en_ingredients": "TADALAFIL",
    "fr_ingredients": "Tadalafil",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155324,
    "drug": {
      "current_status": "MARKETED",
      "id": 28566,
      "drug_code": 90683,
      "updated_date": "2025-05-15T02:34:15-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8260364,
          "ingredient": {
            "id": 3072,
            "ingredient_code": 12346,
            "en_name": "TADALAFIL",
            "fr_name": "Tadalafil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02422115",
      "brand_name": "APO-TADALAFIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149485002"
    },
    "created_date": "2022-02-18T20:01:00-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02422115",
    "company_name": "APOTEX INC",
    "atc_number": "G04BE",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "estimated_end_date": "2022-04-08T00:00:00-04:00",
    "actual_start_date": "2022-02-15T00:00:00-05:00",
    "actual_end_date": "2022-04-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-08T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-TADALAFIL",
    "en_drug_common_name": "TADALAFIL",
    "fr_drug_brand_name": "APO-TADALAFIL",
    "fr_drug_common_name": "TADALAFIL",
    "en_ingredients": "TADALAFIL",
    "fr_ingredients": "Tadalafil",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "4 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155362,
    "drug": {
      "current_status": "MARKETED",
      "id": 8016,
      "drug_code": 5222,
      "updated_date": "2025-05-15T02:30:32-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8250723,
          "ingredient": {
            "id": 1090,
            "ingredient_code": 2414,
            "en_name": "NAPROXEN",
            "fr_name": "Naproxène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00592277",
      "brand_name": "APO-NAPROXEN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "60000",
      "number_of_ais": "1",
      "ai_group_no": "0109634003"
    },
    "created_date": "2022-02-22T14:25:26-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00592277",
    "company_name": "APOTEX INC",
    "atc_number": "M01AE",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2022-03-11T00:00:00-05:00",
    "actual_start_date": "2022-02-14T00:00:00-05:00",
    "actual_end_date": "2022-03-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-03-11T13:26:09-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-NAPROXEN",
    "en_drug_common_name": "NAPROXEN",
    "fr_drug_brand_name": "APO-NAPROXEN",
    "fr_drug_common_name": "NAPROXEN",
    "en_ingredients": "NAPROXEN",
    "fr_ingredients": "Naproxène",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155365,
    "drug": {
      "current_status": "MARKETED",
      "id": 13300,
      "drug_code": 72895,
      "updated_date": "2025-05-15T02:31:30-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254824,
          "ingredient": {
            "id": 380,
            "ingredient_code": 10238,
            "en_name": "TRYPTOPHAN",
            "fr_name": "Tryptophane"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02248540",
      "brand_name": "APO-TRYPTOPHAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0111038003"
    },
    "created_date": "2022-02-22T14:28:29-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02248540",
    "company_name": "APOTEX INC",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2022-03-11T00:00:00-05:00",
    "actual_start_date": "2022-02-14T00:00:00-05:00",
    "actual_end_date": "2022-03-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-03-09T19:56:06-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-TRYPTOPHAN",
    "en_drug_common_name": "TRYPTOPHAN",
    "fr_drug_brand_name": "APO-TRYPTOPHAN",
    "fr_drug_common_name": "TRYPTOPHAN",
    "en_ingredients": "TRYPTOPHAN",
    "fr_ingredients": "Tryptophane",
    "drug_strength": "500MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155368,
    "drug": {
      "current_status": "MARKETED",
      "id": 24596,
      "drug_code": 87189,
      "updated_date": "2025-05-15T02:33:27-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258883,
          "ingredient": {
            "id": 282,
            "ingredient_code": 1221,
            "en_name": "SIMVASTATIN",
            "fr_name": "Simvastatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02386313",
      "brand_name": "SIMVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122415003"
    },
    "created_date": "2022-02-22T14:34:05-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02386313",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2022-07-15T00:00:00-04:00",
    "actual_start_date": "2022-01-29T00:00:00-05:00",
    "actual_end_date": "2022-07-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-07-18T20:24:02-04:00",
    "status": "resolved",
    "en_comments": "Supplier change",
    "fr_comments": "Changement de fournisseur",
    "en_drug_brand_name": "SIMVASTATIN",
    "en_drug_common_name": "Simvastatin",
    "fr_drug_brand_name": "SIMVASTATIN",
    "fr_drug_common_name": "Simvastatin",
    "en_ingredients": "SIMVASTATIN",
    "fr_ingredients": "Simvastatine",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155371,
    "drug": {
      "current_status": "MARKETED",
      "id": 26328,
      "drug_code": 88684,
      "updated_date": "2025-12-03T00:32:13-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8259490,
          "ingredient": {
            "id": 790,
            "ingredient_code": 7426,
            "en_name": "ETHINYL ESTRADIOL",
            "fr_name": "Éthinylestradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.025",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259489,
          "ingredient": {
            "id": 790,
            "ingredient_code": 7426,
            "en_name": "ETHINYL ESTRADIOL",
            "fr_name": "Éthinylestradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.025",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259488,
          "ingredient": {
            "id": 792,
            "ingredient_code": 7492,
            "en_name": "NORGESTIMATE",
            "fr_name": "Norgestimate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.215",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259487,
          "ingredient": {
            "id": 792,
            "ingredient_code": 7492,
            "en_name": "NORGESTIMATE",
            "fr_name": "Norgestimate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259486,
          "ingredient": {
            "id": 790,
            "ingredient_code": 7426,
            "en_name": "ETHINYL ESTRADIOL",
            "fr_name": "Éthinylestradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.025",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259485,
          "ingredient": {
            "id": 792,
            "ingredient_code": 7492,
            "en_name": "NORGESTIMATE",
            "fr_name": "Norgestimate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.18",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02401967",
      "brand_name": "TRI-CIRA LO 21",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "6",
      "ai_group_no": "0636783003"
    },
    "created_date": "2022-02-22T14:36:41-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02401967",
    "company_name": "APOTEX INC",
    "atc_number": "G03AB",
    "estimated_end_date": "2022-03-11T00:00:00-05:00",
    "actual_start_date": "2022-02-14T00:00:00-05:00",
    "actual_end_date": "2022-03-04T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-03-07T19:13:08-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TRI-CIRA LO 21",
    "en_drug_common_name": "TRI-CIRA LO",
    "fr_drug_brand_name": "TRI-CIRA LO 21",
    "fr_drug_common_name": "TRI-CIRA LO",
    "en_ingredients": "ETHINYL ESTRADIOL\r\nNORGESTIMATE\r\nETHINYL ESTRADIOL\r\nNORGESTIMATE\r\nETHINYL ESTRADIOL\r\nNORGESTIMATE",
    "fr_ingredients": "Éthinylestradiol\r\nNorgestimate\r\nÉthinylestradiol\r\nNorgestimate\r\nÉthinylestradiol\r\nNorgestimate",
    "drug_strength": "0.025MG\r\n0.25MG\r\n0.025MG\r\n0.215MG\r\n0.025MG\r\n0.18MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "21 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155374,
    "drug": {
      "current_status": "MARKETED",
      "id": 24598,
      "drug_code": 87190,
      "updated_date": "2025-05-15T02:33:27-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258884,
          "ingredient": {
            "id": 282,
            "ingredient_code": 1221,
            "en_name": "SIMVASTATIN",
            "fr_name": "Simvastatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02386321",
      "brand_name": "SIMVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122415002"
    },
    "created_date": "2022-02-22T14:39:37-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02386321",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2022-07-15T00:00:00-04:00",
    "actual_start_date": "2021-11-15T00:00:00-05:00",
    "actual_end_date": "2022-07-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-07-19T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Supplier change",
    "fr_comments": "Changement de fournisseur",
    "en_drug_brand_name": "SIMVASTATIN",
    "en_drug_common_name": "Simvastatin",
    "fr_drug_brand_name": "SIMVASTATIN",
    "fr_drug_common_name": "Simvastatin",
    "en_ingredients": "SIMVASTATIN",
    "fr_ingredients": "Simvastatine",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155386,
    "drug": {
      "current_status": "MARKETED",
      "id": 24598,
      "drug_code": 87190,
      "updated_date": "2025-05-15T02:33:27-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258884,
          "ingredient": {
            "id": 282,
            "ingredient_code": 1221,
            "en_name": "SIMVASTATIN",
            "fr_name": "Simvastatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02386321",
      "brand_name": "SIMVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122415002"
    },
    "created_date": "2022-02-22T14:47:39-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02386321",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2022-07-15T00:00:00-04:00",
    "actual_start_date": "2021-11-15T00:00:00-05:00",
    "actual_end_date": "2022-07-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-07-18T20:24:40-04:00",
    "status": "resolved",
    "en_comments": "Supplier change",
    "fr_comments": "Changement de fournisseur",
    "en_drug_brand_name": "SIMVASTATIN",
    "en_drug_common_name": "Simvastatin",
    "fr_drug_brand_name": "SIMVASTATIN",
    "fr_drug_common_name": "Simvastatin",
    "en_ingredients": "SIMVASTATIN",
    "fr_ingredients": "Simvastatine",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155391,
    "drug": {
      "current_status": "MARKETED",
      "id": 24600,
      "drug_code": 87191,
      "updated_date": "2025-05-15T02:33:27-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258885,
          "ingredient": {
            "id": 282,
            "ingredient_code": 1221,
            "en_name": "SIMVASTATIN",
            "fr_name": "Simvastatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02386348",
      "brand_name": "SIMVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122415005"
    },
    "created_date": "2022-02-22T14:48:36-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02386348",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2024-01-15T00:00:00-05:00",
    "actual_start_date": "2022-02-17T00:00:00-05:00",
    "actual_end_date": "2024-01-15T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2024-02-05T14:05:36-05:00",
    "status": "resolved",
    "en_comments": "Supplier change",
    "fr_comments": "Changement de fournisseur",
    "en_drug_brand_name": "SIMVASTATIN",
    "en_drug_common_name": "Simvastatin",
    "fr_drug_brand_name": "SIMVASTATIN",
    "fr_drug_common_name": "Simvastatin",
    "en_ingredients": "SIMVASTATIN",
    "fr_ingredients": "Simvastatine",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155395,
    "drug": {
      "current_status": "MARKETED",
      "id": 24600,
      "drug_code": 87191,
      "updated_date": "2025-05-15T02:33:27-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258885,
          "ingredient": {
            "id": 282,
            "ingredient_code": 1221,
            "en_name": "SIMVASTATIN",
            "fr_name": "Simvastatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02386348",
      "brand_name": "SIMVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122415005"
    },
    "created_date": "2022-02-22T14:49:36-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02386348",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2022-07-15T00:00:00-04:00",
    "actual_start_date": "2022-02-17T00:00:00-05:00",
    "actual_end_date": "2022-07-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-07-18T20:25:13-04:00",
    "status": "resolved",
    "en_comments": "Supplier change",
    "fr_comments": "Changement de fournisseur",
    "en_drug_brand_name": "SIMVASTATIN",
    "en_drug_common_name": "Simvastatin",
    "fr_drug_brand_name": "SIMVASTATIN",
    "fr_drug_common_name": "Simvastatin",
    "en_ingredients": "SIMVASTATIN",
    "fr_ingredients": "Simvastatine",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155399,
    "drug": {
      "current_status": "MARKETED",
      "id": 17466,
      "drug_code": 78508,
      "updated_date": "2025-05-15T02:32:00-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256155,
          "ingredient": {
            "id": 2950,
            "ingredient_code": 13353,
            "en_name": "ALENDRONIC ACID",
            "fr_name": "Acide alendronique (Alendronate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "70",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02299712",
      "brand_name": "ALENDRONATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150323002"
    },
    "created_date": "2022-02-22T14:51:29-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02299712",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "M05BA",
    "atc_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
    "actual_start_date": "2021-12-28T00:00:00-05:00",
    "actual_end_date": "2023-04-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2023-11-22T16:13:16-05:00",
    "status": "resolved",
    "en_comments": "Supplier change",
    "fr_comments": "Changement de fournisseur",
    "en_drug_brand_name": "ALENDRONATE",
    "en_drug_common_name": "Alendronate",
    "fr_drug_brand_name": "ALENDRONATE",
    "fr_drug_common_name": "Alendronate",
    "en_ingredients": "ALENDRONIC ACID",
    "fr_ingredients": "Alendronate",
    "drug_strength": "70MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "50",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155417,
    "drug": {
      "current_status": "MARKETED",
      "id": 58660,
      "drug_code": 81334,
      "updated_date": "2025-05-15T02:32:26-04:00",
      "company": {
        "id": 918,
        "created_date": "2017-03-09T13:23:27-05:00",
        "updated_date": "2025-05-15T02:30:19-04:00",
        "company_code": 13433,
        "mfr_code": "",
        "name": "LANTHEUS MI CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1111 DR. FREDERIK-PHILIPS BLVD., SUITE 600",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4M 2X6",
        "post_office_box": "",
        "contact_information": "lmicanada@lantheus.com\r\n1-800-811-5500"
      },
      "drug_ingredients": [
        {
          "id": 8257039,
          "ingredient": {
            "id": 14563,
            "ingredient_code": 20480,
            "en_name": "BICISATE DIHYDROCHLORIDE",
            "fr_name": "Dichlorhydrate de bicisate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.9",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02327848",
      "brand_name": "NEUROLITE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152594001"
    },
    "created_date": "2022-02-22T19:58:01-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02327848",
    "company_name": "LANTHEUS MI CANADA INC",
    "atc_number": "V09A",
    "anticipated_start_date": "2022-03-14T00:00:00-04:00",
    "estimated_end_date": "2022-07-15T00:00:00-04:00",
    "actual_start_date": "2022-04-22T00:00:00-04:00",
    "actual_end_date": "2022-08-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 6,
      "en_reason": "Shortage of an inactive ingredient or component.",
      "fr_reason": "Pénurie d’un ingrédient ou d’un composant inerte",
      "active": true
    },
    "updated_date": "2022-08-17T14:37:57-04:00",
    "status": "resolved",
    "en_drug_brand_name": "NEUROLITE",
    "en_drug_common_name": "Kit for the Preparation of Technetium Tc99m Bicisate for Injection",
    "fr_drug_brand_name": "NEUROLITE",
    "fr_drug_common_name": "Trousse pour la préparation du bicisate de technétium [Tc99m] injectable",
    "en_ingredients": "BICISATE DIHYDROCHLORIDE",
    "fr_ingredients": "Dichlorhydrate de bicisate",
    "drug_strength": "0.9MG",
    "drug_dosage_form": "POWDER FOR SOLUTION\r\nKIT",
    "drug_dosage_form_fr": "Poudre pour solution\r\nTrousse",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "Kits of 2 and kits of 5 vials",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155442,
    "drug": {
      "current_status": "MARKETED",
      "id": 3162,
      "drug_code": 18065,
      "updated_date": "2025-05-15T02:30:57-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8252246,
          "ingredient": {
            "id": 1366,
            "ingredient_code": 1960,
            "en_name": "INDAPAMIDE",
            "fr_name": "Indapamide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02153483",
      "brand_name": "MYLAN-INDAPAMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "80279",
      "number_of_ais": "1",
      "ai_group_no": "0115402001"
    },
    "created_date": "2022-02-23T12:27:21-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02153483",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C03BA",
    "atc_description": "LOW-CEILING DIURETICS, EXCL THIAZIDES",
    "estimated_end_date": "2022-03-08T00:00:00-05:00",
    "actual_start_date": "2022-02-15T00:00:00-05:00",
    "actual_end_date": "2022-03-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-03-10T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-INDAPAMIDE",
    "en_drug_common_name": "INDAPAMIDE",
    "fr_drug_brand_name": "MYLAN-INDAPAMIDE",
    "fr_drug_common_name": "INDAPAMIDE",
    "en_ingredients": "INDAPAMIDE",
    "fr_ingredients": "Indapamide",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155467,
    "drug": {
      "current_status": "MARKETED",
      "id": 4274,
      "drug_code": 20172,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 32,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 7054,
        "mfr_code": "PFR08",
        "name": "PURDUE PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252681,
          "ingredient": {
            "id": 74,
            "ingredient_code": 20280,
            "en_name": "HYDROMORPHONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'hydromorphone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "24",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02125382",
      "brand_name": "HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 24MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "82475",
      "number_of_ais": "1",
      "ai_group_no": "0108698012"
    },
    "created_date": "2022-02-23T14:27:25-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02125382",
    "company_name": "PURDUE PHARMA",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2022-02-23T00:00:00-05:00",
    "estimated_end_date": "2022-04-12T00:00:00-04:00",
    "actual_start_date": "2022-02-23T00:00:00-05:00",
    "actual_end_date": "2022-04-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-04-13T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 24MG",
    "en_drug_common_name": "HYDROMORPH CONTIN",
    "fr_drug_brand_name": "HYDROMORPH CONTIN",
    "fr_drug_common_name": "Capsules de chlorhydrate d’HYDROmorphone* à libération contrôlée",
    "en_ingredients": "HYDROMORPHONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'hydromorphone",
    "drug_strength": "24MG",
    "drug_dosage_form": "CAPSULE (SUSTAINED-RELEASE)",
    "drug_dosage_form_fr": "Capsule (à action soutenue)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155482,
    "drug": {
      "current_status": "DORMANT",
      "id": 99363,
      "drug_code": 96288,
      "updated_date": "2023-11-16T01:03:48-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8369511,
          "ingredient": {
            "id": 782,
            "ingredient_code": 11344,
            "en_name": "AMLODIPINE",
            "fr_name": "Amlodipine (Bésylate d'amlodipine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8369510,
          "ingredient": {
            "id": 2730,
            "ingredient_code": 11907,
            "en_name": "TELMISARTAN",
            "fr_name": "Telmisartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02473488",
      "brand_name": "APO-TELMISARTAN-AMLODIPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0252947003"
    },
    "created_date": "2022-02-23T15:42:09-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02473488",
    "company_name": "AA PHARMA INC",
    "atc_number": "C09DB",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "anticipated_start_date": "2022-02-23T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-09-14T16:12:47-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "AA-TELMISARTAN-AMLODIPINE",
    "en_drug_common_name": "AA-TELMISARTAN-AMILODIPINE",
    "fr_drug_brand_name": "AA-TELMISARTAN AMILODIPINE",
    "fr_drug_common_name": "AA-TELMISARTAN AMILODIPINE",
    "en_ingredients": "AMLODIPINE\r\nTELMISARTAN",
    "fr_ingredients": "Telmisartan",
    "drug_strength": "5MG\r\n80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BTL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155505,
    "drug": {
      "current_status": "DORMANT",
      "id": 8764,
      "drug_code": 60784,
      "updated_date": "2025-12-03T02:32:17-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8367313,
          "ingredient": {
            "id": 1742,
            "ingredient_code": 4924,
            "en_name": "VITAMIN D2",
            "fr_name": "Vitamine D2"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02237450",
      "brand_name": "SANDOZ D-FORTE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108517001"
    },
    "created_date": "2022-02-24T05:13:05-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02237450",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "A11CC",
    "atc_description": "VIT A AND D, INCL COMBINATIONS OF THE TWO",
    "estimated_end_date": "2022-03-11T00:00:00-05:00",
    "actual_start_date": "2022-02-24T00:00:00-05:00",
    "actual_end_date": "2022-03-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-03-11T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ D-FORTE",
    "en_drug_common_name": "SDZ D-FORTE",
    "fr_drug_brand_name": "SANDOZ D-FORTE",
    "fr_drug_common_name": "SDZ D-FORTE",
    "en_ingredients": "VITAMIN D2",
    "fr_ingredients": "Vitamine D2",
    "drug_strength": "50000UNIT",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100SGC BO",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155508,
    "drug": {
      "current_status": "MARKETED",
      "id": 21896,
      "drug_code": 84260,
      "updated_date": "2025-05-15T02:32:49-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257833,
          "ingredient": {
            "id": 2678,
            "ingredient_code": 11860,
            "en_name": "REPAGLINIDE",
            "fr_name": "Répaglinide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02357461",
      "brand_name": "SANDOZ REPAGLINIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0137035002"
    },
    "created_date": "2022-02-24T05:14:45-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02357461",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "A10BX",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "estimated_end_date": "2022-04-08T00:00:00-04:00",
    "actual_start_date": "2022-02-24T00:00:00-05:00",
    "actual_end_date": "2022-04-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-07T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ REPAGLINIDE",
    "en_drug_common_name": "REPAGLINIDE",
    "fr_drug_brand_name": "SANDOZ REPAGLINIDE",
    "fr_drug_common_name": "REPAGLINIDE",
    "en_ingredients": "REPAGLINIDE",
    "fr_ingredients": "Répaglinide",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100TAB BO",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155511,
    "drug": {
      "current_status": "MARKETED",
      "id": 18326,
      "drug_code": 79600,
      "updated_date": "2025-05-15T02:32:10-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256424,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5.0",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02310368",
      "brand_name": "SANDOZ OLANZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783003"
    },
    "created_date": "2022-02-24T05:16:14-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02310368",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2022-04-08T00:00:00-04:00",
    "actual_start_date": "2022-02-24T00:00:00-05:00",
    "actual_end_date": "2022-04-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-06T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ OLANZAPINE",
    "en_drug_common_name": "OLANZAPINE",
    "fr_drug_brand_name": "SANDOZ OLANZAPINE",
    "fr_drug_common_name": "OLANZAPINE",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "5.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100FCT BO",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155534,
    "drug": {
      "current_status": "MARKETED",
      "id": 66916,
      "drug_code": 97349,
      "updated_date": "2025-12-03T00:34:08-05:00",
      "company": {
        "id": 1322,
        "created_date": "2017-03-09T13:24:10-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 16867,
        "mfr_code": "",
        "name": "INDIVIOR UK LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "THE CHAPLEO BUILDING, HENRY BOOT WAY",
        "province": "--",
        "country": "UNITED KINGDOM",
        "city": "HULL",
        "postal_code": "HU4 7DY",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8263734,
          "ingredient": {
            "id": 3394,
            "ingredient_code": 12033,
            "en_name": "BUPRENORPHINE",
            "fr_name": "Buprénorphine (Chlorhydrate de buprénorphine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "1.5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02483092",
      "brand_name": "SUBLOCADE",
      "brand_name_fr": "",
      "descriptor": "PREFILLED SYRINGE & POUCH  - SINGLE DOSE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0142241016"
    },
    "created_date": "2022-02-24T20:44:14-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02483092",
    "company_name": "INDIVIOR UK LIMITED",
    "atc_number": "N07BC",
    "anticipated_start_date": "2022-03-01T00:00:00-05:00",
    "estimated_end_date": "2022-03-05T00:00:00-05:00",
    "actual_start_date": "2022-03-01T00:00:00-05:00",
    "actual_end_date": "2022-03-02T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-03-03T06:00:03-05:00",
    "status": "resolved",
    "en_comments": "There is an anticipated short-term backorder of SUBLOCADE® 300 mg supply, that may impact\r\nsome pharmacies in Canada, for a few days during the first week of March. The anticipated shortage is caused by transportation challenges in North America and will impact the 300 mg dosage strength only.",
    "fr_comments": "Il y a une rupture de stock à court terme prévue pour l'approvisionnement de SUBLOCADEMC 300 mg, qui pourrait avoir un impact sur certaines pharmacies au Canada, pendant quelques jours au cours de la première semaine de mars. La pénurie anticipée est causée par des problèmes de transport en Amérique du Nord et n'impactera que le dosage de 300 mg",
    "en_drug_brand_name": "SUBLOCADE",
    "en_drug_common_name": "SUBLOCADE® (buprenorphine extended-release injection) 300 mg / 1.5 mL",
    "fr_drug_brand_name": "SUBLOCADE®",
    "fr_drug_common_name": "SUBLOCADE® (Buprénorphine à libération prolongée pour injection) 300 mg / 1,5 mL",
    "en_ingredients": "BUPRENORPHINE",
    "fr_ingredients": "Buprénorphine",
    "drug_strength": "300MG",
    "drug_dosage_form": "SOLUTION (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Solution (à libération prolongée)",
    "drug_route": "SUBCUTANEOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée\r\nSous-cutanée",
    "drug_package_quantity": "1 syringe/pack",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155554,
    "drug": {
      "current_status": "MARKETED",
      "id": 3204,
      "drug_code": 18191,
      "updated_date": "2025-05-15T02:30:57-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252260,
          "ingredient": {
            "id": 946,
            "ingredient_code": 1939,
            "en_name": "TRAZODONE HYDROCHLORIDE",
            "fr_name": "Chlohydrate de trazodone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02144263",
      "brand_name": "TEVA-TRAZODONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "80413",
      "number_of_ais": "1",
      "ai_group_no": "0115713001"
    },
    "created_date": "2022-02-24T20:57:12-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02144263",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2022-03-31T00:00:00-04:00",
    "actual_start_date": "2022-02-24T00:00:00-05:00",
    "actual_end_date": "2022-03-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-03-09T20:09:42-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-TRAZODONE",
    "en_drug_common_name": "TEVA-TRAZODONE 50MG",
    "fr_drug_brand_name": "TEVA-TRAZODONE 50MG",
    "fr_drug_common_name": "TEVA-TRAZODONE 50MG",
    "en_ingredients": "TRAZODONE HYDROCHLORIDE",
    "fr_ingredients": "Chlohydrate de trazodone",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155557,
    "drug": {
      "current_status": "MARKETED",
      "id": 18384,
      "drug_code": 79653,
      "updated_date": "2025-05-15T02:32:10-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256441,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02310910",
      "brand_name": "TEVA-ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133055003"
    },
    "created_date": "2022-02-24T20:58:50-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02310910",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2022-03-31T00:00:00-04:00",
    "actual_start_date": "2022-02-24T00:00:00-05:00",
    "actual_end_date": "2022-03-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-01T15:02:30-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-ATORVASTATIN",
    "en_drug_common_name": "TEVA-ATORVASTATIN 40MG",
    "fr_drug_brand_name": "TEVA-ATORVASTATIN 40MG",
    "fr_drug_common_name": "TEVA-ATORVASTATIN 40MG",
    "en_ingredients": "ATORVASTATIN",
    "fr_ingredients": "ATORVASTATIN 40MG",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500,90",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155560,
    "drug": {
      "current_status": "MARKETED",
      "id": 16066,
      "drug_code": 76860,
      "updated_date": "2025-05-15T02:31:46-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255736,
          "ingredient": {
            "id": 670,
            "ingredient_code": 10075,
            "en_name": "FENTANYL",
            "fr_name": "Fentanyl (Citrate de fentanyl)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02282984",
      "brand_name": "TEVA-FENTANYL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123302012"
    },
    "created_date": "2022-02-24T20:59:54-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02282984",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N02AB",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2022-04-20T00:00:00-04:00",
    "actual_start_date": "2022-02-24T00:00:00-05:00",
    "actual_end_date": "2022-04-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-09T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-FENTANYL",
    "en_drug_common_name": "FENTANYL",
    "fr_drug_brand_name": "FENTANYL",
    "fr_drug_common_name": "FENTANYL",
    "en_ingredients": "FENTANYL",
    "fr_ingredients": "Fentanyl",
    "drug_strength": "100MCG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL\r\nTRANSDERMAL",
    "drug_route_fr": "Transdermique\r\nTransdermique",
    "drug_package_quantity": "5",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155563,
    "drug": {
      "current_status": "MARKETED",
      "id": 30318,
      "drug_code": 92367,
      "updated_date": "2025-12-03T00:32:46-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261076,
          "ingredient": {
            "id": 20953,
            "ingredient_code": 23170,
            "en_name": "MIXED SALTS AMPHETAMINE",
            "fr_name": "Sels mixtes d'amphétamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02439298",
      "brand_name": "TEVA-AMPHETAMINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0161310006"
    },
    "created_date": "2022-02-24T21:01:06-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02439298",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2022-04-20T00:00:00-04:00",
    "actual_start_date": "2022-02-24T00:00:00-05:00",
    "actual_end_date": "2022-04-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-21T12:53:55-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-AMPHETAMINE XR",
    "en_drug_common_name": "TEVA-AMPHETAMINE XR",
    "fr_drug_brand_name": "AMPHETAMINE XR",
    "fr_drug_common_name": "AMPHETAMINE XR",
    "en_ingredients": "MIXED SALTS AMPHETAMINE",
    "fr_ingredients": "AMPHETAMINE XR",
    "drug_strength": "30MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155568,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 2550,
      "drug_code": 16124,
      "updated_date": "2025-05-15T03:42:23-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8296509,
          "ingredient": {
            "id": 1222,
            "ingredient_code": 10127,
            "en_name": "PROPRANOLOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de propranolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "120",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02042266",
      "brand_name": "INDERAL-LA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "77910",
      "number_of_ais": "1",
      "ai_group_no": "0101831001"
    },
    "created_date": "2022-02-24T23:40:26-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02042266",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "C07AA",
    "atc_description": "BETA BLOCKING AGENTS",
    "actual_start_date": "2022-02-24T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-02-25T06:00:02-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "INDERAL-LA",
    "en_drug_common_name": "INDERAL-LA",
    "fr_drug_brand_name": "INDERAL-LA",
    "fr_drug_common_name": "INDERAL-LA",
    "en_ingredients": "PROPRANOLOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de propanolol",
    "drug_strength": "120MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)\r\nCAPSULE (SUSTAINED-RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)\r\nCapsule (à action soutenue)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100's",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155571,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 2716,
      "drug_code": 16579,
      "updated_date": "2025-05-15T03:42:52-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8297381,
          "ingredient": {
            "id": 1222,
            "ingredient_code": 10127,
            "en_name": "PROPRANOLOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de propranolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "160",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02042274",
      "brand_name": "INDERAL-LA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "78477",
      "number_of_ais": "1",
      "ai_group_no": "0101831006"
    },
    "created_date": "2022-02-24T23:41:39-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02042274",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "C07AA",
    "atc_description": "BETA BLOCKING AGENTS",
    "actual_start_date": "2022-02-24T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-02-25T06:00:02-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "INDERAL-LA",
    "en_drug_common_name": "INDERAL-LA",
    "fr_drug_brand_name": "INDERAL-LA",
    "fr_drug_common_name": "INDERAL-LA",
    "en_ingredients": "PROPRANOLOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de propanolol",
    "drug_strength": "160MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)\r\nCAPSULE (SUSTAINED-RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)\r\nCapsule (à action soutenue)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100's",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155597,
    "drug": {
      "current_status": "MARKETED",
      "id": 19098,
      "drug_code": 80355,
      "updated_date": "2025-05-15T02:32:17-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8256690,
          "ingredient": {
            "id": 3196,
            "ingredient_code": 13584,
            "en_name": "ATOMOXETINE",
            "fr_name": "Atomoxétine (Chlorhydrate d'atomoxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02318040",
      "brand_name": "APO-ATOMOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150434003"
    },
    "created_date": "2022-02-25T14:06:46-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02318040",
    "company_name": "APOTEX INC",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2022-03-29T00:00:00-04:00",
    "actual_start_date": "2022-02-22T00:00:00-05:00",
    "actual_end_date": "2022-03-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-03-29T12:34:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ATOMOXETINE",
    "en_drug_common_name": "ATOMOXETINE",
    "fr_drug_brand_name": "APO-ATOMOXETINE",
    "fr_drug_common_name": "ATOMOXETINE",
    "en_ingredients": "ATOMOXETINE",
    "fr_ingredients": "ATOMOXETINE",
    "drug_strength": "25MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155600,
    "drug": {
      "current_status": "MARKETED",
      "id": 19102,
      "drug_code": 80357,
      "updated_date": "2025-05-15T02:32:17-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8256692,
          "ingredient": {
            "id": 3196,
            "ingredient_code": 13584,
            "en_name": "ATOMOXETINE",
            "fr_name": "Atomoxétine (Chlorhydrate d'atomoxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02318067",
      "brand_name": "APO-ATOMOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150434005"
    },
    "created_date": "2022-02-25T14:09:13-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02318067",
    "company_name": "APOTEX INC",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2022-04-04T00:00:00-04:00",
    "actual_start_date": "2022-02-22T00:00:00-05:00",
    "actual_end_date": "2022-03-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-01T21:11:24-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ATOMOXETINE",
    "en_drug_common_name": "ATOMOXETINE",
    "fr_drug_brand_name": "APO-ATOMOXETINE",
    "fr_drug_common_name": "ATOMOXETINE",
    "en_ingredients": "ATOMOXETINE",
    "fr_ingredients": "ATOMOXETINE",
    "drug_strength": "60MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155603,
    "drug": {
      "current_status": "MARKETED",
      "id": 9562,
      "drug_code": 63180,
      "updated_date": "2025-12-03T00:30:42-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8253707,
          "ingredient": {
            "id": 1486,
            "ingredient_code": 2115,
            "en_name": "VALPROIC ACID",
            "fr_name": "Acide valproïque (Valproate de sodium)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02239699",
      "brand_name": "APO-DIVALPROEX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0112996001"
    },
    "created_date": "2022-02-25T14:14:33-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02239699",
    "company_name": "APOTEX INC",
    "atc_number": "N03AG",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2022-03-25T00:00:00-04:00",
    "actual_start_date": "2022-02-22T00:00:00-05:00",
    "actual_end_date": "2022-03-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-03-24T13:18:25-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DIVALPROEX",
    "en_drug_common_name": "DIVALPROEX",
    "fr_drug_brand_name": "APO-DIVALPROEX",
    "fr_drug_common_name": "DIVALPROEX",
    "en_ingredients": "VALPROIC ACID",
    "fr_ingredients": "Acide valproïque",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)\r\nTABLET (ENTERIC-COATED)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)\r\nComprimé (entérosoluble)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155606,
    "drug": {
      "current_status": "MARKETED",
      "id": 11148,
      "drug_code": 67424,
      "updated_date": "2025-12-03T00:30:47-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254185,
          "ingredient": {
            "id": 318,
            "ingredient_code": 1201,
            "en_name": "PRAVASTATIN SODIUM",
            "fr_name": "Pravastatine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02243506",
      "brand_name": "APO-PRAVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122563001"
    },
    "created_date": "2022-02-25T14:17:50-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243506",
    "company_name": "APOTEX INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2022-03-25T00:00:00-04:00",
    "actual_start_date": "2022-02-22T00:00:00-05:00",
    "actual_end_date": "2022-03-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-03-25T12:28:14-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-PRAVASTATIN",
    "en_drug_common_name": "PRAVASTATIN",
    "fr_drug_brand_name": "APO-PRAVASTATIN",
    "fr_drug_common_name": "PRAVASTATIN",
    "en_ingredients": "PRAVASTATIN SODIUM",
    "fr_ingredients": "Pravastatine sodique",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155609,
    "drug": {
      "current_status": "MARKETED",
      "id": 11148,
      "drug_code": 67424,
      "updated_date": "2025-12-03T00:30:47-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254185,
          "ingredient": {
            "id": 318,
            "ingredient_code": 1201,
            "en_name": "PRAVASTATIN SODIUM",
            "fr_name": "Pravastatine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02243506",
      "brand_name": "APO-PRAVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122563001"
    },
    "created_date": "2022-02-25T14:25:31-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243506",
    "company_name": "APOTEX INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2022-03-31T00:00:00-04:00",
    "actual_start_date": "2022-02-22T00:00:00-05:00",
    "actual_end_date": "2022-03-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-03-28T12:46:13-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-PRAVASTATIN",
    "en_drug_common_name": "PRAVASTATIN",
    "fr_drug_brand_name": "APO-PRAVASTATIN",
    "fr_drug_common_name": "PRAVASTATIN",
    "en_ingredients": "PRAVASTATIN SODIUM",
    "fr_ingredients": "Pravastatine sodique",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155633,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 11386,
      "drug_code": 67903,
      "updated_date": "2025-05-15T04:03:24-04:00",
      "company": {
        "id": 264,
        "created_date": "2017-03-09T13:22:38-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 7259,
        "mfr_code": "JSO08",
        "name": "JANSSEN INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "19 GREEN BELT DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M3C 1L9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8334269,
          "ingredient": {
            "id": 1396,
            "ingredient_code": 10040,
            "en_name": "OXYBUTYNIN CHLORIDE",
            "fr_name": "Chlorure d'oxybutynine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02243960",
      "brand_name": "DITROPAN XL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0114692001"
    },
    "created_date": "2022-02-25T19:24:17-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02243960",
    "company_name": "JANSSEN INC",
    "atc_number": "G04BD",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "discontinuation_date": "2022-08-31T00:00:00-04:00",
    "anticipated_discontinuation_date": "2022-08-31T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2022-09-08T14:07:15-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "DITROPAN XL",
    "en_drug_common_name": "DITROPAN* XL 5mg Tablets 100's",
    "fr_drug_brand_name": "Ditropan XL",
    "fr_drug_common_name": "DITROPAN* XL 5mg Tablets 100's",
    "en_ingredients": "OXYBUTYNIN CHLORIDE",
    "fr_ingredients": "Chlorure d'oxybutynine",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155636,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 11388,
      "drug_code": 67904,
      "updated_date": "2025-05-15T04:03:24-04:00",
      "company": {
        "id": 264,
        "created_date": "2017-03-09T13:22:38-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 7259,
        "mfr_code": "JSO08",
        "name": "JANSSEN INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "19 GREEN BELT DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M3C 1L9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8334270,
          "ingredient": {
            "id": 1396,
            "ingredient_code": 10040,
            "en_name": "OXYBUTYNIN CHLORIDE",
            "fr_name": "Chlorure d'oxybutynine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02243961",
      "brand_name": "DITROPAN XL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0114692004"
    },
    "created_date": "2022-02-25T19:26:22-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02243961",
    "company_name": "JANSSEN INC",
    "atc_number": "G04BD",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "discontinuation_date": "2022-08-31T00:00:00-04:00",
    "anticipated_discontinuation_date": "2022-08-31T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2022-09-08T14:08:06-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "DITROPAN XL",
    "en_drug_common_name": "DITROPAN* XL 10mg Tablets 100's",
    "fr_drug_brand_name": "Ditropan XL",
    "fr_drug_common_name": "DITROPAN* XL 10mg Tablets 100's",
    "en_ingredients": "OXYBUTYNIN CHLORIDE",
    "fr_ingredients": "Chlorure d'oxybutynine",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155654,
    "drug": {
      "current_status": "MARKETED",
      "id": 62765,
      "drug_code": 92332,
      "updated_date": "2025-12-03T00:32:46-05:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8261058,
          "ingredient": {
            "id": 3022,
            "ingredient_code": 13123,
            "en_name": "ROSUVASTATIN",
            "fr_name": "Rosuvastatine (Rosuvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02438941",
      "brand_name": "ACH-ROSUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148963003"
    },
    "created_date": "2022-02-25T19:32:06-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02438941",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "actual_start_date": "2022-02-25T00:00:00-05:00",
    "actual_end_date": "2022-05-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-05-26T16:12:41-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACH-ROSUVASTATIN",
    "en_drug_common_name": "ROSUVASTATIN",
    "fr_drug_brand_name": "ACH-Rosuvastatin",
    "fr_drug_common_name": "ROSUVASTATIN",
    "en_ingredients": "ROSUVASTATIN",
    "fr_ingredients": "ROSUVASTATIN",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "90",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155660,
    "drug": {
      "current_status": "MARKETED",
      "id": 10176,
      "drug_code": 65047,
      "updated_date": "2025-05-15T02:31:08-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253856,
          "ingredient": {
            "id": 2760,
            "ingredient_code": 1281,
            "en_name": "MESNA",
            "fr_name": "Mesna"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": true
        }
      ],
      "din": "02241411",
      "brand_name": "UROMITEXAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0120705001"
    },
    "created_date": "2022-02-25T20:21:26-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02241411",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "V03AF",
    "atc_description": "ALL OTHER THERAPEUTIC PRODUCTS",
    "anticipated_start_date": "2022-02-25T00:00:00-05:00",
    "estimated_end_date": "2022-03-30T00:00:00-04:00",
    "actual_start_date": "2022-02-25T00:00:00-05:00",
    "actual_end_date": "2022-03-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-03-31T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "UROMITEXAN (mesna) Injection 400 mg/4 mL (100mg/mL). Box of 15 ampoules. Baxter code 2639B2019 can be used as a substitute.",
    "fr_comments": "UROMITEXAN (mesna) Injection 400 mg/4 mL (100 mg/mL). Boîte de 15 ampoules. Le code Baxter 2639B2019 peut être utilisé comme substitut.",
    "en_drug_brand_name": "UROMITEXAN",
    "en_drug_common_name": "Uromitexan",
    "fr_drug_brand_name": "UROMITEXAN",
    "fr_drug_common_name": "Uromitexan",
    "en_ingredients": "MESNA",
    "fr_ingredients": "Mesna",
    "drug_strength": "100MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "ORAL\r\nINTRAVENOUS\r\nORAL\r\nINTRAVENOUS",
    "drug_route_fr": "Orale\r\nIntraveineuse\r\nOrale\r\nIntraveineuse",
    "drug_package_quantity": "15 ampoules / box (Product Code: 2639B2010)",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155663,
    "drug": {
      "current_status": "MARKETED",
      "id": 10336,
      "drug_code": 65461,
      "updated_date": "2025-05-15T02:31:09-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253905,
          "ingredient": {
            "id": 2774,
            "ingredient_code": 5927,
            "en_name": "CYCLOPHOSPHAMIDE",
            "fr_name": "Cyclophosphamide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02241796",
      "brand_name": "PROCYTOX TAB 50MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107630001"
    },
    "created_date": "2022-02-25T20:24:42-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02241796",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "L01AA",
    "atc_description": "ALKYLATINGAGENTS",
    "anticipated_start_date": "2022-02-25T00:00:00-05:00",
    "estimated_end_date": "2022-04-13T00:00:00-04:00",
    "actual_start_date": "2022-02-25T00:00:00-05:00",
    "actual_end_date": "2022-04-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-04-14T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "PROCYTOX (Cyclophosphamide) 25mg oral tablets, bottle of 200 tabs baxter code 2638B3933 can be used as a substitute if aligned to clinical practice.",
    "fr_comments": "PROCYTOX (Cyclophosphamide) Comprimés oraux de 25 mg, bouteilles de 200 comprimés code baxter 2638B3933 peut être utilisé comme substitut s'il est conforme à la pratique clinique.",
    "en_drug_brand_name": "PROCYTOX TAB 50MG",
    "en_drug_common_name": "Cyclophosphamide",
    "fr_drug_brand_name": "PROCYTOX",
    "fr_drug_common_name": "Cyclophosphamide",
    "en_ingredients": "CYCLOPHOSPHAMIDE",
    "fr_ingredients": "Cyclophosphamide",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 Tablets / box (Product Code: 2638B1071)",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155672,
    "drug": {
      "current_status": "MARKETED",
      "id": 338,
      "drug_code": 10867,
      "updated_date": "2025-05-15T02:30:50-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251428,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "900",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251427,
          "ingredient": {
            "id": 10,
            "ingredient_code": 42,
            "en_name": "DEXTROSE",
            "fr_name": "Dextrose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251426,
          "ingredient": {
            "id": 44,
            "ingredient_code": 53,
            "en_name": "POTASSIUM CHLORIDE",
            "fr_name": "Chlorure de potassium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00786306",
      "brand_name": "POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "70988",
      "number_of_ais": "3",
      "ai_group_no": "0300097007"
    },
    "created_date": "2022-02-25T20:28:51-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00786306",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "B05BB",
    "atc_description": "I.V. SOLUTIONS",
    "anticipated_start_date": "2022-02-25T00:00:00-05:00",
    "estimated_end_date": "2022-03-25T00:00:00-04:00",
    "actual_start_date": "2022-02-25T00:00:00-05:00",
    "actual_end_date": "2022-03-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-03-26T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "We have identified four alternative Baxter codes for your consideration if aligned to clinical practice: JB1674, JB1434, JB1264, and JB1984",
    "fr_comments": "Nous avons identifié quatre codes Baxter alternatifs pour votre considération s'ils sont alignés sur la pratique clinique : JB1674, JB1434, JB1264 et JB1984",
    "en_drug_brand_name": "POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR",
    "en_drug_common_name": "Potassium Chloride in 5% Dextrose and 0.9% Sodium Chloride Injection USP",
    "fr_drug_brand_name": "Potassium Chloride in 5% Dextrose and 0.9% Sodium Chloride Injection USP",
    "fr_drug_common_name": "Potassium Chloride in 5% Dextrose and 0.9% Sodium Chloride Injection USP",
    "en_ingredients": "POTASSIUM CHLORIDE\r\nSODIUM CHLORIDE\r\nDEXTROSE",
    "fr_ingredients": "Chlorure de potassium\r\nChlorure de sodium\r\nDextrose",
    "drug_strength": "300MG\r\n900MG\r\n5G",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "14 bags / case (Product Code: 2B2454X)",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155675,
    "drug": {
      "current_status": "MARKETED",
      "id": 16392,
      "drug_code": 77188,
      "updated_date": "2025-12-03T00:31:10-05:00",
      "company": {
        "id": 32,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 7054,
        "mfr_code": "PFR08",
        "name": "PURDUE PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255844,
          "ingredient": {
            "id": 3208,
            "ingredient_code": 13904,
            "en_name": "TRAMADOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de tramadol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02286424",
      "brand_name": "ZYTRAM XL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151694002"
    },
    "created_date": "2022-02-25T20:29:55-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02286424",
    "company_name": "PURDUE PHARMA",
    "atc_number": "N02AX",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2022-02-25T00:00:00-05:00",
    "estimated_end_date": "2022-07-22T00:00:00-04:00",
    "actual_start_date": "2022-02-25T00:00:00-05:00",
    "actual_end_date": "2022-07-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-07-16T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Delay in component.\r\nDelay in shipping the finished good",
    "fr_comments": "Retard dans le composant.\r\nRetard dans l’expédition du produit fini.",
    "en_drug_brand_name": "ZYTRAM XL",
    "en_drug_common_name": "Tramadol Hydrochloride Controlled Release Tablets",
    "fr_drug_brand_name": "ZYTRAM XL",
    "fr_drug_common_name": "Comprimés de chlorhydrate de tramadol à libération contrôlée",
    "en_ingredients": "TRAMADOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de tramadol",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155678,
    "drug": {
      "current_status": "MARKETED",
      "id": 16394,
      "drug_code": 77189,
      "updated_date": "2025-12-03T00:31:10-05:00",
      "company": {
        "id": 32,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 7054,
        "mfr_code": "PFR08",
        "name": "PURDUE PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255845,
          "ingredient": {
            "id": 3208,
            "ingredient_code": 13904,
            "en_name": "TRAMADOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de tramadol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02286432",
      "brand_name": "ZYTRAM XL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151694003"
    },
    "created_date": "2022-02-25T20:33:38-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02286432",
    "company_name": "PURDUE PHARMA",
    "atc_number": "N02AX",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2022-02-25T00:00:00-05:00",
    "estimated_end_date": "2022-07-22T00:00:00-04:00",
    "actual_start_date": "2022-02-25T00:00:00-05:00",
    "actual_end_date": "2022-07-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-07-16T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Delay in component.\r\nDelay in shipping the finished good.",
    "fr_comments": "Retard dans le composant.\r\nRetard dans l’expédition du produit fini.",
    "en_drug_brand_name": "ZYTRAM XL",
    "en_drug_common_name": "Tramadol Hydrochloride Controlled Release Tablets",
    "fr_drug_brand_name": "ZYTRAM XL",
    "fr_drug_common_name": "chlorhydrate de méthylphénidate Capsules à libération contrôlée",
    "en_ingredients": "TRAMADOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de tramadol",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155681,
    "drug": {
      "current_status": "MARKETED",
      "id": 28598,
      "drug_code": 90702,
      "updated_date": "2025-05-15T02:34:15-04:00",
      "company": {
        "id": 16976,
        "created_date": "2020-10-02T23:51:29-04:00",
        "updated_date": "2025-12-03T00:30:15-05:00",
        "company_code": 17602,
        "mfr_code": "",
        "name": "HIKMA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "55 STANDISH COURT, SUITE 1050",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 0G3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260373,
          "ingredient": {
            "id": 1728,
            "ingredient_code": 8833,
            "en_name": "SUCCINYLCHOLINE CHLORIDE",
            "fr_name": "Chlorure de succinylcholine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02422336",
      "brand_name": "SUCCINYLCHOLINE CHLORIDE INJECTION USP",
      "brand_name_fr": "CHLORURE DE SUCCINYLCHOLINE INJECTABLE USP",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0105141001"
    },
    "created_date": "2022-02-25T21:22:03-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02422336",
    "company_name": "TELIP, LLC, A SUBSIDIARY OF TELIGENT, INC.",
    "atc_number": "M03AB",
    "atc_description": "MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",
    "estimated_end_date": "2022-04-08T00:00:00-04:00",
    "actual_start_date": "2022-02-25T00:00:00-05:00",
    "actual_end_date": "2022-04-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-04-27T20:12:01-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SUCCINYLCHOLINE CHLORIDE INJECTION USP",
    "en_drug_common_name": "SUCCINYLCHOLINE CHLORIDE INJECTION USP",
    "fr_drug_brand_name": "SUCCINYLCHOLINE CHLORIDE INJECTION USP",
    "fr_drug_common_name": "SUCCINYLCHOLINE CHLORIDE INJECTION USP",
    "en_ingredients": "SUCCINYLCHOLINE CHLORIDE",
    "fr_ingredients": "Chlorure de succinylcholine",
    "drug_strength": "20MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10 ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155735,
    "drug": {
      "current_status": "MARKETED",
      "id": 100000,
      "drug_code": 98169,
      "updated_date": "2020-04-03T06:54:17-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8264370,
          "ingredient": {
            "id": 74,
            "ingredient_code": 20280,
            "en_name": "HYDROMORPHONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'hydromorphone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02491680",
      "brand_name": "HYDROMORPHONE HYDROCHLORIDE INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108698001"
    },
    "created_date": "2022-02-28T21:17:15-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02491680",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2022-04-01T00:00:00-04:00",
    "estimated_end_date": "2022-06-20T00:00:00-04:00",
    "actual_start_date": "2022-04-01T00:00:00-04:00",
    "actual_end_date": "2022-06-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-06-17T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Supply interruption due to production delays.",
    "fr_comments": "Nous allons éprouver  interruptions d’approvisionnement en raison de retards de production.",
    "en_drug_brand_name": "HYDROMORPHONE HYDROCHLORIDE INJECTION, USP",
    "en_drug_common_name": "HYDROmorphone Hydrochloride Injection, USP 10mg/mL  SD Vial 1mL",
    "fr_drug_brand_name": "Chlorhydrate d’HYDROmorphone",
    "fr_drug_common_name": "Chlorhydrate dHYDROmorphone injectable, USP, 10 mg/mL  fioles DU de 1 mL",
    "en_ingredients": "HYDROMORPHONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'hydromorphone",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "10",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155738,
    "drug": {
      "id": 10848,
      "drug_code": 66736,
      "updated_date": "2025-12-03T00:30:46-05:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254095,
          "ingredient": {
            "id": 2690,
            "ingredient_code": 11188,
            "en_name": "MIDAZOLAM",
            "fr_name": "Midazolam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02242904",
      "brand_name": "MIDAZOLAM INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "MUTI-DOSE VIALS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0119935002"
    },
    "created_date": "2022-02-28T21:21:35-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242904",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "N05CD",
    "atc_description": "HYPNOTICS AND SEDATIVES",
    "anticipated_start_date": "2022-03-01T00:00:00-05:00",
    "estimated_end_date": "2022-03-18T00:00:00-04:00",
    "actual_start_date": "2022-03-01T00:00:00-05:00",
    "actual_end_date": "2022-03-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-03-19T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "We will be experiencing a supply interruption due to a delay in shipping of the drug.",
    "fr_comments": "Nous allons éprouver interruptions d’approvisionnement en raison de retards d’expédition.",
    "en_drug_brand_name": "MIDAZOLAM INJECTION",
    "en_drug_common_name": "Midazolam Injection 1mg/mL  MD Vial 2mL",
    "fr_drug_brand_name": "Midazolam injectable",
    "fr_drug_common_name": "Midazolam injectable, 1 mg/mL  fioles DM de 2 mL",
    "en_ingredients": "MIDAZOLAM",
    "fr_ingredients": "Midazolam",
    "drug_strength": "1MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "10",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 155743,
    "drug": {
      "current_status": "MARKETED",
      "id": 5852,
      "drug_code": 4010,
      "updated_date": "2025-05-15T02:30:30-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8250590,
          "ingredient": {
            "id": 684,
            "ingredient_code": 2011,
            "en_name": "MINOXIDIL",
            "fr_name": "Minoxidil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00514500",
      "brand_name": "LONITEN 10MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "56355",
      "number_of_ais": "1",
      "ai_group_no": "0114429003"
    },
    "created_date": "2022-02-28T21:49:58-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00514500",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "C02DC",
    "atc_description": "ARTERIOLARSMOOTH MUSCLE, AGENTS ACTING ON",
    "anticipated_start_date": "2022-05-27T00:00:00-04:00",
    "estimated_end_date": "2022-09-30T00:00:00-04:00",
    "actual_start_date": "2022-05-21T00:00:00-04:00",
    "actual_end_date": "2022-09-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-10-01T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "LONITEN 10MG",
    "en_drug_common_name": "LONITEN 10MG",
    "fr_drug_brand_name": "LONITEN 10MG",
    "fr_drug_common_name": "LONITEN 10MG",
    "en_ingredients": "MINOXIDIL",
    "fr_ingredients": "Minoxidil",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1x100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  }
]